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Letters:

Evidence-Based Medicine Through Biomedical Research

Jake Adelman, MSI

Mary Pasquale, MSI
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As members of the Fusion Editorial
Board, we have the privilege of sharing
our colleagues’ research accomplishments with the GW community. Te
COVID-19 pandemic has highlighted
the need for timely and efective communication of biomedical research to
inform the practice of evidence-based
medicine. Most of this efort has been
underscored by the surgance of preprint services and larger journals,
increasing the volume of knowledge
such that researchers can help bring
the pandemic to an end.
Despite students working through
COVID-19-related challenges, Fusion
is proud to share the largest edition to
date, with over 70 abstracts from students across all MD classes and across
several disciplines. As highlighted
by our cover, this year we noticed a
trend in pieces about neurology, psychology, and that several students took
advantage of molecular biology techniques to further characterize disease
pathologies.
Fusion is a student-run publication
that aims to showcase the research
achievements of medical students at
GW SMHS. Te 2022 edition of Fusion
includes abstracts from the basic
sciences, clinical and translational
research, public health, and medical
education. The top abstracts from

Fusion were awarded the William
Beaumont Research Award and their
authors will deliver oral presentations
at Medical Student Research Day on
April 28, 2022.
We gratefully acknowledge the
following individuals without whom
this edition of Fusion would not be
possible: David Leitenberg, MD, PhD,
associate professor of microbiology,
immunology, and tropical medicine
at the GW SMHS; medical director
of flow cytometry and immunology
at Children’s National Hospital; and
director of medical student research at
GW SMHS and Tom Kohout, director
of publications at GW SMHS. We would
also like to extend appreciation for
last year’s Fusion editors and current
Beaumont Medical Research Honor
Society Co-Presidents Alice Chen, MSII
and Isabel Park, MSII.
We are very proud of all of our
submissions this year and hope that
you enjoy this year’s edition of Fusion.
Fusion Co-Directors
Jake Adelman
Mary Pasquale
Fusion Editors
Anthara Gnanakumar
Esin Namoglu
Leyn Shakhtour
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Performance Despite the Pandemic
In refecting on the past year, I think it’s
fair to say that it has been another year
dominated by the COVID pandemic.
But I am optimistic that there is an end
in sight. Te huge increases in cases
related to the Omicron variant is clearly
subsiding, and we are all adjusting to a
new normal where COVID will become
another endemic disease, and less of
a public health emergency. Tere is a
lot to be proud of, in terms of how the
medical community has responded
to the COVID pandemic. The rapid
development of efective vaccines as
well as new anti-viral therapeutics has
been remarkable. Also, critical has
been the role of physician scientists
in communicating to the public about
the importance of vaccines and other
public health measures in limiting the
spread of infections. At the same time,
the COVID pandemic has also revealed
unexpected challenges in the way that
medical information is provided and
evaluated by a signifcant proportion
of the population. The widespread
availability of unreliable and/or distorted medical guidance has made
it more clear than ever that training
medical students to evaluate evidence
and become efective communicators
is a critical skill. Encouraging and fostering student participation in research
activities is an important mechanism to
provide these skills.

LETTERS

As seen in this issue of Fusion,
medical student research at the George
Washington University is thriving.
Despite the challenges and restrictions
to on-site access due to the COVID
pandemic, medical students submitted
a record number of abstracts for publication in Fusion. Te studies contained
in this issue demonstrate signifcant
breadth of research interest spanning
basic science research, clinical studies
in a wide variety of disciplines, as well
as public health and medical education
research.
Student participation in extracurricular research activity is also shown
by the record number of students
joining scholarly concentrations. 95%
of the class of 2025 joined a scholarly
concentration which provides support and structure to student research
participation. Tese eforts are clearly
productive, not only as shown by
abstracts in Fusion, but by record participation in Medical Student Research
Day (165 abstracts presented in 2021),
as well as scholarly output defned by
presentations at national meetings and
publications in peer-reviewed journals.
In the most recent graduation questionnaire that standardizes responses
of students to other medical schools
nationally, 74% of our students report
authorship on a manuscript compared
to 61% nationally.

David Leitenberg MD, PhD,
associate professor of microbiology,
immunology, and tropical medicine
at SMHS, and medical director of fow
cytometry and immunology at Children’s
National Hospital

Tese accomplishments would not
be possible without the active engagement of faculty mentors. The signifcant efort of faculty in mentoring
and training our students cannot be
overstated. On behalf of our students,
I thank you for your eforts!

David Leitenberg MD, PhD
associate professor of microbiology,
immunology, and tropical medicine
at SMHS, and medical director of
fow cytometry and immunology
at Children’s National Hospital
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A number of competitive scholarship programs are available to assist
in funding exceptional projects in
health care and medicine, including
diversity targeted fellowships,
including the Jean L. Fourcroy, MD,
Research Award; Health Services
Scholarships; the Lazarus Family
Scholarship Program; and the WT
Gill Fellowship, among others.

Alex Dobek (left) and Sarthak Shah (right) are members of the student-organized Orthopedic
Summer Medical Student Fellowship program that supports students interested in Orthopedic
Surgery. Several members of this group were accepted to present their research at the
American Academy of Orthopedic Surgery 2022 Annual Conference in Chicago.

NEIL ALMEIDA RECEIVES 2021 SPECK AWARD
Neil Almeida,
MD ’21, was
selected as the
2021 recipient
of the annual
Doris DeFord
Speck, BA ’41,
Neil Almeida, MSIV
and George
Speck, MD ’41,
Endowed Prize for outstanding
accomplishments in medical
student research.
Almeida, who is continuing his
medical education as a neurosurgical resident at the University of
Buffalo School of Medicine, is also a
Class of 2021 Alpha Omega Alpha
(AOA) honor society inductee,
a former William H. Beaumont
Research Award winner, and the
recipient of a competitive fellowship
from the American Brain Tumor
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Association and the AOA Carolyn
Kuckein student fellowship.
His record of research accomplishment throughout his years
at medical school includes 14
peer-reviewed manuscripts predominantly related to neurosurgery
and neuro-oncology while in
medical school, with fve frst-author
submissions.
Signifcantly, Almeida also has
played an important leadership role in medical student
research organizations at GW
by serving as co-president
of the Beaumont student
research organization and
was co-founder and president
of the GW student chapter
of the American Association of
Neurological Surgeons.

In 2021, 22 students were
awarded a Gill Summer Research
Fellowship and 54 students were
earned Health Services Scholarships,
both of which are internally funded
programs providing stipend support for medical student summer
research.
For a list of SMHS student
research funding opportunities,
timelines, and application tips visit
the website smhs.gwu.edu/research/
research-workforce/medical-studentresearch/medical-student-fundingopportunities.

METEOR PROGRAM
The Mentored Experience
to Expand Opportunities in
Research (METEOR) program
is a competitive fellowship
for underrepresented-inmedicine students. For more
information, visit the website
smhs.gwu.edu/academics/
md-program/admissions/
METEOR.
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INNAUGURAL AKMAN
INNOVATION AWARD

SMHS STUDENTS WIN NIH MEDICAL
RESEARCH SCHOLARS FELLOWSHIPS

Wyn Dobbs, a rising fourth-year
medical student at the George
Washington University (GW)
School of Medicine and Health
Sciences (SMHS), was selected
as the inaugural undergraduate
recipient of the Akman Innovation
Fund — created in honor of Jeffrey
S. Akman, MD ’81, RESD ’85, former
GW SMHS dean, and designed to
foster ideas, support mentorship,
and promote clinical innovation, Through his award, Dobbs
will delve into the exploration,
understanding, and treatment of
COVID-19.

The National Institutes of Health
(NIH) awarded fellowships to
Allison Distler, MD ’21, and Mario
Pita, MSII, as part of the Medical
Research Scholars Program.

His interest in COVID-19
began as a contact tracer for the
Mississippi Department of Health
before shifting to more clinical
work at GW SMHS. He served as a
research assistant on the Moderna
COVID-19 vaccine trial at GW
and as senior research assistant
and project manager of the GW
Medical Faculty Associates (MFA)
COVID-19 Recovery Clinic and
Biorepository.
While researchers are still
untangling the effects of post-acute
sequelae of COVID-19 (PASC), or
Long COVID, Dobbs, thanks to his
time at the clinic, has identifed a
potential relationship between the
disease and pre-existing asthma. As
part of the mentorship component
of the fund, Dobbs will work with
Adrienne Poon, MD, MPH, assistant
professor of medicine at GW SMHS.
With the Akman Innovation Fund,
he’s planning to use the clinic’s
unique data to pinpoint patients
with asthma and varying levels of
COVID severity to “observe any differences in pulmonary symptoms.

Just 50 students representing
35 U.S.-accredited universities were
selected for the
robust, mentored training
fellowship.
The yearlong research
immersion
program
fosters career
development
Allison
for students
Distler, MD ’21
interested in
becoming physician scientists.
Distler’s project was in
the National Cancer Institute’s
Lymphoid Malignancies Branch,
working with Mark Roschewski,
MD, senior clinician and clinical
cirector of the NCI’s Lymphoid
Malignancies Branch of the Center
for Cancer Research. Disltler
focused on the use of a next
generation sequencing assay to
detect tumor clonotypes in the
plasma of follicular lymphoma (FL)
patients at diagnosis and with serial
monitoring for detection of minimal

residual disease.
Pita worked in the Social
Determinants of Obesity and
Cardiovascular Risk Laboratory
within the National Heart, Lung,
and Blood Institute (NHLBI). Under
the mentorship of Tiffany PowellWiley, MD, MPH, Stadtman TenureTrack Investigator with the NHLBI,
Pita’s project focused on the
effects of neighborhood deprivation and catecholamines
on the migration
of infammatory
monocytes
towards arterial
plaques.
“The future
of medicine
hinges upon
developing
Mario Pita, MSII clinician-scientists
who will make
and translate discoveries at the
bench, achieve success against
rare and refractory diseases, and
address disparities in health and
medicine,” said Thomas R. Burklow,
M.D., director of the MRSP. “[The
program] offers a transformational
training experience that will promote students to become leaders
in American medicine.”

WALTER FREEMAN
RESEARCH WINNER
The Freeman Award is given to the graduating senior who submits the
best scientifc paper based on original research. For 2021, this award was
split and given to two equally deserving students: Aslam Akhtar for his
manuscript titled “Inducible Expression of GDNF in Transplanted iPSCDerived Neural Progenitor Cells” published in Stem Cell Reports; and
Kendrah Osei for the manuscript; “Abbreviated Breast MRI for Screening
High-Risk Women: Comparison with the Full Clinical Protocol”, published
in the Journal of Breast Imaging.

To learn more, please contact the Office of Student Professional Enrichment smhs.gwu.edu/ospe.
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Basic Science:

Effect of Mesenchymal Stromal Cell Delivery Through
Cardiopulmonary Bypass in a Piglet Model
Alice Chen,
MSII
ADVISORS:
Kei Kobayashi,
MD1,2, Nobuyuki
Ishibashi, MD1,2,3
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Congenital heart disease (CHD), a
structural abnormality of the heart or
great vessels at birth, afects approximately 1% of live births worldwide each
year. Research shows that increased
severity of CHD is associated with
increased frequency of neurological
defcits, suggesting a direct correlation
between the functioning of the heart
and brain, resulting in an increased
incidence of structural abnormalities
of the brain in children with structural cardiac abnormalities. Young
children with more complex CHDs
who require cardiac surgery, including
cardiopulmonary bypass (CPB), have
a significantly higher incidence of
developmental abnormalities and neurological defcits, including academic
difculties, behavioral abnormalities,
motor delays, etc.1
Microglia, the resident immune
cells in the central nervous system,
play a key role in neural immune
function. In a previous study, CPB and
circulatory arrest increased microglia
number three days after surgery.
Microglia expansion was prolonged
for up to four weeks. 2 Mesenchymal
stromal cells (MSCs) are multipotent,
non-hematopoietic cells that possess
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FIGURE 1: The number of branch points in microglia in three regions of the cortex.
Data values are expressed as mean ± SEM. P-values were evaluated by two-way ANOVA
with Tukey comparison (n=6, 4, 4,).
immunomodulatory and regenerative properties and regulate microglia
activation. It is hypothesized that intraarterial MSC delivery through CPB in a
survival porcine model is neuroprotective by modulating systemic and brainspecifc infammatory responses.3
To mimic the efects in young CHD
patients, two-week old female piglets
were randomly assigned to one of
three treatment groups: control, CPB,
and CPB+MSC. Te CPB+MSC group
consisted of a CPB surgery, followed by
administration of MSC before weaning.
Microglia undergo morphological
changes from a naïve, ramifed shape
to an amoeboid shape under activated
condition. To analyze the effects of
MSCs on microglia activation, changes
in the length of microglial processes
and number of branch points from the
nuclei were assessed.
Four weeks post-surgery, analysis
using Imaris software showed that
CPB reduced both the length of processes and number of branch points
compared to control in three diferent

cortex regions. CPB+MSC revealed signifcantly longer processes (p=0.0281)
and more branch points (p=0.0232)
than CPB alone, indicating that morphological changes in microglia were
normalized afer MSC delivery.
Bone-marrow derived MSCs regulate microglial activation and participate in the phenotypic switch
from a pro-inf lammatory state to a
repair-permissive state.4 In contrast
to their ramifed morphology under
normal conditions, activated microglia
undergo structural remodeling and
adopt an amoeboid morphology with
highly retracted processes, a hallmark
of brain inflammation, as shown in
the CPB group. Microglia routinely
migrate toward and cluster around
sites of neuronal degeneration induced
by excitotoxic injury.4 In MSC-treated
animals, there are signifcantly fewer
amoeboid microglia, with an associated
increase in the length in processes and
number of branch points to mitigate
Continued on p. 9
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Treatmen, p- 0.029 ; !Region,P - 0.41J7

the efects of CPB, indicating attenuated activation of the microglia. MSC
delivery during CPB is highly efective and shows translational potential
to minimize CPB-induced systemic
infammation and microglial activation in children with CHD.5 In future
studies, repeated cell administration
as well as diferent dosages of MSCs
should be tested to further optimize
MSC treatment for CHD patients.
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Patients on antiretroviral therapy
(ART) must maintain consistent
therapy in order to avoid rebound from
the latent viral reservoir. More studies
are needed to explore the role viral
diversity plays in the potential efcacy
of treatment with broadly neutralizing
antibodies (bNAbs). To do so, we have
characterized HIV-1 genetic diversity
in individuals with varying lengths
of infection, as well as the sensitivity
of their inducible virus reservoir to
bNAbs.
Peripheral blood mononuclear cells
were collected from 8 well-characterized HIV-1+ males on ART with varied
lengths of active infection. Resting CD4
T cells were plated at multiple dilutions
in replicate and maximally stimulated
to induce latent viruses to grow in the
supernatants. Cultures were screened
for the presence of virus antigen and
those that were positive were collected
for analysis. 3-5 viral supernatants of
virus outgrowth were obtained from
each individual. In order to genetically
define each person’s viral reservoir,
the HIV-1 envelope gene (env) was
amplifed and sequenced from these
reservoir-derived outgrowth viruses
by single genome amplifcation (SGS).
At least three sequences were obtained
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FIGURE: Maximum likelihood trees for each participant’s sequencing. Trees are rooted
at midpoint for visualization. Each dot represents a single sequence and is colored based
on the well from which it originated. Bootstraps over 90% are indicated. Trees revealed
80% of wells harbored a single virus. Despite utilizing a very small sample size in the
analysis, we observed a clear trend toward diversity in individuals with short active
infections.
from each well’s supernatant. All
sequences from an individual were
aligned and used to generate a neighborhood-joining tree. If a single virus
outgrowth was confrmed phylogenetically in the well, these sequences were
then used to generate a well consensus
sequence. Consensus sequences were
generated and aligned to produce a
maximum-likelihood tree displaying
all sequences in this study. Wells

containing single viruses were then
titered and measured for sensitivity to
bNAbs in the standard HIV-1 TZM-bl
neutralization assay.
Neighbor-joining trees for each
participants’ sequencing revealed
80% of wells harbored a single virus.
Analyzing consensus sequences from
Continued on p. 11
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single virus wells, we observed a wide
range of genetic diversity within each
individual as measured by average
pairwise distance. For individuals with
higher levels of viral diversity, no wells
had identical viruses and branched
separately; however, low-diversity

BASIC SCIENCE

individuals harbored essentially 1-2
diferent viruses. Despite utilizing a
very small sample size in the analysis,
we observed a clear trend toward lower
diversity in individuals with short
active infections. We observed that
greater diversity is associated with
increased resistance to bNAbs. Overall,
our data suggests that average pairwise

distance (APD) of HIV-1 env increases
with infection length and is associated
with greater resistance to bNAbs; however, individuals who start ART early
in infection and develop limited virus
variation are more likely to be sensitive
to bNAb treatment.
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*Disclaimer: Masks are essential to
lowering the risk of acquiring airborne
diseases and exposure to pollution such
as wildfres. This project was not created
to justify not wearing a mask but to look
at the possibility of respirable particles
coming from masks.
Face masks have become ubiquitous
and a critical protection in daily life for
users due to the COVID-19 pandemic
as well as to California wildfres. Due to
the increased demand and supply shortages, the Centers for Disease Control
and Prevention recommends the reuse
of approved particulate fltering facepiece respirators or the alternative use of
other personal protective face coverings
such as surgical masks or fabric masks.
Tese medical face masks, excluding
fabric masks, are usually made from
three polypropylene layers. This is a
petroleum-based plastic and creates
concern for the risk of inhalation of
microplastics, risk of long-term usage,
as well as environmental contamination.1 Some studies have shown masks
can release fber debris, in particular,
respirable microplastics and have
concluded there can be a microplastic
inhalation risk when reusing masks.2
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FIGURE: A. (top panel) SEM image containing particles from a mechanically aged N95
mask with a scale bar of 10 μm. B. (bottom panel) SEM image of a particle from a new
fabric mask with a scale bar of 10 μm.
Te objective of this project was to
identify the potential respirable particles from new and aged masks (N95,
surgical, and fabric).
Sonication w it h deionized
water pref iltered through 0.4μm

polycarbonate membrane flters was
used to maximize the release of debris
particles from new and aged masks.
Aged masks were created through
Continued on p. 13
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metronomically-timed mechanical
rubbing at 120 beats per minute. Each
mask was individually sonicated with
released particle collected on a 0.8μm
polycarbonate membrane filter for
scanning electron microscopy (SEM)
analysis. A 0.8 μm aluminum sputter
coated polycarbonate membrane flter
was also used for Raman spectroscopy
analysis. Particle collection was done
for new and aged N95s, surgical masks,
and fabric masks along with controls
of deionized water preparations. SEM
images of non-overlapping felds were
acquired for each sample and were used
to classify 100 randomized particles
within each field based on size and
structure. Te particle size classes by
diameter were ≤2.5 μm which were
considered as respirable, 2.5-10 μm
which was considered as inhalable,
and ≥10 μm and structure classes were
described as fbrous versus non-fbrous.
To be considered fbrous, particles had
a length-to-width ratio ≥3:1. For determination of elemental composition,
some particles were also analyzed using
energy-dispersive X-ray. Masks were
used for Raman Spectroscopy to create
plastic reference spectrums which were
matched to samples collected from
sonication and fltered through the aluminum sputter-coated polycarbonate
membrane flters.
These results demonstrate the
possibility of inhalable and respirable
particles coming from all three types
of face masks. N95 masks released

TABLES 1–3: Tables display the results of the particle count and classifcation.
All three types of masks for both new and used, over 95% of particles release from
sonication were inhalable, over 85% of particles were respirable, and greater than 70%
were non-fbrous. For the new mask group, N95 masks had the greatest proportion of
respirable particles released, followed by surgical masks, then fabric masks. For the
aged mask group, N95 masks demonstrated the release of the greatest proportion of
respirable particles, followed by fabric masks, and then surgical masks. Fabric masks
released the greatest proportion of fbers within the new masks group and aged group;
however, N95 FFR released the greatest proportion of respirable fbers within both mask
groups.
Table1. Particlecountsb1 size.The bottomtwo rowssummarizethe oarticlesbv resoirablevs inhalable.
New
N95
Surgical Fabric
Aged
N95
Surgical Fabric
Masks
Masks
<2.5µm
<2.5µm
94.3
92.0
85.0
93.7
88.7
90.3
2.5-10µm 5.3
5.3
11.3
2.5-10µm 5.7
8.7
9.7
>10µm
>10µm
0.3
2.7
3.7
0.7
2.7
0.0
respirable 94.3
inhalable 99.7

85.0
96.3

respirable 93.7
inhalable 99.3

88.7
97.3

90.3
100.0

Surgical

Fabric

Surgical

Fabric

95.7
4.3

78.3
21.7

Aged
N95
Masks
Non-fibrous 95.0

87.0
13.0

71.3
28.7

92.0
97.3

Table 2 Part1c
• Ie countsbv morp1
hoom.
I
New
N95
Masks
Non-fibrous 86.0

Fibrous

14.0

Fibrous

5.0

I I ted WI·th fib
Table 3 Percenaae o resoirable vs •1nhaIable fib
I ers. Cacua
1 ers on
New
N95
Surgical Fabric
Aged
N95
Surgical
Masks
Masks
Respirable 95.2%
84.6%
80.0%
respirable 93.3%
87.2%
fiber%
fiber%
lnhalable 100.0%
100.0%
83.1%
lnhalable 100.0%
100.0%
fiber%
fiber%

the greatest proportion of respirable
particles and fabric masks released the
greatest proportion of inhalable particles. Respirable particles were both
fbrous and non-fbrous with aerodynamic characteristics to enter the deep
lungs and long-term retention in the
lungs. However, these particles were
released by sonication and thus, the
collection process may not replicate the
actual breathing patterns of humans
to demonstrate the actual numbers of

CLINICAL TRANSLATIONAL RESEARCH | ANESTHESIOLOGY

Fabric

88.4%
100.0%

particles released from a mask during
respiration.
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INTRODUCTION: About half of the
adults in the U.S. consume alcohol
regularly, with 10% of this population
reporting excessive alcohol usage.1
Roughly three percent of this cohort
have reported experiencing alcohol
withdrawal symptoms. 2 Symptoms
are complex and can ofen vary from
person to person. However, the timeline in which the symptoms occur is
well characterized. In the frst 6–12
hours after the last drink, patients
may present with nausea, dizziness,
anxiety, and tremors. Afer 12 hours,
patients begin to experience psychosis
in the form of auditory and/or visual
hallucinations. By 24–48 hours, these
symptoms may be complicated by
severe shaking and mild seizures. Afer
48 hours, patients may experience the
most feared complication of alcohol
withdrawal: delirium tremens.3 With
this condition, elevated heart rate,
increased temperature, seizures, hypertension, severe psychosis can greatly
increase mortality associated with
alcohol withdrawal syndrome (AWS).
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The first-line treatment of AWS
includes benzodiazepines such as
lorazepam, diazepam, and chlordiazepoxide. A more recent addition for
AWS treatment is dexmedetomidine,
an alpha-2 agonist shown to improve
ref rac tor y del i r iu m t remens by
decreasing the length of active alcohol
withdrawal symptoms.4 When used
for sedation of non-intubated patients
during the treatment of alcohol withdrawal, dexmedetomidine may reduce
symptom severity while preventing
respiratory depression. Te addition
of dexmedetomidine to a Clinical
Institute Withdrawal Assessment
(CIWA) based benzodiazepine treatment strategy, the standard treatment
modality for alcohol withdrawal, may

scores greater than 7 between January
2019 and March 2020 were included.
We collected demographic and clinical
data including CIWA score, benzodiazepine usage, dexmedetomidine usage,
and intubation. Te primary outcome
measure was intubation. Odds ratio
(OR) was determined for intubation
events based on exposure to dexmedetomidine and benzodiazepine usage.
RESULTS: A total of 68 charts
were analyzed. The mean patient
age was 51, 54 patients were men. 44
patients received standard CIWAbased benzodiazepine therapy without
dexmedetomidine, of these 24 (54.5%)
were intubated during hospitalization.
Twenty-four patients received dexmedetomidine in addition to standard

The addition of dexmedetomidine to a Clinical Institute Withdrawal
Assessment (CIWA) based benzodiazepine treatment strategy, the
standard treatment modality for alcohol withdrawal, may reduce
benzodiazepine usage and ultimately the need for intubation.
reduce benzodiazepine usage and
ultimately the need for intubation.
We sought to determine whether the
addition of dexmedetomidine to a
CIWA-based benzodiazepine protocol
reduced the risk of intubation for
patients admitted to our intensive care
units with severe alcohol withdrawal.
METHODS: A single center, retrospective cohort study at our urban,
academic medical center compared
patients receiving dexmedetomidine in
addition to the standard CIWA-based
benzodiazepine protocol to standard
therapy alone. Patients with CIWA

therapy; seven of these patients (29.1%)
were intubated, with OR = 0.34 [95%
CI: 0.12-0.99; p=0.048]. The mean
CIWA score was 14.9 for the standard
therapy group and 17.4 for the group
receiving dexmedetomidine (p=0.21).
Te mean dose of IV lorazepam given
in the 12 hours prior to intubation were
0.9 mg for the standard therapy group
and 1.8 mg for the dexmedetomidine
group (p=0.65).
CONCLUSIONS: In this series of
patients with severe alcohol withdrawal
Continued on p. 15
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syndrome, the addition of dexmedetomidine to CIWA-based benzodiazepine
therapy correlates with a signifcantly
lower frequency of intubation. No signifcant benzodiazepine-limiting efect
was demonstrated. Future prospective
analysis is necessary to explore the
relationship of these observations.
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Mask ventilation (MV) is one of the
key steps in airway management as it
is essential for reducing the incidence
of hypoxia and hypercarbia during
periods of apnea during intubation.
Although patient factors such as age,
BMI, lack of teeth, presence of a beard,
and history of a sleep breathing disorder can increase suspicion for a diffcult MV, at present there is no single
test that can defnitively predict the
difculty of MV. Te measurement of
the lateral parapharyngeal wall thickness (LPWT) has been shown to correlate with severity of obstructive sleep
apnea (OSA), which is a known risk
factor for difcult MV.1 Tis is likely
due to a narrower and more collapsible
lateral airway in patients with sleepdisordered breathing. Given that OSA
is presumed to be a clinical indicator
of difculty in MV, and that the size of
the LPW is indicative of presence and
Continued on p. 17
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FIGURE: Ultrasonographic measurement of LPWT. A. Scanning position to obtain
LPWT measurement. With the patient supine, a high-frequency curvilinear probe was
placed on the lateral neck in the longitudinal plane. B. Identifcation of the ICA was
assisted with color Doppler imaging,and the lateral wall of the pharynx was visible as a
hyperechoic interface (arrows). Distance was measured from the internal border of the
ICA to the LPWT.
Abbreviations: ICA = internal carotid artery; LPWT = lateral pharyngeal wall thickness
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severity of OSA, we hypothesized that
the LPW can help predict the difculty
of MV in routine airway management
of elective surgical patients. Te primary aim of this study was to assess
the efcacy of point-of-care ultrasound
(POCUS) to measure the LPWT in the
preoperative setting to help predict diffculty of MV.
Eighty-eight adult patients who
were scheduled for elective surgery
requiring general anesthesia were
enrolled in the study. In the preoperative arena, the patient was placed in the
supine position, and a curvilinear US
transducer was placed in the coronal
orientation on the lateral neck below
the mastoid process (Figure 1). The
LPWT was measured as the distance
between the inferior border of the
internal carotid artery (ICA) and the
lateral wall of the pharynx, as described
by Chen et al.2 Standard preoperative
measurements including body mass
index (BMI), neck circumference, and
Mallampati score were also recorded.
Following intubation, difculty of MV
was assessed by the attending anesthesiologist and graded according to a
standardized MV scale developed by
Han et al, in which a score of 1 corresponds to an easy MV and a score of 4 is
assigned when the provider is unable to
MV.3 Te subjective difculty was also
assessed and recorded.
A total of 88 patients were enrolled.
Measurements of the LPWT ranged

TABLE: TP-valies for Correlation of Measurements
Mask Ventilation Score

Subjective Difficulties

*0.003

BM!
LPWT

0.183
0.635

Mask ventilation score

*0.003

Subjective difficulties

0.183

* indicates statistical significance <0.05 using Kendall's tau
Abbreviations: BMI

= body mass index;

LPWT = lateral parapharyngeal wall thickness

from 1.52 to 4.43 centimeters. 71% of
patients were easy MV (MV score= 1),
18% required oral airway (MV score=
2), 10% required two providers (MV
score= 3), and one patient was unable
to be mask ventilated (MV score= 4).
There was a statistically significant
correlation between LPWT and MV
score (P = 0.004) (Table 1). Ordinal
logistic regression analysis revealed
that every 1 cm increase of LPWT was
associated with a 3.17 odds of increase
in MV score. Tere was also a statistically signifcant correlation between
BMI and MV score (P = 0.003) as well
as between subjective difculty of MV
and standardized MV score (P = 0.008)
(Table 1). There was no correlation
between LPWT and BMI (P = 0.459) or
between LPWT and Mallampati score
(P = 0.381).
In addition to confirming that
standard preoperative measurements
such as BMI are useful in predicting diffcult MV, our study also suggests that

CLINICAL TRANSLATIONAL RESEARCH | ANESTHESIOLOGY

POCUS measurement of the LPWT is
predictive of difcult MV prior to intubation and can be utilized for airway
management planning.
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Lung cancer is the most common
cause of cancer-related death globally. As a preventive measure, the
United States Preventive Services Task
Force (USPSTF) recommends annual
screening of high risk individuals with
low-dose computed tomography (CT).
Te resulting volume of CT scans from
millions of people will pose a signifcant
challenge for radiologists to interpret.
To fll this gap, computer-aided detection (CAD) algorithms may prove to
be the most promising solution. A
crucial frst step in the analysis of lung
cancer screening results using CAD is
the detection of pulmonary nodules,
which may represent early-stage lung
cancer. Te objective of this work is to
develop and validate a reinforcement
learning model based on deep artifcial
neural networks for early detection of
lung nodules in thoracic CT images.
Inspired by the AlphaGo system, our
deep learning algorithm takes a raw CT
image as input and views it as a collection of states, and outputs a classifcation of whether a nodule is present or
not. Te dataset used to train our model
is the LIDC/IDRI database hosted by the
lung nodule analysis (LUNA) challenge.
In total, there are 888 CT scans with
annotations based on agreement from at
least three out of four radiologists. As a
result, there are 590 individuals having
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FIGURE 1: Visual illustration of a sample nodule and non-nodule structure in the
lung nodule analysis dataset. Frame (A) is a nodule. Frames (B–D) are non-nodules.
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FIGURE 2: A diagram of a reinforcement model. An agent in a given state (s)
and reward (r) completes an action in the environment. This results in a change of
environment and either an increase/decrease in reward as a result of that action.

one or more nodules, and 298 having
none. Our training results yielded an
overall accuracy of 99.1% [sensitivity
99.2%, specifcity 99.1%, positive predictive value (PPV) 99.1%, negative predictive value (NPV) 99.2%]. In our test,
the results yielded an overall accuracy

of 64.4% (sensitivity 58.9%, specifcity
55.3%, PPV 54.2%, and NPV 60.0%).
These early results show promise in
solving the major issue of false positives
in CT screening of lung nodules, and
may help to save unnecessary follow-up
tests and expenditures.
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The majority of pituitary adenomas
(PA) in the elderly (≥ 65 years old) are
nonfunctional and treated with surgical
intervention when symptomatic. Tis
study involving a large multicenter
national registry examined treatment
trends and surgical outcomes in this
population compared to nonelderly
patients (<65 years old)
Our study queried the National
Cancer Database (NCDB) for adult
patients ≥ 18 years old who were diagnosed with pituitary adenoma from
2004 to 2016. Univariate and multivariate logistic regression was used to
evaluate the prognostic impact of age
and other covariates on 30/90-day postsurgical mortality (30M/90M), length
of inpatient stay ≥ 5 days (LOS), and
extent of resection (EOR). A systematic
literature review was performed to
compare these real-world outcomes to
previous series.
The 96,399 cases met inclusion
criteria, of which 25, 464 elderly PA
patients were identifed. 27.0% of total
cases were microadenomas and 73.0%
were macroadenomas. 53.3% of elderly
PA patients were treated with surgery,
1.9% underwent up-front radiotherapy,
and 44.9% were observed without treatment. Elderly patients had increased
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FIGURE 1: Patient Age by Post-Surgical Outcomes Stratifed by CharlsonDeyo Comorbidity Score. 1A: 30 Day Mortality; 1B: 90 Day Mortality; 1C:
Length of Stay ≥ 5 Days; 1D: Gross Total Resection. Outcomes generally
worsen with increasing patient age, which persists in subgroups based on
comorbidity status.

TABLE 1: Multivariate Analysis of Surgically Treated Elderly Pituitary Patients
(n=12,365)
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The OR values are calculated with multivariate logistic regression.
** Indicates statistical signifcance.
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rates of 30M: 1.4% vs 0.6%, 90M: 2.8%
vs 0.9%, prolonged LOS: 26.1% vs
23.0%, and subtotal resection: 27.2%
vs 24.5% (all p≤001) compared to nonelderly PA patients (Figure 1-D). On
multivariate analysis, age, tumor size,
and Charlson-Deyo comorbidity score
(CD score) were independently associated with worse post-surgical mortality
(Table 1). High volume facilities (HVF)
had significantly better outcomes
compared to low-volume facilities
(LVF): 30M (0.9% vs 1.8%, p<0.001),
90M (2.0% vs 3.5%, p<0.001), and LOS
(21.8% vs 30.0%, p<0.001), but no statistical diference in gross total resection (73.7% vs 71.8%, p=0.083). With
increased patient age, the mortality
diference between HVF and LVF was
greater. A systematic literature review
comprised of 22 studies demonstrated
an elderly PA mortality rate of 0.7%,
which is dramatically lower than real
world NCDB outcomes and speaks to
substantial selection bias in previously
published literature.
In conclusion, our fndings confrm
that elderly patients with PA are at
higher risk of mortality when compared
to their younger counterparts. Surgical
risk in this age group may have been
previously underreported in the literature, and surgical resection at HVF may
allow for improved outcomes.
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EES = Endoscopic Endonasal Surgery; GTR = Gross Total Resection; HSPA = Hormone
Secreting Pituitary Adenoma; LOS = Length of Stay; MTS = Microscopic Transsphenoidal Surgery; NFPA = Nonfunctioning Pituitary Adenoma; TC = Transcranial; TS-NOS =
Transsphenoidal Surgery—Not Otherwise Specifed.
*Represents a median value.
‡ Extracted here is data on the subset of pituitary adenoma patients from a larger series
on intracranial tumors in the elderly.
§ Extent of resection defned as “Radical tumor removal”.
¶ Extent of resection defned as combined GTR or near total resection (90-100%
resection).
#These values are combined with younger PA cohort.
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Percutaneous Cryoablation on an Insulinoma in a
Patient with Symptomatic Hypoglycemia Refractory to
Bland Microsphere Embolization
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MSII
ADVISORS: Nevil
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Medicine Department of Radiology

FIGURE: 1 A. Axial and B. sagittal contrast enhanced CT images demonstrating an
enhancing mass within the ventral body of the pancreas (white arrow).

We present a 62-year-old male with
hepatitis C cirrhosis, portal hypertension and inoperable cholangiocarcinoma undergoing chemotherapy, who
was found to have a 1.6 cm enhancing
exophytic pancreatic body mass on a
computed tomography (CT) done for
staging of his cholangiocarcinoma
(Fig. 1). Four months afer diagnosis of
the pancreatic mass, the patient developed symptoms of intractable fasting
hypoglycemia requiring three admissions within one month to outside
institutions for dextrose infusions. Te
patient reported no history of diabetes
or hypercalcemia and no family history
of parathyroid, pituitary, or pancreatic
disease. He was initially treated conservatively with diazoxide and achieved
euglycemia. However, two months
afer starting diazoxide, he developed
palpitations, requiring its cessation. His
hypoglycemia returned and within two
weeks he presented to our institution
with a fasting glucose level of 14 mg/
dL. A 10% dextrose (D10) intravenous
infusion was initiated and surgical
consultation was obtained, given the
intractable nature of the symptomatic
hypoglycemia. Surgical intervention
was determined high-risk considering

the patient’s underlying cirrhosis and
portal hypertension. Te patient was
referred to interventional radiology
and was initially felt that the patient
could potentially beneft from bland
embolization as previously described.1
Selective bland embolization was
performed using 70-150 µm LC Bead
LUMI radiopaque microspheres via
microcatheter (Fig. 2A). Immediate
post-embolization noncontrast CT
demonstrated contrast staining of the
pancreatic mass compatible with successful LC Bead LUMI microsphere
embolization (Fig. 2B). However, the
patient’s severe hypoglycemia did
not improve, requiring continued
hospitalization and D10 infusion.
Two days post-embolization, it was
decided to attempt cryoablation of
the insulinoma using CT-guidance.
The patient underwent CT-guided
placement of two cryoprobes. The
freezing protocol consisted of 2 cycles
of a 10-minute freeze and 8-minute
active thaw. Periodic CT imaging was
performed during the procedure to
monitor in real-time the “ice ball” that
was formed, which completely covered
of the targeted mass, including a 5 mm
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margin of normal pancreas (Fig. 3).
Afer fnishing 2 freeze/thaw cycles, the
probes were removed. Within 3 hours
of completing the cryoablation, the
D10 infusion was tapered and serum
glucose levels returned to normal. Te
patient was discharged post-operative
day 2. Te patient remains stable clinically 18 months post-cryoablation, with
no further hypoglycemic events. Te
patient underwent CT scans at 2, 6, 12,
and 18 months, all demonstrating lack
of enhancement within the pancreatic
mass. Te patient continues to undergo
systemic treatment for his inoperable
cholangiocarcinoma.
Cryoablation has been used as a
palliative treatment modality for locally
advanced pancreatic cancer but has not
been previously described in the treatment of a pancreatic insulinoma.2,3
Aside from potential thermal injury
to the pancreatic parenchyma leading
to acute pancreatitis, additional anatomic considerations are necessary to
consider, including the risk of injury to
the pancreatic duct, common bile duct,
duodenum, and adjacent vasculature.
Continued on p. 22
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As the developing ice ball is well visualized on CT during cryoablation, the
zone of ablation can be more precisely
monitored in comparison to hyperthermic ablation techniques, such as
radiofrequency ablation (RFA) and
microwave ablation (MWA). In this
patient, cryoablation was utilized, as
the insulinoma was localized near the
splenic vein, inferior mesenteric vein,
and duodenum, necessitating precise
control of the ablation zone. RFA or
MWA would have posed increased
risk of thermal injury. To our knowledge, the use of cryoablation to treat
symptomatic hypoglycemia from a
pancreatic insulinoma has not been
previously described.

REFERENCES
1. O’Donohoe RL, Patel S, Bryant TJ, et al.
Transarterial embolization for mitigation
of severe hypoglycemia in 2 patients with
primary pancreatic insulinoma. J Vasc
Interv Radiol 2019;30:476-479.
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of primary and metastatic pancreatic cancer.
World J Gastroenterol. 2021;27:4322-4341.

FIGURE 2: A. Digital subtraction angiography via a microcatheter within the anterior
pancreaticoduodenal artery demonstrating a hypervascular mass within the pancreas
(black arrow). B. A noncontrast CT performed post-embolization demonstrating
radiopaque beads within the insulinoma (white arrow). C. Axial noncontrast CT image
demonstrating the pancreatic mass (black arrow) with a cryoprobe along its medial
border. D. Axial CT fuoroscopy image demonstrating an ice ball within the targeted
insulinoma (white arrow) with cryoprobe medially.

3. Linecker M, Pfammatter T, Kambakamba
P, DeOliveira ML. Albation strategies for
locally advanced pancreatic cancer. Dig
Surg. 2016;33:351-359.
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Clinical Outcomes of Non-Hodgkin Lymphoma Patients on
Acalabrutinib Including Off-Label Utilization
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Acalabrutinib (acala), a Bruton’s
Tyrosine Kinase inhibitor (BTKi),
received accelerated FDA approval for
treatment of mantle cell lymphoma
(MCL) in 2017. Since approval, there
has been limited “real world” data,
especially in the setting of of-label utilization. We performed a retrospective
analysis of all patients (pts) who had
received acala for NHL at the University
of Pennsylvania for on- and of-label
indications. We examined the safety
and efcacy of acala; response assessments were determined by treating
physician using standard, diseasespecifc criteria. Survival analyses were
completed as described by Kaplan and
Meier.
We identifed 23 pts treated with
acala (83% males [n=19]). Te majority
(65%) of pts received acala 100 mg
twice daily, with the rest receiving 100
mg once daily. Diagnoses were chronic
lymphocytic leukemia (CLL) (n=10;
44%), MCL (n=9; 39%), and diffuse
large B-cell lymphoma (DLBCL) (n=4;
17%). One DLBCL was GCB subtype
and three were ABC subtype; two of
four DLBCL pts were transformed from

I
0.8

0.6

0.4

0.2

0.0
0

10

lS

20

Months

Overall Survival
1.0 ____

1

__

0.8

0.6

0.4

0.2

0.0 '------------------------------------'
0

10

lS

20

Months

FIGURE:
marginal zone lymphoma and two were
de novo. Te median age at diagnosis
was 61 years, median age at acala start
was 69 years. Sixteen (70%) of the pts
were Ann Arbor/Rai stage III or IV
at diagnosis. Te median number of
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prior therapies was three (range 0-12).
Of note, the GCB-DLBCL patient had
previously undergone both allogeneic
(alloSCT) and autologous (autoSCT)
Continued on p. 24
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stem cell transplants and four of the
MCL patients (44%) also had prior allo
and/or autoSCTs. All CLL pts (n=10;
100%) had at least a partial response
(PR), including 1 complete response
(CR) by iwCLL criteria. In the MCL
cohort of 9 pts, 8 (88%) had at least a
PR (including 1 CR), and one patient
(11%) had stable disease (SD). One MCL
pt achieved a CR and moved to alloSCT.
One (25%) of the DLBCL pts had a PR
(ABC subtype), and three (75%) had SD
(one GCB and two ABC-DLBCL.) At
the time of last follow up, two DLBCL
pts had SD and remained on acala, one
progressed afer 10 months, and one
died due to disease progression. Te
12-month progression free survival
(PFS) was 89% for CLL and 83% for
MCL; 12 months overall survival (OS)
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was 89% for CLL and 100% for MCL
respectively. (Figure 1).
Of note, 16 pts (70%) had been on
ibrutinib previously and all pts discontinued (d/c) ibrutinib due to intolerance. Acala related toxicities included:
26% (n=6) arthralgias/myalgias, 13%
(n=3) infection, 13% (n=3) bruising/
bleeding, 9% (n=2) rashes, and 4%
(n=1) diarrhea. Ten (43%) of pts tolerated acala without any side efects. Of
note, there were 6 pts with a history of
atrial fbrillation (afb) or an afb-related
toxicity of ibrutinib, and none of our pts
experienced new afb while on acala. In
total, six pts d/c acala: 1 patient moved
to alloSCT, 3 had disease progression,
1 d/c due to toxicity (fatigue/bleeding/
bruising), and 2 pts died. One death was
unrelated to lymphoma (renal cancer).
Our "real world" experience with
acala demonstrates its efficacy and

tolerability in the setting of NHL,
supporting previously published literature.1,2 Te response rates in our
CLL and MCL cohorts were 100% and
88% respectively and only one patient
discontinued acala for intolerance.
Our experience supports pilot data
showing efcacy and tolerability and
thus further research in other B-cell
malignancies is warranted, especially
in the aggressive/refractory DLBCL
population.

REFERENCES:
1. Wang M, Rule S, Zinzani PL, et al. Acalabrutinib in relapsed or refractory mantle
cell lymphoma (ACE-LY-004): a singlearm, multicentre, phase 2 trial. Lancet
2018;391(10121):659-667.
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a l. Aca labrutinib in treat ment-naive
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Database Mining of Cancer Datasets for Roles of P38 MAPK
Isoforms Head and Neck Squamous Cell Carcinoma
Simran
Sandhu, MSII

TABLE: Summary of signifcant results for each MAPK isoform in unstratifed, HPV--HNSCC. Row one
displays statistically signifcant changed in each isoformas gene expression in the three groupings of HNSCC

ADVISOR: Tatiana
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tumor analysis with comparison to normal tissue. Row two highlights the variations in overal survival in

1. George
Washington
University (GW) School of Medicine and
Health Sciences Departments of Anatomy
and Cell Biology
2. GW Cancer Center

correlations between a protein kinase and a specifc immune cell infltrate. Row four similarly outlines the

As cancer therapy targeting becomes
increasingly specifc, an area of potential therapeutic targets that remains
largely unelucidated includes the p38
family of mitogen-associated protein kinases (MAPK). Tese protein
kinases are implicated in adaptive cellular response to numerous stressful
stimuli and also modulate different
processes important to tumorigenesis.
However, the isoform-specifc roles of
these MAPKs have largely not been
studied in cancers, including head
and neck squamous cell carcinoma
(HNSCC). Furthermore, it is currently
clinically pertinent to stratify HNSCC
by whether a patient is positive for
human papilloma virus (HPV), and
investigation of HPV+ HNSCC versus
HPV- HNSCC in relationship to the
isoforms has also not been performed.1
We examined correlations of p38α,
p38β, p38γ, and p38δ isoforms (encoded
by MAPK14, MAPK11, MAPK12,
and MAPK13 genes, respectively) in
HNSCC (unstratified and stratified
by HPV status) with gene expression,
survival, prognosis, immune cell tumor
infltration, and biological pathways.
These analyses were performed
on H NS C C d at a s e t s f rom T he
Cancer Genome Atlas (TCGA) using

each group on the basis of high MAPK isoform expression. Row three displays whether overall immune
cell infltration into the tumor was increased, decreased, or mixed on the basis of statistically signifcant
levels of immune cell biomarkers (increased, decreased, or mixed) on the basis of statistically signifcant
correlations between a protein kinase and the specifc immune biomarker.
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several web-based bioinformatic tools
including GEPIA, LinkedOmics,
TIMER and TIMER2.0, as well as
GSCA and GSCAlite.
Our results highlighted distinct
roles for each of the p38 isoforms in
processes important to tumorigenesis
in HNSCC which remained largely
consistent between HPV- HNSCC and
unstratifed HNSCC (Table). In HNSCC
patients, higher p38β/MAPK11 expression level correlated with improved
overall survival, and increased levels
of immune biomarkers in the tumor
microenvironment. p38γ/MAPK12
expression level was higher in HNSCC
tumors compared with normal tissue,
and was especially high in HPV- relative to HPV+ HNSCC tumors. Immune
biomarker levels were both positively
and negatively correlated with p38γ/
MAPK12 expression in HNSCC and
HPV- HNSCC samples, but mostly
positively correlated in HPV+ HNSCC
samples. p38δ/MAPK13 expression
was overwhelmingly negatively correlated with immune biomarker levels;
conversely, p38α/MAPK14 expression
positively correlated with immune
biomarker levels in HNSCC samples.
Given our results, in HNSCC,
we postulate a tumor suppressing
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role for p38α and p38β, and a tumor
promoting role for p38γ and p38δ.
Of special interest, p38β/MAPK11
and p38γ/MAPK12 are suggested to
play larger roles in HNSCC than their
counterparts p38α/MAPK14 and p38δ/
MAPK13, which have traditionally
been more associated with pathways
of tumorigenesis. Furthermore, our
analysis did not display large diferences in the protein kinases’ functions
in tumor-related pathways, regardless
of stratification of HNSCC by HPV
status. Exploration of these results
may lead to improved pharmacologic therapy for HNSCC, and our
data suggest possible comprehensive
applicability of potential therapeutic
regimens with regards to HPV+ and
HPV- HNSCC patients. Additionally,
further investigation of the novel roles
of p38β/MAPK11 and p38γ/MAPK12
in HNSCC may be expanded to other
cancer types and provide potential
therapeutic targets there.
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TABLE 1: Summary of signidfcant results for each MAPK isoform in unstratifed,
BRAD-mustated, and NRAS-mutated SKCM. Row one displaces statistically signifcant
changes in each isoforms gene expression in the three groupings of SKCM tumors with
comparison to normal tissue. Row two ighlights the increase in disease-free survival
assiociated with increased p28δ/MAPK13 expression. Row three displays whether
overall immune cell infltration into the tumore microenvironment was increased,
decreased, or mixed on the basis of statistically signifcant corrolations between a
protein kinase and a specifc immune cell infltrate. Row four similarly outlines the levels
of immune cell biomarkers (increased, decreased, or mixed) on the basis of statistically
signifcant correlations between a protein kinase and the specifc immune biomarker.
MAPKlsofo,m Gene E1q1ftiSion

Terapeutic treatments for cancers are
moving in the direction of personalized
medicine, but the data for novel
therapeutic targets are limited. One
such group of targets includes the p38
family of mitogen-associated protein
kinases (MAPK), which are involved
in adaptive cellular stress response
and varying roles in tumorigenesis.
In cutaneous melanoma (SKCM),
isoform-specifc roles of these MAPKs
have largely not been elucidated.
Additionally, these isoforms have
not been investigated in context of
clinically important driver mutations,
BR AF and NR AS. 1 We examined
correlations of p38α, p38β, p38γ,
a nd p38δ isoforms (encoded by
MAPK14, MAPK11, MAPK12, and
MAPK13 genes, respectively) with
gene expression, survival, prognosis,
immune cell tumor infltration, and
biological pathways in SKCM.
These analyses were performed
on SKCM datasets from Te Cancer
Genome Atlas (TCGA). This SKCM
dataset was ana lyzed as a whole
(unstratifed SKCM) as well as divided
into BR AF-mutated a nd NR ASmutated SKCM. Aforementioned
analyses were conducted using several
web-based bioinformatic tools: GEPIA,
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LinkedOmics, TIMER and TIMER2.0,
unstratified, BRAF- mutated, and
as well as GSCA, GSCAlite, and
NRAS- mutated tumors correlated
cBioPortal. Further BRAF- and NRASwith decreased levels of immune
mutated immune cell infiltration
infltration and immune biomarkers,
and immune biomarker expression
and p38α/MAPK14 expression was
analyses were performed manually
correlated with a mixed response:
using GraphPad Prism.
positively correlating with specific
Our resu lts
highlighted
In BRAF-mutated SKCM, our results suggest a
distinct roles for
each of the p38
tumor promoting role for all isoforms; in NRASMAPKs in SKCM,
and even identifed
mutated SKCM, p38δ/MAPK13 and p38α/
diferences for the
isoforms based of
MAPK14 displayed tumor suppressing roles.
driver mutation
stratifcation.
Table 1 provides
a summary of gene expression, disease
biomarkers and negatively correlating
free survival, immune cell infltration,
with others. p38δ/MAPK13 expression
and immune cell biomarker expression
was increased in BR AF-mutated
for each of the four isoforms in the
SKCM, and positively correlated
three SKCM groups. In SKCM data,
with immune biomarker levels, but
p38β/MAPK11 expression level was
in unstratified and NRAS-mutated
increased specifcally in BRAF-mutated
SKCM, expression was decreased,
tumors, but correlated with increased
although the same correlation with
levels of immune biomarkers in the
immune biomarker levels remained. Of
tumor microenvironment for both
note, in unstratifed SKCM, high levels
BRAF- and NRAS- mutated tumors.
High p38γ/MAPK12 expression in
Continued on p. 27
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Continued from p. 26
of MAPK13 associated with improved
disease-free survival.
Given these summarized results, as
well as identifcation of pathway specifc
functions of the isoforms and specifc
identities of the over- and underrepresented immune cell biomarkers, we
suggest differing tumor promoting
and tumor suppressive roles for the
p38 isoforms in SKCM (Table 2). In
BRAF-mutated SKCM, our results suggest a tumor promoting role for all isoforms; in NRAS-mutated SKCM, p38δ/
MAPK13 and p38α/MAPK14 displayed
tumor suppressing roles. Unstratifed
data points to a tumor promoting role
for p38γ/MAPK12, a suppressive role

BASIC SCIENCE

TABLE 2: Summary of postulated tumor promoting and tumor suppressive roles for
p38/MAPK isoforms in unstratifed, BRAF-mustated, and NRAS-mutated SKCM.
Unstratified
SKCM
MAPK11

-

MAPK12

1'
,!,
1' ,!,

MAPK13
MAPK14

BRAF-

NRAS-

Mutated

Mutated

SKCM

SKCM

1'
1'
1'
1'

-

for p38δ, and a mixed suppressive and
promoting role for p38α.
Our analysis demonstrated unique
roles for the isoforms in SKCM, with
functional differences particularly
emphasized in the driver mutations for
SKCM. Further investigation of these
relationships raises the possibility of

-

,!,
,!,

Legend

-

1'
,!,
1',!,

Tumor Promoting
Tumor Suppressing
Mixed

pharmacologic targeting for a more
indiv idua lly-specia lized medica l
approach in treatment of SKCM.
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Melanoma. Cell, 161(7), 1681–1696. https://
doi.org/10.1016/j.cell.2015.05.044
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INTRODUCTION: Antisynthetase
syndrome (aSS) is an autoimmune
myopathy characterized by interstitial lung disease, myositis including
dermatomyositis or polymyositis,
Raynaud’s phenomenon, and arthritis
of anti-tRNA synthetase antibodies.1
Antisynthetase syndrome seldom
presents with cardiac involvement,
as one study reported a frequency of
only 3.4%. Here we present a case of
antisynthetase syndrome with induced
cardiomyopathy.2
CASE: A 59-year-old man with a
history of cardiomyopathy, lef ventricular systolic dysfunction, and
interstitial lung disease, presented to
the emergency department (ED) with
shortness of breath, muscle weakness,
and weight loss. Prior cardiac history
includes biventricular heart failure with
20–25% ejection fraction. Upon presentation, the patient underwent a cardiac
MRI which revealed severely dilated
cardiomyopathy, right moderate circumferential pericardial efusion with
no focal or difuse areas late gadolinium
enhancement (Figure). A previous
diagnosis of aSS was made from the
presence of antibodies against EJ, aminoacyl tRNA synthetase, and Ro60+.

a.

b.
FIGURE: Cardiac MRI showing moderate to severe concentric left ventricular
hypertrophy, left ventricular dilation with left ventricular end diastolic volume of 217 ml,
severe right ventricle dilation with right ventricular end diastolic volume of 263 ml as
well as moderate circumferential pericardial effusion. a. Short axis diastole. b. Long axis
diastole.

Continued on p. 29
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Electromyography of right vastus lateralis, right deltoid, and right sternocleidomastoid muscles were all consistent
with infammatory myositis. Prior to
presentation at the ED, the patient was
on immunosuppressants, but had a history of non-compliance. In the ED, labs
were consistent with profound electrolyte disturbances including a potassium
of 1.6, magnesium of 0.04, corrected
serum calcium of 4.9, as well as BNP
of 15,000, and troponin of 0.04. A CT
scan was consistent with cardiomegaly,
enlarged pulmonary artery and lower
lobe predominant interstitial fbrotic
changes. An EKG revealed lef anterior
fascicular block. Lef heart catheterization was negative for ischemic disease,
while right heart catheterization was
compatible with mild pre-capillary
pulmonary hypertension. The treatment plan for this patient was multifaceted given the complex nature of the
case. For heart failure, the patient was
treated with spironolactone, carvedilol,
Sacubitril/Valsartan, as well as a maintenance diuretic. For aSS the patient
was given IVIG for 5 days. Follow-up
echocardiogram prior to discharge
indicated anEF of 35–40%. Te patient
was eventually discharged with close
outpatient follow-up.
DISCUSSION: Given the patient’s
initial presentation, diferent etiologies were ruled out including parasitic,

ischemic, as well as infltrative diseases.
In this case, the patient tested positive
for anti-aminoacyl tRNA synthetase
antibodies, which are pathognomonic
for aSS. 3 Amongst all presentations
for cardiac antisynthetase syndrome,
cardiac involvement with histologic
evidence of myocarditis has been well
documented in the literature; although
in clinical practice the diagnosis is typically based on less invasive tests such
as MRI, EKG, and troponin levels.4
Myocarditis as the etiology of dilated,
as in this case, cardiomyopathy occurs
in 30% of cases. A systematic review
in patients with active myopathies
suggested that the most common ECG
fndings include conduction abnormalities leading to premature ventricular
contractions, lef anterior hemiblock,
and AV block. Te gold standard for
myocarditis remains endomyocardial
biopsy; however, in this case, biopsy was
deferred given the clinical evidence of
active myositis secondary to anti-synthetase syndrome and successful treatment with corticosteroids and IVIG.
Elsewhere in the literature, cases of aSS
cardiomyopathies have been successful
managed with adjuvant medications
such as azathioprine, cyclophosphamide, and rituximab.5
CONCLUSION: aSS is a rare syndrome that is not typically associated
with cardiac involvement. In cases
where there is an association, patients
commonly present with histological
evidence of myocarditis, and less

CLINICAL TRANSLATIONAL RESEARCH | CARDIOVASCULAR

commonly with dilated cardiomyopathy and features of heart failure.
Therapies are not well studied, and
medical management varies from case
to case. Directed guideline-medical
therapy, IVIG and steroid use in antisynthetase syndrome provided clinical
beneft in this case.
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BACKGROUND: Tetralogy of Fallot
(TOF) is among the most common
cyanotic congenital heart diseases in
adults, accounting for up to 10% cases.1,2
While 30–40-year survival is excellent at 85%-90%, patients are at risk of
arrhythmias and sudden cardiac death
(SCD) afer repair.3,4 Te objective was
to determine the frequency of various
arrhythmias and assess therapies used
to treat each type.
METHODS: A retrospective review
was conducted of all adults with repaired
TOF (n=242) from the Washington
Adult Congenital Heart Program at
Children’s National Hospital. Data
were extracted from patient charts and
analyzed in R, Version 4.1. We used a
Chi-squared Goodness of Fit test to
compare frequency of any arrhythmia
with the 43% reported by Khairy et al.5
RESULTS: With a mean age of 38.1
years (55% female, 64% white), and
mean follow-up duration of 30.2 years,
29.8% of the cohort (n=72) developed
at least one arrhythmia, signifcantly
lower than the 43% previously reported
(X2=17.3; p < 0.0001). Te most frequent was ventricular tachycardia
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TABLE:
Arrhythmia Type

Sick sinus syndrome (n=l)
3rd degree AV block (n=8)
Atrial tachycardia (n=22)
AVNRT(n=l)
Atrial flutter (n=25)
!ART (n=5)
Atrial fibrillation (n=9)
PVC's (n=7)
Ventricular tachycardia
(n=37)

Response
to
medical
theraov
0
0

Response
to ablation

PM
implant

ICD
Implant

ICD
Therapies

0

I

0

0

0

8

0

9

0

0

0

0

0

3
I

0

0

0

5
2

9
3

0

0

0

0

0

0

3
5

I
I
2

0

0

0

0

0

0

0
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6

(n=37). Medical therapy had a 41.6%
success rate; ablation (n=27) carried
a 74.1% success rate. Devices (pacemaker=9; ICD=28) were implanted
in 37 patients (ICD, 67.8% primary
prevention). Twelve patients with ICDs
had shocks (three inappropriate), nine
had antitachycardia pacing, and six
had both. In our series, there were no
cases of SCD.
CONCLUSION: Te frequency of
arrhythmias in adults with repaired
TOF approximates 30% in our cohort,
less than what has been reported previously. Catheter ablation was efective
for those who failed medical therapy.
Future investigation will aim to identify
risk factors associated with the development of various arrhythmias.
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Two to fve years following implantable cardioverter-defbrillators (ICD)
implantation, clinical studies suggest
that up to 20% of ICD recipients are at
high risk for the development of severe
anxiety-related disorders such as posttraumatic stress disorder (PTSD) or
generalized anxiety disorder (GAD),
while in the era of COVID-19, this
number may be greater.1 Therefore,
the main objective of our study was
to implement a web-based self-report
questionnaire to evaluate the impact of
COVID-19 on the psychosocial distress
of ICD patients within the GW ICD
clinic community.
All ICD patients reporting to
the George Washington University
Cardiology ICD clinic for routine
follow-up care from March 2020 to
September 2021 were asked if they
would like to volunteer to complete
an electronic tablet-based (Survey
Monkey™) self-report questionnaire.
An informed consent letter was ofered
and read to the participants. To assess
ICD-induced anxiety, depression, and

PTSD-like symptoms in 16%–21% of
exacerbated psychosocial distress from
ICD recipients, while psychosocial disCOVID-19, we adapted the Florida
tress from COVID-19 was not evident.
Shock Anxiety Scale (FSAS), Patient
Given the impact of anxiety related
Hea lth Questionnaire-2 (PHQ2),
dis-orders on adverse cardiovascular
GAD-2, Diagnostic and Statistical
outcomes, this at-risk population may
Manual of Mental Disorders(DSM-5)
beneft from a mental health service
panic attack scale, and the Coronavirus
2-4
screen and referral program.
Anxiety Scale (CAS). Tis protocol
was adapted from a similar study from
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Given the impact of anxiety related dis-orders on
for continuous
variables and
adverse cardiovascular outcomes, this at-risk popuFisher’s exact
test.
lation may beneft from a mental health service
A tota l of
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naire. Within this population, 21%
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3. Ford J, Finch JF, Woodrow LK, et al. The
anxiety (GAD-2) while 16% for PTSD
Florida Shock Anxiety Scale (FSAS) for
/ panic symptoms (DSM-5 Panic).Of
Patients with Implantable Cardioverter
these subjects, 28% reported receiving
Defibrillators: Testing Factor Structure,
a shock from their device. No statistiReliability, and Validity of a Previously
cally signifcant diferences in positive
Established Measure. Pacing and Clinical
Electrophysiology. 2012;35(9):1146-1153.
screens were determined for male and
female subject comparisons. Positive
4. Kroenke K, Spitzer RL, Williams JBW. Te
screens for males vs. females respecPatient Health Questionnaire-2: validity of
a two-item depression screener. Med Care.
tively were (3.5% vs. 8.7% FSAS), (15.5%
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mias. Presented at: Jan. 21, 2021.
the CAS.
These findings support previous
research in identifying anxiety and

CLINICAL TRANSLATIONAL RESEARCH | CARDIOVASCULAR

31

Clinical Translational Research: Critical Care

Cresting Mortality: Defning a Plateau in
Ongoing Massive Transfusion
Parker
Chang, MSII
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Blood-based balanced resuscitation
is the standard of care in massively
bleeding trauma patients, but there
is no data as to when this therapy no
longer significantly improves mortality. We sought to determine if there
is a threshold beyond which further
massive transfusion will not improve
in-hospital mortality.
Te Trauma Quality Improvement
database was queried for all adult
patients registered between 2013 and
2017 who received at least one unit
of blood (PRBC) within four hours
of arrival. In-hospital mortality was
evaluated based on the total transfusion volume (TTV) at four and 24
hours in the overall cohort (OC) and
in a balanced transfusion cohort (BC),
composed of patients who received
a transfusion at a ratio of 1:1 – 2:1
PRBC:plasma. A bootstrapping method
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FIGURE 1:

FIGURE 2:

in combination with multivariable
admission. In the BC, mortality plaPoisson regression (MVR) was used
teaued at a TTV of 39 (95% CI, 36-41)
to fnd a cutof afer which additional
units and 53 (95% CI, 41-42) units at
transfusion of blood products no
four and 24 hours following admission,
longer afected in-hospital mortality.
respectively (fgures 1, 2).
MVR was used to control for age, sex, race,
These [total transfusion volumes] can be used
highest abbreviated
injury score in each
as markers for resuscitative timeouts in order
body region, comorbidities, advanced directo assess the plan of care moving forward.
tives limiting care, and
the primary type of
surgery performed for
hemorrhage control.
Transfusion thresholds exist beyond
Te OC consisted of 99,042 patients
which ongoing transfusion is not assoof which 28,891 and 30,768 received a
ciated with any clinically signifcant
balanced transfusion during the frst
change in mortality. Tese TTVs can
four and 24 hours, respectively. Te
be used as markers for resuscitative
mortality rate plateaued afer a TTV
timeouts in order to assess the plan of
of 41 (95% CI, 40-41) units in the OC
care moving forward.
at 4 hours and afer a TTV of 53 (95%
CI, 52-53) units at 24 hours following
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Tere are many potential complications associated with endotracheal
tube (ETT) malpositioning in critical
care settings, such as accidental extubation, bronchial migration or vocal
cord herniation.1,2,3 Tese events can
prolong patient recovery and lengthen
ICU stays.4 Te goal of this study is to
demonstrate that point of care ultrasound (POCUS) is noninferior to chest
X-ray (CXR) in identifying proper ETT
depth.

FIGURE: The image is a photo from a POCUS assessment. A linear transducer is placed
superfcial to the cricoid cartilage in the sagittal plane. The X demonstrates the cricoid
cartilage and * marks the 1st tracheal ring. The hyperechoic lines are the ETT, which runs
beyond the 1st tracheal ring in this image.

underwent daily POCUS assessment
of ETT positioning by novice sonographers (medical students). ICU/ED
physicians led four hourlong informa l training
The high specifcity and NPV values sugsessions to teach medical
students POCUS technique.
gest that if ETT position appears within
Subjects were excluded if
they were COVID positive,
normal limits on POCUS (tip of ETT
had c-spine precautions,
had recent neck surgery,
between 3–7 tracheal rings), ETT position
or planned to be extubated
within 24 hours. Patient
is likely adequately positioned even when
ETT position was measured
using POCUS assessment
performed by novices.
(balloon cuf border ending
between 3–7 tracheal rings)
and compared to daily CXR
We conducted an observational
landmarks (5 cm +/- 2 cm above
cohort study of intubated patients
carina). Recommendations based
across four multidisciplinary ICUs at an
on sonographic and radiographic
urban academic hospital. Each patient
landmarks were compared to assess
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sensitivity and specifcity of POCUS
to evaluate need for ETT repositioning.
Statistical significance was assessed
using the Clopper-Pearson binomial
confdence interval.
Twenty patients were enrolled for a
total of 62 ventilator-days. Te cohort
was majority female (55%), Black/
African American (75%) and mean age
55 +/- 18 years. In 58 instances (93.5%),
both sonographic and radiographic
landmarks agreed on maintenance of
ETT position. In one instance (1.6%),
sonographers recommended ETT
repositioning while radiographic
landmarks did not. In three instances
(4.8%), ETTs appeared in place by
sonographic but not radiographic landmarks. Te data yields a specifcity of
98.31% CI [90.91,99.96] for proper ETT
Continued on p. 34
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Continued from p. 33
placement with a negative likelihood
ratio of 1.02 CI [.98, 1.05] and negative
predictive value (NPV) of 95.08% CI
[94.92,95.24].
Te high specifcity and NPV values
suggest that if ETT position appears
within normal limits on POCUS (tip of
ETT between 3–7 tracheal rings), ETT
position is likely adequately positioned
even when performed by novices.
Further studies should investigate
the use of POCUS as a monitoring
alternative and as a reliable tool postintubation to confrm ETT depth.
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Decision Support Alerts for Delays in Trauma Resuscitations
hindering both team communication
and decision support.4 To address this
discrepancy and support delay alerts,
ADVISORS:
we implemented a progress slider.
Randall Burd,
Unlike other tasks in the protocol,
MD, PhD,1 Angela
the process of establishing IV access
Mastrianni,2
requires multiple steps. While the
Aleksandra
checkbox only supports a binary outSarcevic, PhD2
come, the progress bar allows the leader
to indicate if the task is not started, in
1 Children’s National Hospital Depart
progress, or complete. Afer releasing
2 Drexel University Department of
this feature on the checklist, we evaluComputing and Informatics
ated the accuracy of documentation
before and afer its introduction.
A Python script was used to parse
Children’s National Hospital is a
140
pediatric resuscitations from April
Level-1 pediatric trauma center serving
2018-May 2019 and determined that
the District of Columbia metropolitan
the median time from patient arrival
area. About 600 children are treated
to IV access confrmation was seven
through the trauma department each
minutes. Delay alerts were
implemented based upon
The introduction of the IV slider decreased
this time or afer the secondary survey, whichever
came first. 5 The IV task
the percentage of premature checkoffs,
slider was implemented
in November 2020; 218
leading to fewer missed alerts in task
pediatric resuscitations
from June 2020 to May
completion delays.
2021 were video reviewed
for IV access confirmation and compared to alert triggers
year, with each case video recorded for
to determine the accuracy of alerts.
quality, safety, and research review.
Alert accuracy was defined as false
During pediatric trauma resuscitaalert, missed alert, true alert, or true
tions, a senior resident or fellow uses a
non-alert. The number of false and
digital checklist based on the Advanced
missed alerts were then analyzed with
Trauma Life Support (ATLS) protocol,1
the IV slider implementation at three
indicating completion of tasks while
intervals: checkbox only, checkbox and
junior surgical residents, nurses, and
slider, and slider alone.
respiratory therapists provide handsStatistical analysis identified no
on care. Prior work showed that the
signifcant diferences in the number
“Confirm intravenous (IV)/intraosof delays between each cohort. Te perseous (IO) access has been established”
centage of missed alerts decreased with
task was often checked-off before
the introduction of the IV slider and
completion.2,3 Discrepancies between
the elimination of the checkbox design
the state of resuscitation and informa(76.7% vs. 40.0% vs. 10%; p < 0.001). Te
tion recorded on the ATLS checklist
percentage of false alerts increased with
regarding IV access is problematic,

Allison Hu,
MSII

BASIC SCIENCE

the same progression (14.3% vs. 23.7%
vs. 36.6%; p=0.02).
CONCLUSIONS: Te introduction of
the IV slider decreased the percentage
of premature checkoffs, leading to
fewer missed alerts in task completion
delays. The same feature, however,
increased the rate of cases with false
alarms. Further modifcations to the
checklist will be necessary to minimize
false alerts.
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Atopic der mat it is is a ch ron ic ,
infammatory skin disease associated
with sleep disturbance. When caring for
geriatric patients, several factors such
as sleep disturbance, polypharmacy,
cognition, social support, and mobility
should be considered. Our study
investigated the association of older
adult age with atopic dermatitis severity
and sleep disturbances.
Tis was a cross-sectional, dermatology practice-based study of adults
(≥18 years) with atopic dermatitis
diagnosed by Hanifn-Rajka criteria.
Patients were serially recruited from
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the eczema clinic at an academic med0.80 [0.45-1.41]; Patient-Oriented
ical center between 2014–19. Patients
Eczema Measure: 0.55 [0.29-1.06]).
underwent full body skin exam and
However, older adult age was associcompleted electronic questionnaires.
ated with increased number of nights of
Atopic dermatitis severity was assessed
sleep disturbance from atopic dermatitis
using Eczema Area and Severity Index,
(2.14 [1.16-3.92]). Older adult age was
SCORing Atopic Dermatitis total and
also associated with increased fatigue
itch subscores, Investigator’s Global
(1.81 [1.05-3.09]), trouble sleeping (1.98
Assessment, Patient-reported Global
[1.16-3.36]), and trouble staying asleep
Assessment of atopic
dermatitis severity,
When caring for geriatric patients [with Atopic
and Patient-Oriented
E cz ema Me a su re.
dermatitis], several factors such as sleep disturFrequency of sleep
d i s t u rba nc e s w a s
assessed, including
bance, polypharmacy, cognition, social support,
d i f f ic u lt y f a l l i ng
asleep and staying
and mobility should be considered.
asleep.
Older adult age
(≥65 years) was not associated with
(2.26 [1.32-3.89]), but not with difculty
AD severity in the following measures
falling asleep (1.16 [0.66-2.03]), in atopic
(adjusted odds ratio [95% confdence
dermatitis patients.
interval] for Eczema Area and Severity
While older adult patients with
Index: 1.47 [0.68-3.18]; total SCORing
atopic dermatitis had similar disease
Atopic Dermatitis: 1.10 [0.52-2.34]
severity compared to younger adults
and itch subscore: 1.00 [0.55-1.81];
with atopic dermatitis, they had more
Investigator’s Global Assessment: 1.87
profound sleep disturbances than
[0.98-3.56]; Patient-reported Global
younger adults, particularly trouble
Assessment of atopic dermatitis severity:
staying asleep.
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Evaluating Provider Perceptions and Attitudes About the
Unique Needs of Older Adult Patients in Dermatology Clinics
Jaya
Manjunath,
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ADVISOR: Adam
Friedman, MD1
1. George
Washington University School of Medicine
and Health Sciences Department of
Dermatology
Previous literature has identified
important principles of geriatrics to
consider in older adult dermatology
patients, including cognition, polypharmacy, mobility, and social support. We aimed to assess provider

perceptions and attitudes about the
unique needs of older adult patients
in dermatology. 169 health care practitioners completed the survey. 92.9%
of the survey respondents were dermatologists, and 6.5% were dermatology
advanced practice providers.
The following barriers to care in
older adult patients were identifed by
dermatology providers (%): hearing
problems (82.9%), lack of a social
support system (82.8%), immobility
(74.4%), ability of the patient to communicate clearly (69.5%), transportation (77.5%), financial limitations
(72.2%), Medicare limitations (66.9%),
poor psychosocial functioning (77.5%)
and telehealth due to the COVID-19
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pandemic (71.2%). Additionally, providers identifed the following barriers
to treatment in the older adult population: poor psychosocial functioning
(89.9%), polypharmacy (87.8%), lack
of social support system (88.5%), poor
adherence to medications (81.1%), and
lack of a primary care physician (72.3%).
Overall, practitioners selected lack
of social support system, difculty in
comprehending treatment plans, and
limited fnancial means as the three
most pressing issues afecting the care
of older adult patients. Additional
research is warranted to develop interventions to reduce barriers to care and
treatment for older adult patients in
dermatology clinics.
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Current data supports the potential for
targeting the cutaneous endocannabinoid system to treat eczematous dermatoses.1-3 However, our understanding
of patient knowledge and utilization of
cannabis/cannabis-derived products as
treatments for eczema is limited, highlighting both a gap and opportunity to
engage with the eczema community.
An online survey was used to assess
the use, knowledge, and attitudes of a
broad scope of cannabis product types
was advertised by the National Eczema
Association (NEA) via social media and
NEA network dissemination.
Of the 76 respondents to the survey,
69 (88.46%) were individuals diagnosed
with eczema and seven (8.97%) were
primary caregivers of a dependent
diagnosed with eczema. Respondents
most frequently used OTC products
purchased without recommendation
from a dermatologist (22 [36.07%],
n=61) and least frequently used medical
cannabis recommended by a dermatologist (2 [3.12%], n=64). Most respondents
held favorable attitudes on the usage
of medical cannabis to treat eczema
(“strongly approve,” 20 [39.22%], and
“approve,” 12 [23.53%], n=51) (Figure 1).
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Note: Zero respondents selected
"Disapprove" or "Strongly disapprove•

23.53%

FIGURE 1: Respondents’ Approval of Using Medical Cannabis to Treat Eczema (n=51)

Would you be interested in learning more about the potential
uses of medical cannabis in treating eczema? (n=51)
Would you be comfortableseeing a dermatologistwho
recommendedmedical cannabis products to you? (n=SO)
Do you support medical cannabis use? (n=SO)

0
•

Yes

•

No

50
Percentof Respondents

100

FIGURE 2: Respondents’ Attitudes on Medical Cannabis
All respondents supported medical cannabis use (50 [100%], n=50) and most
respondents (47 [94%], n=50) would
be comfortable seeing a dermatologist
who recommended medical cannabis
(Figure 2). 94% of respondents (47,
n=50) would be interested in learning
about using medical cannabis for treatment of eczema, but most had never discussed this topic with their health care
provider (54 [93.10%], n=58). 46.67% of
respondents (28, n=60) were unsure if
OTC cannabis-derived products were
regulated by the FDA.
Eczema patients are open to learning
about cannabinoids and many are
already using OTC products. As both
consumer interest/use and the cannabis industry continue to outpace
medical research and guidelines,

dermatologists need to be prepared to
counsel patients on cannabinoid applications in dermatology.
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Though biologic agents have shown
excellent efficacy in treating many
patients with moderate to severe plaque
psoriasis, a subset of these patients are
refractory to treatment with multiple

biologic agents.1 Certain variables such
as demographics, degree of disease
severity, genetics, and prior experience with biologic therapy have been
shown to infuence response to single
biologic therapy in patients with plaque
psoriasis.2 We examined clinical data
from 222 psoriasis patients at UCSF;
171 reported use of only a single biologic agent and 51 reported prior use of
three or more biologics at enrollment
from 2006 to 2020. We analyzed demographic features, clinical features, and
co-morbidities associated with use of
three or more biologics. On multivariate
analysis, use of three or more biologics
was associated with greater duration of
psoriasis (22.9 vs. 19.3 years [p = .01]),
initial presentation of psoriasis on the
gluteal clef (15.7% vs 4.7% [p=0.05]),
less family history of psoriasis (43.1% vs
54.7% [p = .01]), and lower prevalence

of high cholesterol (19.6% vs 22.8%
[p=0.008]). Erythrodermic type psoriasis (13.7% vs 2.9% [p=0.06] trended
towards signifcance with use of three
or more biologics). Tese results may
suggest certain subsets of patients with
psoriasis are harder to treat with biologics. In the next phase of this project,
patient data (demographics, disease
severity, treatment history, etc.) will
be collected using a novel, physician
crowd-sourced database that will allow
physicians to contribute cases of psoriasis patients who have failed multiple
biologics or cases who have responded
to a single biologic.
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Psoriasis is an immune-mediated
disease characterized by skin and systemic inflammation that affects 125
million people worldwide. However,
the underlying pathways contributing
to psoriasis pathogenesis have not been
fully elucidated. Tis project utilizes
single-cell transcriptomes of T-cells
and other immune cell types from
healthy and psoriatic skin in an efort to
identify key biomarkers and pathways
of psoriasis. T-cells were clustered into
subtypes and diferential gene expression analysis was performed between
lesional and healthy skin to identify
psoriatic marker genes in each T-cell
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subtype. Regulatory CD4+ T-cells in
psoriasis lesional skin were found to
upregulate cytokines such as IL-32, as
well as genes in the interferon-gammamediated signaling, NF-κB signaling,
and putrescine catabolic pathways. As
a result, psoriatic Tregs may amplify
several of the pathways behind psoriasis
and drive inf lammation via IL-32,
which has been previously found to
be signifcantly upregulated in plaque
psoriasis. Ongoing work includes using
stratifcation by HLA type, VDJ analysis to more closely investigate psoriatic
TCR abnormalities, and incorporation
of more patient data.
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Abdominal pain is a common presentation in United States Emergency
Departments (EDs).1 Intra-abdominal
infections (IAIs), such as appendicitis
and diverticulitis, contribute to a signifcant proportion of abdominal pain
cases, 2 but it can be challenging to
distinguish them from abdominal pain
arising from non-infectious causes.
Computerized tomography (CT) is
the most specifc and sensitive in the
diagnosis of most IAIs but is costly,
carries a risk of malignancy, and can
prolong length of stay in the ED.3,4 In
our prospective observational study, we
tested the diagnostic utility of mRNA
biomarkers from circulating neutrophils in blood (RNAv).
METHODS: A cohort of 542 patients
at the GW Hospital ED presenting
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FIGURE 1: Overall study design.
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WBC Count (10'/µI)

with abdominal pain were screened
for inclusion and exclusion criteria to
obtain 100 patients, all of whom provided informed consent. All subjects
enrolled in the study were clinically
diagnosed through CT imaging and
conventional laboratory tests. Whole
blood was collected, from which RNA
was isolated. Additionally, CD15+
cells, buffy coat cells, and platelets
were isolated from a subset of subjects.
Droplet digital PCR (ddPCR) was performed to quantify neutrophil activation transcripts neutrophil defensin 1a
(DEFA1), alkaline phosphatase (ALPL),
and interleukin 8 receptor ß (IL8RB/
CXCR2). Transcript abundance was
calculated as a percentage of Actin B
(ACTB) transcript. Neutrophil elastase
activity of isolated CD15+ cells was
measured through a fuorometric and
colorimetric assay (Figure 1).
RESULTS: Based on a previous
study, we established cutofs for the
presence of an IAI, considered to be
RNAv positive (+), as ≥20 %ACTB for
ALPL + IL8RB and/or ≥10 %ACTB for
DEFA1.5 When clinical outcomes were
grouped based on probability of infectious etiology, RNAv exhibited high
sensitivity in diagnosing likely infections: appendicitis (10/10), diverticulitis
(5/6), cystitis (3/3), peritonitis (1/1),
pyelonephritis (5/5), and tubo-ovarian
abscess (1/1) (Figure 2). Among 34 cases
with a clinically unlikely IAI, RNAv
detected immune activation in 12 cases
that included a clinical diagnosis of
fbroids, gastritis, or ruptured ovarian
cyst. In the Unlikely Infectious group,
RNAv was positive for nine of the 18
with no organic cause of abdominal
pain, which suggests that conventional
diagnostics can miss up to 50% of
IAIs in the ED. When compared with
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FIGURE 2: RNA Biomarkers relative to clinical diagnosis in patients with abdominal
pain. The subject groupings were classifed based on their fnal diagnosis of conditions
that are “Likely”, “Uncertain”, or “Unlikely” infectious. For each fnal diagnosis, the
mean white blood cell count (WBC) (left graph), mean RNAv Score (middle graph), and
percentage of patients with abnormal RNAv score (right graph) are shown.
the Unlikely Infectious group, it was
found that the Likely Infectious group
had higher white blood cell count
(OR=24.89, p<0.003), neutrophil to lymphocyte ratio (OR=6.82, p<0.020), and
%ALPL+%IL8RB (OR=9.38, p<0.000).
When assessing correlations between
the RNAv test and conventional laboratory tests, the absolute neutrophil count
has a moderate to strong positive correlation with RNAv scores except DEFA1
which is consistent with previous work:
%ALPL (r=0.70), %DEFA1 (r=0.14),
%IL8RB (r=0.40), combined %ALPL
and %IL8RB (r=0.58). In a subset of 15
patients from which CD15+ cells were
isolated, neutrophil elastase activity
was also positively correlated with
RNAv score (r=0.65).
CONCLUSION: The RNAv test
is highly sensitive in detecting likely
infectious causes of abdominal pain. If
further confrmed, it may provide valuable clinical utility by assisting in ruling
out infectious causes of abdominal pain
before the use of imaging, invasive
surgical procedures, or antibiotics. Te
positive association between RNAv and
neutrophil elastase activity suggests
that both tests can detect neutrophil
activation in response to infection.
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STUDY OBJECTIVES: A lt hough
approximately 335,000 cases of biliary
colic present to emergency departments
(EDs) in the US annually, minimal data
exists on the benefts of hospital admission for these patients.1 While there is
limited evidence that ED readmissions
contribute to increased patient costs for
these patients, there is wide variability
in the assessed need for hospital admission and/or surgical intervention.2,3
Our objective was to compare one-year
surgery rates, ED visits, complications,
readmissions, and costs in ED patients
with uncomplicated biliary colic who
were admitted versus those that were
discharged.
METHODS: Using the State ED
Database (SEDD) from the Maryland
Healthcare Cost and Utilization Project
(HCUP), a census of all ED visits in
the state, we identifed patients with a
primary diagnosis of uncomplicated
biliary colic seen between 2016 and
2018. We divided patients into those
initially admitted and initially discharged. With unique identifers from
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Admitted to Hospital
on Index ED Visit
(N=492)
Obtained Immediate
Cholecystectomy on
Index ED Visit
(N=119)

Did NOT Obtain
Immediate
Cholecystectomy on
Index ED Visit (N=373)

Not Admitted to
Hospital on Index ED
Visit (N=280)
Obtained
Cholecystectomy
Within 1 Year of
Index ED Visit (N=79)

Did NOT Obtain
Cholecystectomy
Within 1 Year of Index
ED Visit (N=201)

FIGURE 1: CONSORT diagram for patients followed in the study.
ambulatory surgery, inpatient, and
SEDD databases, we followed selected
patients for one-year outcomes. We
used Medicare Relative Value Units
(RVUs) and HCUP cost-charge ratio
fles to estimate direct costs of care, and
then performed a multivariate logistic
regression analysis comparing groups.
RESULTS: Of the 772 patients eligible for the study, 64% (N=492) were
admitted to the hospital while 36%
(N=280) were discharged. Admitted
patients had signifcantly higher repeat
hospitalizations per patient (0.037 ±
0.018 vs 0.007 ± 0.010) and one-year
costs ($9542 ± $571 vs $1035 ± $87)
than those discharged on initial visit.
Tere was no signifcant diference in
recurrent ED visits rates, deaths, or
new-onset complications of biliary colic
(i.e., acute cholecystitis, cholangitis,
gallstone pancreatitis, etc.) between
admitted and non-admitted patients.
Logistic regression analysis (accuracy
= 72%) showed that hospital admission was associated with obesity (OR
= 1.46; 95% CI 1.25 - 1.67) and mood

disorders (OR=1.36; 95% CI 1.161.56) but no association was observed
between admission and race, gender,
and insurance status. Of note, there
was a statistically signifcant covariant
relationship between obesity and mood
disorders (p < 10-74).
We then analyzed outcomes for
patients who received a cholecystectomy versus those who did not in the
admitted and discharged groups. Of
those admitted, 24% obtained cholecystectomy during the initial hospital
stay, and immediate cholecystectomy
was associated with fewer repeat hospitalizations (0.000 vs 0.049 ± 0.023),
fewer recurrent ED visits (0.000 vs 0.027
± 0.017), and higher costs ($11757 ±
$1232 vs $8848 ± $617) than patients
who were admitted but did not obtain
an immediate cholecystectomy on
initial visit. Of those discharged, 28%
obtained cholecystectomy within one
year, and cholecystectomy was associated with more repeat hospitalizations
Continued on p. 43
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(0.027 ± 0.036 vs 0.000), more recurrent
ED visits (0.080 ± 0.072 vs 0.005), and
higher incurred costs ($1597 ± $179 vs
$817 ± $80).
CONCLUSIONS: In our analysis
of ED patients with uncomplicated
biliary colic from a single state, repeat
visits were extremely low (less than 0.04
visits per patient) for both discharged
and admitted groups of patients and

were therefore not signifcant drivers
of the cost of care. Consequently, oneyear costs of care were almost ten-fold
higher ($9542 ± $571 vs $1035 ± $87) for
patients that obtained an initial hospital
admission on their index ED visit, and
immediate cholecystectomy was not
associated with lower costs.
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STUDY OBJECTIVES: There are
approximately 300,000 cases of acute
appendicitis in the US annually.1
Laparoscopic appendectomy is currently the preferred method for management for these patients,2 but nonoperative management has been cited
as a viable alternative to surgery, 3
though the literature comparing these
treatments has been conficting. Te
primary objective of this study was
to compare ED patients with acute
appendicitis who receive immediate
appendectomy versus those who receive

Excluded (N=l)
Died on index visit or
in visit unrelated to
appendicitis

Obtained Non-Surgical
Management on Index
Visit (N=311)
Obtained
Appendectomy
Within 1 Year of
Index ED Visit (N=58)

Did NOT Obtain
Appendectomy
Within 1 Year of Index
ED Visit (N=253)

FIGURE : CONSORT diagram for patients followed in the study.
non-operative management in initial
visit for the following one-year outcomes: total costs, repeat ED visit,
hospital length of stay (LOS), and repeat
hospital admissions.
METHODS: Using the State ED
Database (SEDD) from the Healthcare
Cost and Utilization Project (HCUP) for
the state of Maryland, patients with the
ICD-10 codes for a primary diagnosis
of uncomplicated appendicitis (K35.30,
K35.80, and K35.890) who were seen
in an ED between 2016 and 2018 were
identifed. Patients who received appendectomy on initial visit were compared
to patients who obtained non-surgical
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management. Identifed patients were
then followed for one year by means
of unique identifers in the SEDD, the
State Ambulatory Surgery Database,
and the State Inpatient Database. Costs
were estimated using Medicare Relative
Value Units and HCUP Cost-Charge
Ratio fles, and a multivariate logistic
regression analysis was performed to
compare the two groups.
RESULTS: Of the 3476 patients
analyzed in this study, 91% (N=3165)
obtained an appendectomy on initial visit, while 9% (N=311) received
Continued on p. 44
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non-surgical management. Patients
who obtained an immediate appendectomy had lower repeat hospitalizations
per patient (0.0 vs 0.115 ± 0.038), lower
recurrent ED visits (0.003 ± 0.002 vs
0.074 ± 0.030), lower combined length
of stay (2.3026 ± 0.0823 vs 3.8581 ±
0.4823 days), and lower one-year costs
($5631 ± $204 vs $7425 ± $1132) than
patients who obtained non-surgical
management on initial visit. Nonsurgical management on initial visit
was associated with appendicolith/
bowel obstruction (OR = 1.23; 95% CI
1.15 - 1.31), increasing age (OR = 1.19,
95% CI 1.07 - 1.31), and ischemic heart
disease (OR=1.21; 95% CI 1.02-1.21) but
no association was observed between

44

management type and race, gender,
insurance status, CMDF CCI score (a
measure of medical comorbidity)4, or
pregnancy.
CONCLUSIONS: Operative treatment of patients presenting to the ED
with uncomplicated appendicitis was
associated with significantly lower
one-year costs, combined LOS, hospital
readmissions, and repeat ED visits than
non-operative treatment. Tis study
suggests that initial surgical intervention may not only be the most clinically efective choice, but also the most
cost-efective choice when compared to
nonsurgical alternatives.

REFERENCES
1. Perez KS, Allen SR. Complicated appendicitis and considerations for interval

appendectomy. JAAPA. 2018 Sep;31(9):35-41.
2. Werkgartner G, Cerwenka H, El Shabrawi A,
Bacher H, Hauser H, Mischinger HJ, Wagner
M, Wagner D. Laparoscopic versus open
appendectomy for complicated appendicitis
in high risk patients. Int J Colorectal Dis.
2015Mar;30(3):397-401.
3. Salminen P, Paajanen H, Rautio T, Nordström P, Aarnio M, Rantanen T, Tuominen
R, Hurme S, Virtanen J, Mecklin JP, Sand
J, Jartti A, Rinta-Kiikka I, Grönroos JM.
Antibiotic Terapy vs Appendectomy for
Treatment of Uncomplicated Acute Appendicitis: Te APPAC Randomized Clinical
Trial. JAMA. 2015 Jun 16;313(23):2340-8.
4. Glasheen WP, Cordier T, Gumpina R,
Haugh G, Davis J, Renda A. Charlson
comorbidity index: icd-9 update and ICD-10
Translation. Am Health Drug Benefits.
2019;12(4):188-197.

Fusion | 2022

Clinical Translational Research: Infectious Disease

Clinical Epidemiology and Outcomes of
Candidemia in Hospitalized Children
Rishika
Bheem, MSII
CO-AUTHORS:
Benjamin
Hanisch,1 Emily
Anususinha,1 Rana
F. Hamdy1
ADVISORS: Rana F. Hamdy2

TABLE: Baseline Characteristics of Patients with Candida Bloodstream Infection
SD: standard deviation; IQR: interquartile range; PICU: pediatric intensive care unit; NICU:
neonatal intensive care unit; BMT: bone marrow transplant; CICU: cardiac intensive care
unit; NSU: neurosurgical unit; SCU: surgical care unit; CLABSI: central-line associated
bloodstream infection
Episodes
(N = 100)

Mean ± SD

Median (IQR)

5.81 ± 6.51 years

2.62 (9.68) years

0-1month

14

12.36 ± 5.47 days

11.5 (7.5) days

1 month -< 1 year

19

5.60 ± 3.38 months

5.82 (6.12) months

1 year - <5 years

29

2.53 ± 1.06 years

2.48 (1.95) years

5 years - <12 years

15

7.95 ± 1.99 years

8.18 (2.74) years

12 years +

23

16.5 ± 1.97 years

16.86(2.46) years

Duration (days) of
Hospital Stay:

57.15 ± 64.69

34.5 (44.75)

Duration (days) of admission postpositive blood culture:

38.54±41.44

22(29.5)

Age Range

1. Children’s National Hospital Division of
Infectious Diseases

PURPOSE: Candidemia is the most
common invasive fungal infection in
hospitalized children, and the third
most common cause of pediatric
nosocomial bloodstream infections.1-3
Te distribution of species of Candida
causing bloodstream infections in hospitalized children has shifed over time,
as have the resistance patterns to antifungal drugs. Te objective of this study
is to investigate the epidemiology, the
species distribution, patient outcomes,
and the species’ time to positivity (TTP)
for Candida bloodstream infections.
METHODS: This retrospective
cohort study analyzed all patients
<21 years of age with a positive blood
culture for Candida admitted to
Children’s National Hospital between
January 1, 2010, and December 31,
2020. Demographic features, baseline clinical characteristics, clinical
outcomes including complications,
Candida species and susceptibilities,
duration of fungemia, and TTP for
yeast were collected from the electronic
health records through structured
chart review.
RESULTS: One-hundred episodes
of Candida (94 patients) were included
in this study. Te mean age of patients

Hospital Acquired Infection

62

Where in the hospital
General Hospitalist Service

19

PICU

19

NICU

17

Heme/Oncology/BMT

16

Intestinal Rehabilitation Unit

12

CICU

10

NSU/SCU

3

Other

4

Central Line

89

CLABSI

52

Unknown if CLABSI or not

31

Not a CLABSI

6

Total Removed Central Line

70

Total CLABSI Removed Central Line

49

Central Line

in the cohort was 5.81 ± 6.51 years
(Table). Te mean duration of admission was 57.15 days ± 64.69. Further,
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46% of episodes were admitted to
critical care units, while 16% were
admitted to the hematology/oncology/
bone marrow transplant unit, and
12% were admitted to the intestinal
rehabilitation unit. Sixty-two percent
of episodes were hospital-acquired
and 52% of episodes were deemed a
central-line associated bloodstream
infection (CLASBI). C. parapsilosis/
guilliermondii was the most identifed
pathogen (44), followed by C. albicans
(38), C. lusitaniae (8), C. tropicalis (7),
C. krusei (2), C. famata (1), C. glabrata
(1). Ninety-four percent of isolates
showed susceptibility to fuconazole,
with two episodes of C. krusei, one
episode of C. glabrata, one episode of
C. parapsilosis/guilliermondii, one
episode of C. tropicalis, and one episode
of C. albicans demonstrating resistance
to fuconazole. Te mean TTP for C.
albicans was 37.72±17.56 and non-C.
albicans was 30.24±14.07 (p=0.031).
Te mean TTP for CLABSIs was 27.37
± 14.90 and non-CLABSIs was 38.38 ±
15.05 (p=0.003) (Figure).
CONCLUSION: Candida bloodstream infections occurred most
frequently in critically ill children
admitted in the intensive care unit,
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FIGURE: Average Time to Positivity (TTP)
* = p-value < 0.05
CLABSI = Central Line Associated Blood Stream Infection

and more than half were determined
to be CLABSIs. Te time to positivity
was signifcantly longer for CLABSIs
than non-CLABSIs and for C. albicans
vs. non-C. albicans species. Te vast
majority of isolates were susceptible to
fuconazole.
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The novel SARS-CoV-2 virus, commonly known as COVID-19, was
declared a pandemic by the World
Health Organization in March 2020.
COVID-19 causes a wide spectrum of
clinical conditions, ranging from mild
anosmia to life-threatening acute respiratory distress syndrome (ARDS).1,2,3,4,5
Fever and dyspnea are common symptoms upon hospital admission, 2 but
there is no strong consensus on which
symptoms are indicative of severe
COVID-19. It remains difcult to predict which patients are at increased risk
for severe disease that necessitates ICU
admission and/or intubation.
Given that many patients initially
present with respiratory symptoms,
patients generally receive chest imaging
upon admission and repeatedly during
hospitalization. Te American College
of Radiology issued guidelines in

March 2020 regarding the appropriate
were 365 patients with an average age
use of chest radiography and comof 61.4 years (range: 20-105; SD 17.8).
puterized tomography (CT) scans in
Initially 335/365 (91.78%) patients
patients with suspected or confrmed
received a chest radiograph and abnormalities were present on 273/335
COVID-19 disease. It is currently rec(81.49%).
ommended that chest CT not be used
A statistically significant relaas frst-line imaging, and portable chest
tionship was found between ICU
radiography may be recommended
admissions and a chest radiograph
when radiography is necessary due to
revealing opacities (P<0.04), in a difthe need for careful infection control.3
Common fndings on chest radifuse distribution (P<0.004) or bilatography include patchy, hazy, reticeral distribution (P<0.04). However,
ular, and widespread opacities, while
the Mann-Whitney U test revealed
chest CT findings
common in patients
w it h COV I D -19
Patients with diffuse or bilateral opacities, or
i n c lu d e g r o u n d
g lass opacit ies,
pleural effusion on initial imaging should be
reticular pattern,
and crazy paving.4
considered high risk for ICU admission and
T he s e f i nd i ngs ,
though, are nonmortality.
specific and indicate the need for
caref u l exa mination of chest imaging of known
no statistically signifcant diference
COVID-19 positive patients to identify
(P=0.21) in severity scores for ICU
any commonalities.
admission. A statistically signifcant
Te purpose of this study is to deterrelationship was also found between
mine whether there is an association
the presence of diffuse (P<0.001) or
between initial chest imaging findbilateral (P<0.007) opacities; pleural
ings, ICU admission, and mortality in
efusion (P<0.031); or underlying pulCOVID-19 positive patients, which may
monary conditions (P<0.048) on initial
potentially be used to identify patients
chest radiograph and mortality. Te
at risk for adverse outcomes.
one-sided Mann-Whitney U test indiA retrospective chart review of
cated that the patients who died had a
COVID-19 positive inpatients at a
statistically signifcantly larger severity
tertiary care facility between March
score (P=0.00004) than patients who
1, 2020, and May 31, 2020 was consurvived.
ducted. Initial chest imaging reports
Our results identify initial chest
were reviewed for keywords. EMR was
imaging findings that may portend
reviewed for data on ICU admission
poor prognosis. Patients with difand mortality. Statistical analyses utifuse or bilateral opacities, or pleural
lized were Mann-Whitney U, Fisher's
exact, and chi-squared tests. Included
Continued on p. 48
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efusion on initial imaging should be
considered high risk for ICU admission and mortality. Underlying pulmonary pathology present on initial
imaging increases risk of ICU admission and mortality, confrming fndings
established by prior research. Initial
radiographic fndings can be used to
stratify patients at increased risk for
mortality and efciently allocate hospital resources.
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The Effects of Parenting Stress Between Poverty and
Language Outcomes at One and Two Years
potentially underestimating the efects
of poverty on emerging language skills
in infancy. It remains unclear how
poverty and parenting stress may afect
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BACKGROUND: Poverty and parenting
social diversity, socioeconomic disadstress are associated with well-estabvantage, and delivery hospital.
lished impairments on language develMETHODS: At birth,
maternal demographic
Socioeconomic adversity at birth and
stressor indices (race,
age, and education) were
parenting stress did not predict language
calculated as a proxy for
family-level poverty, as
outcomes at age 1. However, by age 2,
systemic inequalities disproportionately impose
financial hardships on
higher socioeconomic adversity composites
A f r ic a n A mer ic a n s ,
teenagers, and mothers
at birth (p=.005) predicted worse overall
who did not graduate
high school. The Area
language ability.
Deprivation Index
(ADI) quantified community-level poverty,
opment, which predicts academic
which aggregates local family incomes,
success throughout school.1 Te Family
housing quality, and employment
Stress Model has been proposed as a
opportunities into national percenmechanism linking socioeconomic
tiles of neighborhood disadvantage.4
adversities to early language skills, with
Principal component analysis (PCA)
parenting stress moderating this rela2,3
computed composites of socioeconomic
tionship. However, most prior studies
adversity. At subsequent 1- and 2-year
sample school-age children and are
assessments, mothers reported general
not enriched for low-income families,
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parenting stress (Parenting Stress
Index, 3rd Edition) and child receptive, expressive, and overall language
abilities were assessed (Bayley Scales
of Infant and Toddler Development,
3rd Edition). Stepwise linear regression models assessed the independent
and interactive efects of poverty and
parenting stress on children’s language
outcomes at ages 1- and 2- years afer
adjustment for child sex, preterm birth,
and infant temperament.
RESULTS: Socioeconomic adversity at birth and parenting stress did
not predict language outcomes at age
1. However, by age 2, higher socioeconomic adversity composites at birth
(p=.005) predicted worse overall language ability. Receptive language skills
were most impacted, as communitylevel poverty (p=.002), family-level
poverty (p=.01), and parenting stress
(p=.04) had signifcant main efects.
Interaction terms with socioeconomic
adversity composites (p=.02) and community-level poverty (p=.02) revealed
signifcant moderating efects of parenting stress between socioeconomic
adversity and receptive language skills
at age 2. As shown in the fgure, high
parenting stress (≥ 85th percentile)
predicted impaired receptive language
irrespective of disadvantage. Low/
normal parenting stress was not a
signifcant bufer against the efects
of poverty on language development.
DISCUSSION: Tis study suggests
that socioeconomic adversity at birth,
particularly living in a disadvantaged
neighborhood, is a significant risk
factor for impaired language development by age 2. General parenting stress
is also of concern, but only regarding
Continued on p. 50
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receptive language. It may be too early
to observe these efects at age 1, as language is less typically developed at this
stage. By identifying disadvantaged
mothers at birth, interventionalists
may narrow persisting achievement
gaps by helping socially disadvantaged
infants master emerging language
skills before the efects of poverty set in.
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There are two critical phenomena
occurring in college students across
America: Students are becoming
increasingly sedentary, and students’
levels of negative emotional states continue to deteriorate.1
There is a wealth of studies that
have examined the correlation between
activity and mental health. Te most
famous of these studies is referred to
as the Profle of Mood States (POMS)
Iceberg profile, which indicates six
subscales of emotional state: confusion,

FIGURE 1: The POMS “Crater" Profle.

has been well-studied and documented,
little research exists to show the relationship between sedentary time and
emotional state.
To help understand the mood state
profile of college students who are
sedentary, a cross-sectional
study was performed, conThis study could highlight how widesisting of 62 University of
Utah kinesiology underspread the rising emotional crisis among
graduate participants —
25 male, 37 female. Tese
participants each comcollege students is.
pleted a self-report questionnaire describing their
anger, vigor, and tension. 2,3 Tis study
demographics, minutes of sedentary
demonstrated that elite athletes who
behavior per day, and also completed a
exercised more ofen than the general
Profle of Mood States questionnaire.
population were expected to have
Te participants were grouped into two
lower levels of confusion, anger, tencategories based on their responses,
sion, depression, and fatigue, but much
more sedentary (>8 hr/day) or less
2
higher levels of vigor. When these two
sedentary (<7 hr/day). Te grouping
groups were graphed on a comparison
numbers were chosen because of the
chart, a very large and singular spike
standard American 9 a.m.–5 p.m. work
was seen on the vigor scale.2 Tis spike
schedule.1 Tis placed 27 students in the
in vigor is what coined the phrase
less sedentary group, and 35 in the more
2
“Iceberg.”
sedentary group. Once the data and the
Although the relationship between
participants were grouped, the POMS
exercise quantity and emotional state
subscale scores were standardized and
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graphed on a comparison chart. Data
was standardized using the “standardize” function in excel, which is
analyzed using the sum, mean, and
standard deviation of the raw data. Te
process was performed for both groups,
and the standardized data was used to
make the conclusions. It was originally
theorized that results would be similar
to the POMS Iceberg Profle study, with
the less sedentary group showing a large
spike on the vigor subscale. However,
the results show no statistical signifcance between the two groups in confusion, anger, tension, depression, or
fatigue subscales. Tere was, however,
a signifcant drop in the vigor score of
the more sedentary group. Tis drop led
to what we now call a POMS “Crater”
Profle, a direct reversal of the POMS
Iceberg Profle.
Te implications of this study are
notable for the emotional well-being
of college students, as college students
across the United States are spending
on average 76% of their waking hours
performing sedentary activity.1 With
Continued on p. 52
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a minimum of 12 waking hr/day, this
puts the average college student being
sedentary for 9 hr/day minimum, well
over the 8 hr/day threshold as defned
by this study. Tis study could highlight how widespread the rising emotional crisis among college students is.
Universities should take action to help
students be more successful and have
more vigor, and they should ensure
policies that allow students more time
to be standing or active throughout the
day, especially during rigorous class
schedules.
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TABLE: Parent reported behavioral and cognitive problems on standardized
instruments
Scores

Median
T-scores

Interquartile
Range

N (%) clinically
elevated, (defnition)

BRIEF Global executive composite,
(N=20)

58.5

53.5-67.8

3/20 (15%), (>70)

CBCL Total Problems (N=21)

57

52-64

6/21 (29%), (> 63)

CBCL Internalizing
Problems (N=20)

59

55.5-65.8

7/20 (35%), (>63)

CBCL Externalizing
Problems (N=20)

55.5

48.2-62.2

4/20 (20%), (>63)

CBCL Anxious/Depressed (N=20)

58

51.8-63.5

2/20 (10%), (>70)

CBCLDSM-5 Anxiety
Problems (N=20)

61.5

53.5-69.8

5/20 (25%), (>70)

routine neuropsychological (NP)
screening at developmental transitions
for all patients with TS.1 Our objective
was to characterize the spectrum of
cognitive impairment in patients with
TS referred from the newly established
multidisciplinary TS specialty clinic at Children’s
National Hospital.
Turner syndrome (TS) is a rare genetic
METHODS: Te study
prot
o c ol w a s d e e me d
condition caused by a partial or completely
exempt by the institutional
review board. We retromissing second X-chromosome in a
spectively reviewed data
from all completed neuphenotypic female.
ropsychology (NP) assessments between 1/1/2019
and 5/31/2021 along with
karyotype, age at diagnosis, and age at
and renal defects, skeletal anomalies,
estrogen start. Descriptive analyses of
lymphedema, hearing loss, metabolic
parent reports, impairments based on
syndrome, and cognitive difficul1
the
evaluator’s interpretation of scores
ties. While patients typically exhibit
as
stated
in the NP summary report,
normal intelligence and strong verbal
and Spearman correlation with clinical
abilities, impairment in mathematics,
factors
(SAS V9.4) are presented.
executive function, visuospatial ability,
RESULTS: Of 75 patients, 23 (31%)
as well as diagnoses of autism, attenhad completed NP assessment, with
tion defcit disorders and anxiety are
median age 11.4y (2.3-20.2), 48%
common. 2,3 Guidelines recommend

Turner syndrome (TS) is a rare genetic
condition caused by a partial or completely missing second X-chromosome
in a phenotypic female. TS is characterized by short stature, primary
ovarian insufciency, congenital heart
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were of 45,X karyotype and 30% were
diagnosed in the pre/perinatal period.
Parent-reported T-scores (mean 50,
SD 10) on BRIEF (Behavior Rating
Inventory of Executive function v1
or v2) and CBCL (Child Behavior
Checklist) are shown in Table. In the
summarized NP report, 5/23 (22%)
had autism; 7/23 (30%) attention defcit
disorder, 9/23 (39%) developmental
delays, 14/23 (61%) impaired academic
function, 13/23 (57%) social difculties, 11/23 (48%) memory problems,
12/23 (52%) impairment in math, 13/23
(57%) impaired visual-spatial abilities,
16/23 (70%) impairment in executive
functioning, and 12/23 (52%) anxiety
disorder. In 11 patients with data on
treatment of primary ovarian insuffciency, the age at estrogen start was
positively correlated with memory
impairment (p=0.009), but other correlations were not signifcant.
CONCLUSIONS: Our data confrm
the high prevalence of NP impairment
in TS afecting multiple domains, in
Continued on p. 54
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Continued from p. 53
excess of parental reports. One limitation is a potentially biased sample since
the pandemic led several families to
delay the assessment, and those that
were completed may refect patients
with a greater degree of impairment.
Future studies are necessary to assess
barriers to following through with NP
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testing afer referral, optimal tools for
assessing areas of deficit in TS, frequency of testing, and the impact of test
results on treatment planning.
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BACKGROUND: Te purpose of this
study was to examine the concerns of
brain health and wellness of former
NCAA Division I (DI) football athletes compared to former National
Football League (NFL) athletes. Tis
study aimed to understand (1) How
post-concussion symptoms, measured
using the Neurobehavioral Symptom
Inventory (NSI), compare between
former NCAA DI football athletes and
former NFL athletes, and (2) How these
groups of former athletes describe the
role that playing football had on their
brain health.
METHODS: We utilized a mixed
methods design incorporating a survey
of former NFL athletes and former
NCAA DI football athletes (N = 131)

TABLE: Means, standard deviations, and independent t-tests for former NFL and
Division I College Football Athletes
Former NFL Players

Former Division 1
College Football Athletes

M

SD

M

SD

U

Estimated
p-value

Total Number of
Concussions Sustained

8.995

9.068

4.72

6.426

735

0.01

Worry

5.011

2.254

5.92

2.06

849

0.233

NSI Score

11.94

13.517

10.52

7.875

1179

0.651

Variable

and subsequent semi-structured interviews (N = 19). Survey data was analyzed using descriptive and inferential
statistics; analysis of the interviews was
descriptive.
RESULTS: Several themes were
captured from the interviews, including
(1) concerns about living with the consequences of sport concussions, (2) concerns for developing long-term sequelae
from sport concussions and chronic
traumatic encephalopathy (CTE), (3)
expressing concerns for long-term
efects or symptoms, (4) difculties differentiating between normal aging and
long-term efects of sport concussions,
and (5) concerns for the long-term
sequelae from sport concussions in
current and former athletes at all levels
of football. Tere was a signifcant difference in the number of concussions

CLINICAL TRANSLATIONAL RESEARCH | NEURO-PSYCHOLOGY

sustained between former NCAA DI
football athletes and former NFL athletes, but no signifcant diference in the
NSI scores or self-reported worry about
future brain health, measured on a scale
from 1-8 (Table).
CONCLUSIONS: No significant
diference exists in concern about brain
health between former NFL and former
NCAA DI football athletes despite
former NCAA DI football athletes
having signifcantly fewer self-reported
sport concussions and less total playing
time. Tis is signifcant for current and
future health care professionals to recognize that worry about sequelae from
sport concussions is individual to each
patient. Athletes' concerns about brain
health in relation to multiple concussions will be important to address in
future research.
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C A S E D I AG N O S I S: A p a t i e nt
with acquired Wernicke-Korsakoff
Syndrome (WKS) due to hyperemesis
gravidarum induced nutritional thiamine defciency.
CASE DESCRIPTION: We present
the case of a previously healthy,
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non-alcohol drinking, 26 year old
female who suffered hyperemesis
gravidarum and spontaneous abortion
during a pregnancy. Two weeks afer
pregnancy loss, the patient developed
severe memory impairment, ataxia,
nystagmus, and poly neuropathy.
Laboratory results revealed a vitamin
B1 level of less than 20.0 (undetectable)
and neuro-imaging revealed hyperintensities in her mammillary bodies.
Intravenous thiamine replacement
was initiated and she was discharged
to an acute inpatient rehabilitation
facility (IRF). In the (IRF), she had
an admission total self-care GG0130
score of 29 and an admission mobility
GG0170 score of 34. Her total self care
goal score was 42 while her mobility
goal score was 64. On discharge, 10
days after admission, she reached a
total self care goal of 42 and a mobility
score of 79. Based on clinical notes and
scores from occupational and physical
therapy, the patient demonstrated
continued improvement and signifcant

recoveries in functional impairment
from physical rehabilitation.
DISCUSSION: This patient, a
young, non-alcoholic woman, does not
ft the classic demographic of WKS,
which typically presents as an older
alcoholic male. Due to this rare presentation, we believe that she exhibited
an extremely positive response to the
acute inpatient rehabilitation. In just 10
days, she was able to exceed discharge
goals and regain signifcant function.
As such, for patients of this demographic, it may be helpful to refer them
to the acute inpatient rehabilitation for
improvement and optimization of their
functionality.
CONCLUSIONS: Tis young female
with Wernicke-Korsakof secondary to
acquired thiamine defciency was an
atypical presentation for her diagnosis.
Her quick progression with acute inpatient rehabilitation services can inform
goals for similar patients in the future.
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BACKGROUND: In people who use
drugs (PWUD) with opioid use disorder (OUD), buprenorphine is a vital
treatment to decrease opioid use and
overdose. FDA prescribing information for buprenorphine advises dosing
up to 24mg/day, however doses of
buprenorphine up to 32mg have been
shown to be safe and efective.1 Further,
treatment retention increases linearly
with higher doses of buprenorphine
up to 32mg2 and doses over 16mg are
associated with decreased opioid use.3
However, 32mg dosing is not recommended in SAMHSA guidelines and
is ofen not supported by insurance.
We aimed to understand the outcomes
associated with buprenorphine dosing
of 32mg/day relative to 24mg/day.
METHODS: ANCHOR is a single
center study of PWUD with HCV,
OUD, and opioid misuse within three
months, who were treated for HCV
and ofered buprenorphine. Patients
initiating buprenorphine were induced

30

20

10

0

32mgVisit

24mgVisit
FIGURE 1: Percentage of Self-Reported Drug Use
on 16mg/day and up-titrated to 32mg/
day as needed. Patient-endorsed drug
use, mode of drug use and urine drug
screens (UDS) were collected at frst
visit post-dosage increase, and afer two
weeks on increased dose. For analysis,
the cohort was divided into individuals
stabilized on 24mg (24mg-cohort) and
32mg (32mg-cohort). Comparisons
were made looking at drug use factors of both cohorts at 24mg dosing,
and within the 32mg-cohort alone,
comparing visits on 24mg to visits on
32mg. Fisher’s exact test was used for
statistical analysis.
RESULTS: Seventy three participants initiated buprenorphine treatment. Patients were predominantly
male (54,74%) and Black (71,96%),
injected daily (46,63%), and had a mean
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OUD-DSM5 score of 9.4. Te average
age at which opioid use was initiated
was 21.4 years.
Over the course of median 64 weeks
of buprenorphine treatment (IQR197785), one (1.3%) patient remained on
16mg, 18 (25%) patients stabilized on
24mg (24mg-cohort), and 54 (74%)
patients stabilized on 32mg (32mgcohort). Stabilizing on 32mg was not
signifcantly associated with housing
status, baseline IDU frequency, previous MOUD treatment, hazardous
alcohol use, comorbid mental illness, or
age of opioid initiation (p> 0.05 for all).
When comparing 24mg and 32mgcohort patients at visits receiving 24mg/
day, 32mg-cohort patients were more
Continued on p. 58
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Continued from p. 57
100

likely to endorse drug use (p=0.04),
despite also being more likely to
have buprenorphine present in UDS
(p=0.004). Tere was no statistically
signifcant association between mode
of drug use (p=0.44), or UDS positive
for opioids (p=0.20).
When looking only at the 32mgcohort patients, and comparing factors at visits while on 32mg vs 24mg,
patients were less likely to endorse prior
week drug use (p=0.04) or being triggered to use by cravings (p=0.017) or
withdrawal (p=0.017) while on 32mg.
Tere was no signifcant association
between dose strength and presence
of buprenorphine in UDS (p=0.31) or
UDS positive for opioids (p=0.65).
CONCLUSION: Higher buprenorphine doses have been associated with
better retention and outcomes.1,3 In
our cohort, patients who stabilized on
32mg were more likely to endorse drug
use while on 24mg compared to those
stabilized on 24mg. Afer increasing
to 32mg dosing, these patients were
less likely to endorse drug use, triggers of craving, and withdrawal. Tese
data indicate that there are some
patients who beneft from 32mg/day of
buprenorphine. Consideration should
be given to modifying treatment guidelines and insurance policies to facilitate
higher dosing in these patients.
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FIGURE 2: Percentage of UDS Negative for Buprenorphine
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OBJECTIVES: To estimate the costeffectiveness of alternative risk-dictated strategies utilizing prophylactic
tranexamic acid for the prevention of
postpartum hemorrhage.
METHODS: We constructed a
microsimulation-based Markov decision-analytic model estimating the
cost-efectiveness of three alternative

Figure 1. Simplified model structures - (1) four strategies,
(2) health states, (3) vaginal delivery subtree, (4)
cesarean delivery subtree

"':_-=--

FIGURE 1: Simplifed model structures. (1) four strategies, 2) health states, 3) vaginal
delivery subtree, (4) cesarean delivery subtree

patients irrespective of hemorrhage
risk. Each strategy diferentially modified risk-specific hemorrhage probabilities by estimates of tranexamic
acid’s prophylactic efcacy. Outcome
measu res i ncluded
i ncrement a l cost s ,
Our fndings suggest that routine prophylaxis
quality-adjusted lifeyears, and outcomes
with tranexamic acid would likely result in
aver ted. Costs and
benefts were considsubstantial cost-savings and reductions in
ered from the health
care system and sociadverse maternal outcomes in this context.
etal perspectives over
a lifetime time horizon
and were discounted at
an annual rate of 3%.
risk-dictated strategies for tranexamic
One-way deterministic Monte Carlo
acid prophylaxis versus no prophylaxis
probabilistic sensitivity analyses were
in a cohort of 3.8 million pregnant
performed to assess parameter uncerwomen delivering in the United States:
tainty across a wide range of literaturetranexamic acid in high hemorrhage
supported estimates.
risk patients only, tranexamic acid in
R E S U LT S: A l l i nt e r v e nt i o n
high and medium hemorrhage risk
strategies were dominant versus no
patients, and tranexamic acid in all
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prophylaxis, implying that they were
simultaneously more effective and
cost-saving. Prophylaxing delivering
women irrespective of hemorrhage risk
produced the most favorable results
overall, with estimated cost savings
greater than $690 million and up to
149,505 PPH cases, 2,933 hysterectomies, and 70 maternal deaths averted,
per annual cohort. Treshold analysis
suggested that tranexamic acid is likely
to be cost-saving for health systems at
costs below $190 per gram.
CONCLUSIONS: Our findings
suggest that routine prophylaxis with
tranexamic acid would likely result in
substantial cost-savings and reductions
in adverse maternal outcomes in this
context.

Continued on p. 60
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Lichen sclerosus (LS) is a chronic condition which can result in anogenital
scarring and vulvar squamous cell
carcinoma (SCC) if not treated appropriately. In pediatric patients, the risk
of developing long-term complications related to scarring is unknown.1
Although LS often symptomatically
improves at puberty, active disease can
persist through adulthood.1 Te goal of
this survey is to identify variations in
methods of diagnosis, treatment regimens and long-term management of
PVPLS in individuals assigned female
at birth.
We administered a 35-question
survey on diagnosis and management
of PVPLS through the North American
Society for Pediatric and Adolescent

Gynecology and Pediatric Dermatology
(p < .001). Only 41 (42%) recommended
Research Alliance. Survey responses
lifelong follow-up. Tere was not a stawere collected electronically between
tistically signifcant diference in recJuly 13 and Aug. 30, 2021.
ommendation for long-term follow-up
There were 102 responders. The
between the specialties (p =.66).
majority were attending physicians
Initial treatment was similar among
(n=95, 93%) consisting of 44 (46%)
various specialties, likely refecting the
pediatric and adolescent gynecologists,
presence of guidelines and uniformity
38 (40%) pediatric dermatologists. More
in training for newly diagnosed PVPLS.
than half (n= 55, 55%) treated only two
However, there was considerable variapatients with PVPLS per month. Only
tion in maintenance therapy and long23 (23%) of the responders were comterm follow-up despite the risk of perpletely confdent in diagnosing PVPLS.
sistence of PVPLS into adulthood.2 Tis
potentially refects a lack of confdence
Tere was not a statistically signifcant
difference in confidence
in diagnosis between speLichen sclerosus (LS) is a chronic condition
cialties (p=0.39). Sixty-six
(65%) used clinical features
which can result in anogenital scarring
(history and physical) alone
for diagnosis. Tere was a
and vulvar squamous cell carcinoma (SCC)
statistically signifcant difference in the use bacterial/
if not treated appropriately.
fungal cultures (p = .01),
parasite testing (p = .01),
STI testing (p = .04 and
the use of a Wood’s lamp (p=.03) for
because of limited exposure and /or lack
diagnosis between specialties. Only 12
of guidelines for the long-term manage(12%) reported use of biopsy for diagment of PVPLS.3 Further studies are
nosis and the diference between the
needed to elucidate the natural history
specialties was not statistically diferent
of PVPLS and to identify optimal long(p= .63). Vitiligo was identifed as the
term management.
most difcult diagnosis to diferentiate
REFERENCES:
from PVPLS (n=54, 53%). Less than half
1. Morrel B, van Eersel R, Burger CW et al. Te
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lines for the management of lichen sclerosus,
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2018. Br J Dermatol. 2018;178(4):839-853.
recommended by 66 (65%). Tere was
3. Pergialiotis V, Bellos I, Biliou EC, et al. An
a statistically significant difference
arm-based network meta-analysis on treatbetween the specialties with a greater
ments for vulvar lichen sclerosus and a call
for development of core outcome sets. Am J
number of pediatric dermatologists
Obstet Gynecol. 2020 Jun;222(6):542-550.
recommending maintenance therapy

CLINICAL TRANSLATIONAL RESEARCH | OB-GYN

61

Vulvar Disorders Encountered at a Multidisciplinary
Pediatric Clinic: A Retrospective Chart Review
Aneka
Khilnani, MS,
MSIII
ADVISORS: Tazim
Dowlut-McElroy,
MD,1,2 Kaiane
Habeshian, MD3
1. Pediatric and Adolescent Gynecology,
Eunice Kennedy Shriver National Institute
of Child Health and Human Development
(NICHD), National Institutes of Health (NIH)
2. Children’s National Hospital Pediatric
and Adolescent Gynecology, Department of
Surgery
3. Children’s National Hospital and George
Washington University School of Medicine,
Department of Dermatology
Vulvar dermatology is a feld in which
many pediatricians, gynecologists,
and dermatologists may lack sufcient
comfort and training, leading to delays
in diagnosis and treatment.1 Anogenital
vitiligo and lichen sclerosus (LS) can
be difcult to distinguish, especially in
skin of color, in part because depigmentation in LS can persist afer symptom
resolution and because vitiligo can coexist with symptomatic dermatoses.2
Proper diagnosis is essential because
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TABLE: African American (AA) patients with LS experienced the longest time from
symptom onset to diagnosis (18.76 months vs 10.6 months in other races, P=0.024).
Time from symptom onset to LS diagnosis (months)

African American
18.76

undertreated LS is associated with
long-term sequelae including scarring
and squamous cell carcinoma.3
Data were extracted from 180
patients seen over a 3.5 year period in
a joint dermatology-gynecology clinic
at an academic children’s hospital.
Descriptive statistics were used to analyze data on diagnosis, symptom onset
to time of diagnosis, and misdiagnosis
by race.
L S (5 8 . 59 %), v u l vov a g i n it i s
(18.18%), and vitiligo (17.17%) were the
most common diagnoses. Vitiligo was
most frequently initially misdiagnosed
(50%) as another disease and most
frequently diagnosed in patients with
darker skin tones. LS and vitiligo were
most frequently misdiagnosed as each
other. African American (AA) patients
with LS experienced the longest time
from symptom onset to diagnosis (18.76
months vs 10.6 months in other races,
P=0.024; table).

Other
races

P-value

10.6

0.024

I I I

LS and vitiligo may present more
similarly to each other in darker skin
tones.4 Further research is needed to
elucidate disease presentation in skin
of color with the aim of developing criteria to distinguish LS and anogenital
vitiligo.
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Genetic screening and testing has only
recently become an accessible assessment for genetic risk. Unfortunately,
these technologies have been underutilized in minority populations despite
their usefulness for predicting diseases
like sickle cell disease (SCD), often
found in African American and Black
and Hispanic populations. We surveyed
prenatal patients to understand current
choices, beliefs and experiences surrounding genetic screening and testing,
specifcally for sickle cell disease.
In this cross-sectional survey, we
collected information from 322 women

during prenatal visits from July 2019
Regarding sickle cell health behaviors,
through May 2021. Responses to quesonly the responses to the statements
tions about pregnancy screening and
about if sickle cell is not in their family,
testing practices were analyzed for
then it is likely not in themselves or
trends to identify barriers to care and
their children, and partners’ opinions
education about testing and screening
about genetic screening remained
for sickle cell disease. Patients were
significant (p=0.011 and p=0.081,
asked to rate whether they agree or disrespectively).
agree with statements regarding sickle
Our f indings suggest gaps in
cell health behaviors. We used χ2 tests
screening, testing, and educational
to compare categorical variables by
Our fndings suggest gaps in screening, testing,
self-reported race.
Binar y logistic
and educational efforts between African
regression was
used to determine
American/Black and White patients, as well as
the odds ratios and
confdence intervals
for each outcome.
differences in opinions regarding pregnancy
Women were a
mean (SD) age of
management with a family history or gesta33.3 (6.1). 42.9% of
patients self-identitional diagnosis of sickle cell disease.
fed as White while
41.3 of patients selfidentifed as African American/Black.
efforts between African American/
Screening questions were adjusted for
Black and White patients, as well as
differences in race, insurance, and
differences in opinions regarding
education levels to show signifcant difpregnancy management with a family
ferences in responses between African
history or gestational diagnosis of sickle
Americans/Blacks and Whites for
cell disease. Future research should
screening for SCD (p=0.047, OR 95%
focus on decreasing these health care
CI= 0.455 [0.210-0.989]) and plans to
gaps and improving education that
meet with genetic counselors (p=0.049,
address concerns about SCD for relOR 95% CI = 0.299 [0.090-0.993]).
evant populations.
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PURPOSE: Selective laser trabeculoplasty (SLT) is a procedure commonly
used as a primary or adjunctive therapy
in glaucoma to lower intraocular
pressure (IOP). Currently, there is no
consensus on whether SLT causes a
decrease in IOP in the untreated contralateral eye.1,2,3 Our study investigates
the pre- vs post-operative change in IOP
and the number of medications used in
a patient’s untreated contralateral eye
within 12 months afer receiving SLT.
DESIGN: A retrospective observational study was conducted on
patients who v isited t he George
Washington University Department
of Ophthalmology between January
1st, 2008 and January 1st, 2020 with
primary open-angle, pseudoexfoliation,
pigmentary, or normal-tension glaucoma and who received 360 degrees
SLT. Patients were excluded if they
had laser or glaucoma surgery either
prior to or within 12 months after
SLT, if they had other glaucoma types,
or if they used steroid medications.
Demographics were collected and the
pre- vs post-SLT IOP and number of
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TABLE: Mean IOP values in the untreated contralateral eye within 12 months
following SLT.

-

I Number I
I
I
Observed Mean Std. Dev Std. Error

95% Confidence
interval

I
T-value

P-value

125

15.21

3.55

0.32

14.59

15.84

125

14.29

3.50

0.31

13.67

14.91

3.33

0.0006

125

14.22

3.61

0.32

13.58

14.86

3.09

0.0025

125

14.74

3.53

0.32

14.12

15.36

1.59

0.1149

medications were analyzed using a
in the mean number of medications
paired samples t-test and ANOVA.
in the untreated eye post-SLT. 3 Tis
RESULTS: A total of 125 patients
study’s population also improves on
were included in this study. Mean
the previous study’s external validity.
IOPs for the untreated eyes at baseThere were 125 patients (previously
line, 6-week post-operation, 6-month
291, 432, 323) with diverse backgrounds
post-operation,
a n d 12 -m ont h
First-time SLT glaucoma patients have a statistipost-operation
were 15.21 ± 3.55
cally signifcant decrease in IOP and medications
mmHg, 14.29 ±
3.5 mmHg (P <
used in the untreated contralateral eye at 6 weeks
0.05), 14.22 ± 3.61
mmHg (P < 0.05),
and 6 months after treatment.
and 14.74 ± 3.53
mmHg (P > 0.05),
respectively. For
(African American (57.6%), Caucasian
the same time points, the mean number
(31.2%), Asian (5.6%), Hispanic/Latino
of medications were 1.73 ± 1.29, 1.68 ±
(4%), not reported (1.6%) - previously
1.31 (P < 0.05), 1.68 ± 1.30 (P < 0.05),
unreported2 or homogenous3) and
1.68 ± 1.29 (P > 0.05), respectively.
DISCUSSION: The mean pre-op
no history of laser treatments (previIOP and number of medications in
ously included patients with prior laser
the untreated eye had a statistically
treatments2,3).
signifcant reduction at 6 weeks and
CONCLUSION: First-time SLT
6 months post-SLT but not at 12
glaucoma patients have a statistimonths post-SLT. This study differs
cally signifcant decrease in IOP and
from previous research in showing
a statistically significant reduction
Continued on p. 65
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medications used in the untreated contralateral eye at 6 weeks and 6 months
afer treatment.
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Te aim of this study was to investigate
the relationships between groups of
genes within the atrophic, myogenic,
fbrogenic, adipogenic/metabolic, and
inf lammatory pathways and multifidus muscle health in individuals
undergoing surgery for lumbar spine
pathology.
Lu mba r spine pat holog y is a
common feature of lower back and/or
lower extremity pain and is associated
with observable degenerative changes
in the lumbar paraspinal muscles
that are associated with poor clinical
prognosis.1 Te multifdus muscle is of
particular interest due to its role in stabilizing the lumbar spine. Degenerative
changes visualized on magnetic resonance imaging (MRI) (Figure 1) typically include the accumulation of fat
(white) and the deposition of fbrotic
tissues within the muscle compartment
(grey) with worsening degree of degeneration (left to right). 2 Despite how
commonly this degenerative phenotype
is observed in this patient population,

66

FIGURE 1: Pathological Muscle Adaptations
compartment. These measures were
the underlying molecular mechanisms
are not well understood. Prior work has
used to investigate the relationships
demonstrated relationships to indibetween gene expression patterns and
3
vidual genes, however this is thought
muscle size and quality.
to oversimplify complex underlying
Relationships between gene expresphysiology. To our knowledge only one
sion and imaging (Figure 2) revealed
prior study has cumulatively looked at
associations between (a) lower expresgene expression
among multiple
Lumbar spine pathology is a common feature
pathways associated with muscle
of lower back and/or lower extremity pain and
health in individuals with LSP,4 yet
is associated with observable degenerative
did not examine
gene expression
changes in the lumbar paraspinal muscles that
levels a longside
objective measures
are associated with poor clinical prognosis.1
of muscle health.
Multifdus
muscle biopsies
were obtained from patients (n=59)
sion of adipogenic/metabolic gene
undergoing surgery for lumbar spine
(PPARD), and (b) higher expression of
pathology to analyze 42 genes from
fbrogenic gene (COL3A1) and lower
atrophic, myogenic, fbrogenic, adipofat fraction on MRI (r=-0.346, p=0.018,
genic/metabolic, and inf lammatory
and r=0.386, p=0.047 respectively).
gene pathways using quantitative
Additionally, (c) lower expression of
polymerase chain reaction. Multifdus
myogenic gene (mTOR) was related to
muscle morphology was examined
greater lean muscle cross-sectional area
preoperatively at the level and side
(r=0.388, p=0.045).
of biopsy using T2-weighted MRI to
Fibrogenic and adipogenic/metadetermine whole muscle compartment,
bolic genes were related to pre-operative
lean muscle, fat cross-sectional areas,
and proportion of fat within the muscle
Continued on p. 67
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13

FF by PPARD Expression

muscle quality, and myogenic genes
were related to pre-operative muscle
size. Tese fndings provide insight into
important molecular pathways associated with muscle health in the presence
of lumbar spine pathology, establishing
a foundation for future research that
addresses how these changes impact
outcomes in this patient population.
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INTRODUC TION: Wit h modern
antiretroviral therapy (ART), human
immunodefciency virus (HIV) infection has become a chronic condition.
Patients diagnosed with HIV now
live longer but with more medical
comorbidities than the general population.1–4 Patients with HIV also face
certain medical conditions more ofen
than patients without HIV, including
osteonecrosis (ON).3,4 ON has a 3–100
times higher incidence in patients with
HIV not on ART when compared to the
general population (0.135%).3–5 HIV is
shown to be a risk factor for ON, and
early literature suggests that antiretroviral therapy (ART) may be an additional, independent risk factor.3,4 Our
study aimed to assess to what extent
ART increases the odds of developing
ON in the HIV+ population.
METHODS: Utilizing an insurance
database (PearlDiver Technologies)
from 2010–20, we selected patients
using the international classifcation
of disease (ICD) for ART, HIV, and
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TABLE 1: Multivariate analysis results reported as odds ratios, 95% confdence
intervals, and p-values.
CATEGORY

HIV+/ART+ vs HIV+/ART
OR

95% CI

p-value

TOTAL ON

1.401

1.384 - 1.419

<.001

ON of Hip

1.405

1.384 - 1.426

<.001

ON of Knee

2.56

2.393 - 2.738

<.001

ON of Shoulder

1.054

1.010 - 1.100

0.016

ON. Our comparison groups were
(Table 2). ON of any joint, including
HIV on ART with ON (HIV+/ART+)
each individually, was also signifcant
and HIV not receiving ART with ON
and included in the multivariate
(HIV+/ART-). Subcategorization, via
analysis. Multivariate analysis found
ICD codes, was also used to identify
that patients in the HIV+/ART+ cohort
which joints were afected by ON (hip,
had higher odds of developing ON
knee, shoulder). Chi-squared uniwhen compared to the HIV+/ARTvariant analysis compared incidence
cohort in any joint (OR=1.401; 95%
rates as well as age, gender, long-term
CI:1.384-1.419; p<0.001), hip (OR:1.405;
steroid use, sickle
cell disease, hyperThis retrospective case-control study found that
lipidemia, a nd
elixhauser comorpatients who are HIV+ and on ART have a higher
bidity criteria for
st at ist ic a l sigrisk of developing ON than HIV+ patients who
nificance (p<0.2).
Signifcant criteria
were cont rol led
are not on ART.
for in multivariate
analysis as independent variables. Statistically signif95% CI:1.384-1.426; p<0.001), knee
cant ON of any joint and sub-analysis
(OR:2.56; 95% CI:2.393-2.738; p<0.001)
of individual joints (p<0.05) were used
and shoulder (OR:1.054; 95% CI: 1.010as dependent variables for multivariate
1.100; p=0.016) (Table 1).
analysis.
CONCLUSION: Tis retrospective
RESULTS: In total, 219,853 patients
case-control study found that patients
were found to have HIV between
who are HIV+ and on ART have a
2010-2020. Of those patients, 123,710
higher risk of developing ON than
had a history of ART, while 96,143
HIV+ patients who are not on ART.
did not. Univariate analysis was
Tis diference remained signifcant
significant for age, gender, and all
when stratifying by joint. However,
comorbidities, except coagulopathy
ART remains the gold standard for
(p=0.365), metastatic cancer (p=0.404),
Continued on p. 69
and nonmetastatic cancer (p=0.642)
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the treatment of HIV and, due to the
well-known dangers of untreated HIV,
we do not recommend discontinuing
ART to decrease the risk of ON. Further
studies are warranted to determine if
the increased risk of ON is modifable
or if the risk associated with individual
antiretroviral medications difers in a
clinically meaningful way. Physicians
should be aware of the risks ART may
pose to HIV+ patients and monitor
them closely to mitigate potential complications of ON.
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TABLE 2: Demographic and comorbidity univariate results. P-value <0.2 was considered
signifcant and included in multivariate analysis. P-value bolded if NOT signifcant.

I

Total
219853

I HIV+/ART+ IHIV+/ART I P-value
123,710

96,143

<.001

Avg.

44.61

46.32

<0.001

Std. Dev.

12.13

15.77

AGE

GENDER
Female

84968

37,974

46,994

Male

136882

87,736

49,146

<.001

Alcohol abuse

5232

2,574

2,658

<.001

Anemia, Blood Loss

5730

2,196

3,534

<.001

Anemia, Nutritional

25207

11,295

13,912

<.001

Arrhythmias

38892

20,719

18,173

<.001

Chronic Kidney Disease

22768

13,619

9,149

<.001

Chronic Pulmonary Disease

48598

26,642

21,956

<.001

Coagulopathy

13129

7,389

5,740

0.365

Depression

54170

32,548

21,622

<.001

Diabetes Mellitus

44893

19,272

25,621

<.001

Drug abuse

35863

20,981

14,882

<.001

Fluid/Electrolyte Disorders

46106

26,951

19,155

<.001

Heart Failure

18035

8,785

9,250

<.001

Hyperlipidemia

73554

38,193

35,361

<.001

Hypertension

64605

34,307

30,298

<.001

Hypothyroidism

24303

8,272

16,031

<.001

Leukopenia

10216

6,860

3,356

<.001

Liver Disease

39118

20,522

18,596

<.001

Long-term Steroid Use

4733

2,488

2,245

<.001

Lymphoma

3636

2,493

1,143

<.001

Metastatic Cancer

4581

2,567

2,014

0.404

Nonmetastatic Cancer

15070

8,567

6,503

0.642

Obesity

25561

11,952

13,609

<.001

Other Neurological Disorders

15984

8,540

7,444

<.001

Paralysis

4895

2,649

2,246

<.001

Peptic Ulcer Disease

2157

1,092

1,065

<.001

Perivascular Disease

23289

13,105

10,184

<.001

Psychoses

16396

8,606

7,790

<.001

Pulmonary Circulatory Disorders

7290

3,971

3,319

<.001

Rheumatoid Arthritis/Collagen
Vascular Disease

13452

4,811

8,641

<.001

COMORBIDITIES

Sickle Cell Disease

2201

1,006

1,195

<.001

Smoking

49961

29,938

20,023

<.001

Valvular Disease

18293

9,069

9,224

<.001
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BACKGROUND: Total knee arthroplasty (TKA) is the gold-standard for
surgical knee replacement.1 However,
there has been a recent trend to use
less invasive procedures for knee
arthroplasties that can preserve more
function, such as unicompartmental
arthroplasties (UKA’s) — medial or
lateral compartment, patellofemoral
arthroplasties (PFA’s), and bicompartmental arthroplasties (BKA’s). Early
studies with UKA’s and BKA’s showed
poor patient outcomes leading to limited usage, but recent literature has
shown improved outcomes. 2,3 There
has also been a movement towards
using robotic-assisted surgeries in
many procedures, with multiple studies
showing an increase in utilization in
robotic-assisted knee arthroplasties
from 2009 to 2014.4,5 Tere is limited
literature examining the recent trends
in utilization for each knee arthroplasty
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modality. Te aims of the study were:
(CAGR: -10.49%; p=0.013) from 2010
(1) compare the trends in utilization of
to 2019 but no signifcant diference
PFA’s, UKA’s, BKA’s, and TKA’s and (2)
in that of UKA (p=0.224) and TKA
stratify the trends for robotic-assisted
(p=0.421). Of the PFA, UKA, BKA,
and non-robotic-assisted PFA’s, UKA’s,
and TK A procedures performed,
BKA’s, and TKA’s.
6.88%, 8.83%, 17.49%, and 7.41% were
METHODS: A retrospective cohort
performed under robotic assistance,
analysis was conducted using data
respectively. For both UKA (CAGR:
collected from the PearlDiver data+19.81%; p=0.002) and TKA (CAGR:
base from 2010 to 2019. Patients who
+3.90%; p=0.038) there was a signifcant
underwent PFA, UKA, BKA, and
increase in the utilization of robotic
TKA for an indication of osteoarthritis
As the use of robotic-assisted procedures
were identifed using
Current Procedural
becomes more popular, other arthroplasty
Terminology (CPT)
codes. CPT codes for
procedures may become less favorable and
robotic-assisted procedures was included
decline in their prevalence. The results from
t o a n a l y z e t re nd s
of robot ic-assisted
for each ar t hrothis study contribute to the scarce body of
plasty type. Trends
a na ly sis wa s done
research for robotic-assisted knee arthroplasusing the PearlDiver
“BREAKDOWN”
ties and adds data on each of the arthroplasty
function to determine
the number of PFA,
modalities.
UKA, BKA, and TKA
procedures performed
each year from 2010 to 2019 for total
assistance from 2010 to 2019, but no
procedures, robotic-assisted prosignifcant diference in that for PFA
cedures, and non-robotic-assisted
(p=0.724) and BKA (p=0.951).
procedures.
CONCLUSIONS: TKA is still the
RESULTS: 1,243,677 patients
most used arthroplasty procedure for
underwent an arthroplasty procedure
OA (92.58% utilization rate). While
for OA of the knee, composed of 4,111
outcomes have improved from earlier
(0.33%) PFA’s, 87,028 (7.00%) UKA’s,
studies with PFA’s, UKA’s, and BKA’s,
1,109 BKA’s (0.09%), and 1,151,429
this has not corresponded with a
TKA’s (92.58%). There was a sigchange in utilization in these procenifcant decrease in the utilization of
dures, but rather a decrease in PFA and
PFA (Compound annual growth rate
[CAGR]: -5.73%; p=0.011) and BKA
Continued on p. 71
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BKA utilization. Our analysis suggests
that the decrease in PFA and BKA
utilization may be attributed to the
transition to more innovative surgical
techniques employing robotic assistance. As the use of robotic-assisted
procedures becomes more popular,
other arthroplasty procedures may
become less favorable and decline in
their prevalence. Te results from this
study contribute to the scarce body
of research for robotic-assisted knee
arthroplasties and adds data on each
of the arthroplasty modalities. Future
studies should investigate outcomes

following robotic-assisted and nonrobotic-assisted arthroplasties to provide evidence-based recommendations
that physicians can refer to when discussing arthroplasty procedures with
their patients.
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Te average age for individuals living
w it h hu ma n i m mu nodef icienc y
virus (HIV) is increasing with the
development of h ig h ly ef fec t ive
treatment options.1 With the population
continuing to age, and more cases
of degenerative spinal conditions
arising, surgeons are performing
lumbar arthrodesis on older patients.2-4
Tus, the demand for lumbar fusions
continues to increase in seropositive
patients with HIV, 5 so analysis of
the relationship between HIV and
complications/outcomes following
lumbar fusion is imperative. However,
no studies exist that evaluate the
impact of HIV on long-term revision
rates following lumbar fusion. This
study aims to understand how HIV
impacts 2-year revision rates and
90-day postoperative complication
rates following primary lumbar fusion
for degenerative spine conditions.
Data collection was done using
PearlDiver Patient Records Database,
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FIGURE: Breakdown of PearlDiver Patients Included in the Study.
a national insurance database from
2010-2019. Patients who underwent
primary lumbar fusion for degenerative
diseases were identifed and divided
into a cohort of patients that are HIV
positive (HIV), have asymptomatic
HI V (A HI V), acqu i red i mmu ne
deficiency syndrome (AIDS), and
HIV-negative patients. Univariate
and multivariable regression analyses
were performed to determine rates of
revision surgery, surgical site infection
(SSI), neurological complications,
sensor y def icit s , bowel / bladder
dysfunction, and myelopathies within
two years of surgery as well as 90-day
postoperative complications.
In total, 216,587 patients who
underwent primary lumbar fusions
for degenerative spinal conditions

were included in this study (Figure
1). Of these, 631 patients (0.29%)
had a diagnosis of HIV at the time
of their procedure, including 502
patients (0.23%) with a diagnosis of
asymptomatic HIV and 129 patients
(0.06%) with a diagnosis of AIDS at
the time of lumbar fusion (Figure 1).
Relative to the control cohort, patients
diagnosed with HIV had no diference
in odds of two-year revision surgery,
surgical site infection (SSI), neurological
complications, sensory defcits, bowel/
bladder dysfunction, and myelopathies.
However, patients with HIV did have
increased odds of postoperat ive
pneumonia (OR 1.592; 95% CI 1.0482.314; p=0.021) (Table 1). In terms
Continued on p. 73
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TABLE: Multivariate Analysis of 2-Year Complications and 90-Day Medical Complications Following Lumbar Fusion
ALL HIV Patients

Asymptomatic HIV

AIDS

Multivariate

Odds
Ratio

25%

75%

P-value†

Odds
Ratio

25%

75%

P-value†

Odds
Ratio

25%

75%

P-value†

NEUROLOGICAL
COMPLICATIONS

0.127

0.007

0.560

0.039

5.32E06

1.95E33

2.31E34

0.908

-

-

-

-

DYSFUNCTION

0.646

0.441

0.911

0.018

0.568

0.358

0.854

0.011

-

-

-

-

MYELOPATHIES

-

-

-

-

-

-

-

-

-

-

-

-

OSTEOPOROSIS

-

-

-

-

0.223

0.013

0.988

0.134

2.765

0.673

7.488

0.087

RENAL FAILURE

1.251

0.827

1.821

0.265

-

-

-

-

2.912

1.521

5.213

0.001

ANEMIA

0.934

0.718

1.197

0.601

0.866

0.638

1.152

0.340

-

-

-

-

-

-

-

-

0.641

0.418

0.939

0.030

-

-

-

-

1.323

0.650

2.463

0.406

BOWEL BLADDER

ARRHYTHMIA
WITH AFIB
ARRHYTHMIA
WITHOUT AFIB
HEART FAILURE

0.633

0.323

1.109

0.142

0.632

0.276

1.265

0.231

-

-

-

-

BLOOD TRANSFUSION

-

-

-

-

-

-

-

-

0.605

0.185

1.451

0.327

PULMONARY
EMBOLISM

-

-

-

-

-

-

-

-

-

-

-

-

1.656

0.693

3.337

0.202

PNEUMONIA

1.592

1.048

2.314

0.021

-

-

-

-

3.564

1.883

6.207

0.001

RESPIRATORY
COMPLICATIONS

1.326

0.767

2.127

0.275

-

-

-

-

2.585

1.075

5.264

0.017

SEPSIS

1.202

0.668

1.982

0.505

-

-

-

-

2.702

1.122

5.514

0.013

CELLULITIS

†Pearson’s chi-squared test
Bolding equals signifcance p<0.05
Continued from p. 72
of 90-day medical complications,
AIDS patients had greater odds of
respiratory complications (OR 2.585;
CI 95% 1.075-5.264; p=0.017) and
septic complications (OR 2.702; 95% CI
1.122-5.514; p=0.013) (Table 1).
Our results indicate that HIVpositive status does not afect 2-year
revision rates following lumbar fusion.
If appropriate prophylaxis strategies are
taken before and afer the procedure,
HIV-positive patients may be successful
lumbar fusion candidates, especially
with a well-controlled HIV viral
load. As the number of HIV positive
patients undergoing elective surgery
increases, it is imperative that surgeons

carefully weigh the risks and benefts of
operating on patients with a diagnosis
of HIV and monitor their patients
closely postoperatively to mitigate
potential complications.
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Cervical disc replacement (CDR) has
gained greater popularity in the past
decade and is gaining traction as an
option for operative management for
patients with neck pain due to cervical
degenerative disc disease (CDDD).
CDR, in comparison to traditional
anterior cer vical discectomy and
fusion (ACDF), has become a more
desirable option for treating CDDD
due to its ability to preserve motor
function, restore the biomechanical
properties of the intact cervical spine,1-3
prevent adjacent segment degeneration (ASD),4,5 and be performed in the
outpatient setting. Outpatient CDR has
been an increasing trend in recent years
because it increases patient satisfaction
and reduces hospital-related costs.
Current literature investigating outpatient versus inpatient CDR has shown
a similar safety profle among the two
cohorts. However, most of these studies
have relatively small sample sizes with

74

I

Remainingpatientswith
I

I

I

single level CDR (N - 2,294)

RemainingPatientswith
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Patientswith
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I
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I

I
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inpatient (N - 187)

I
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outpatient (N - 49)

FIGURE: Breakdown of PearlDiver Patients Included in the Study
short-term follow-up. Our study aimed
tear, as well as 90-day postoperative
to investigate the safety profle of outcomplications.
patient versus inpatient single-level and
There were 2,294 patients who
multi-level CDR by analyzing shortunderwent single-level CDR, and 236
term and long-term outcomes using
patients underwent multi-level CDR
an extensive patient
database.
[I]t is imperative that surgeons carefully
A ret rospect ive
cohort study was done
weigh the risks and benefts of operating on
using the PearlDiver
patient database
patients in an outpatient setting and monitor
between 2010 and 2019.
Patients who undertheir patients closely postoperatively to mitiwent single-level and
multi-level CDR with
gate potential complications.
a follow-up of at least
two years were identified. Patients within
each procedure cohort were subdivided
(Figure 1). Of the patients who underinto an outpatient and an inpatient
went single-level CDR, 506 patients
group. Univariate and multivariable
underwent outpatient CDR, and 1788
analyses were performed to identify
underwent inpatient CDR (Figure 1). Of
1-year and 2-year surgical complicathe patients who underwent multi-level
tions, including anterior revision, posCDR, 49 patients underwent outpatient
terior revision, incision and drainage,
decompression laminectomy, and dural
Continued on p. 75
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CDR, and 187 underwent inpatient
CDR (Figure 1). In the single-level CDR
cohort, patients undergoing outpatient
CDR were found to have lesser odds of
a decompressive laminectomy at 1-year
following the initial procedure (OR:
0.471; CI: 0.205 to 0.945; p=0.05) (Table
1). No other significant differences
in 1-year or 2-year surgical or 90-day
medical complications were found for
the single-level CDR cohort. In addition, no signifcant diferences in 1-year
and 2-year surgical complications and
90-day postoperative complications
were found on multivariable analysis
of outpatient versus inpatient multilevel CDR.
As more patients undergo CDR, performing the procedure in an outpatient
setting is gaining traction to reduce
costs and improve patient satisfaction. Our study found that performing
single-level and multi-level CDR on
an outpatient basis has a similar safety
profle to performing these procedures
in an inpatient setting. Additionally,
there is no statistical diference in longterm outcomes for outpatient multiplelevel CDR compared to inpatient. Te
outpatient setting for a single-level
CDR was found to have lesser odds of

TABLE: Multivariable Analysis of Surgical Outcomes and Complications following
Single-Level Outpatient Cervical Disc Replacement compared to Single-Level Inpatient
Cervical Disc Replacement
Single-Level CDR Outpatient
Odds Ratio

95% Confdence
Interval (Lower)

95% Confdence
Interval (Upper)

P-value

0.471

0.205

0.945

0.050

Total
1-year Decompression
Laminectomy

1-year decompression laminectomy.
If appropriate strategies are taken,
performing a single-level CDR in
the outpatient setting could lead to
better long-term surgical outcomes
for patients. However, it is imperative
that surgeons carefully weigh the risks
and benefts of operating on patients
in an outpatient setting and monitor
their patients closely postoperatively to
mitigate potential complications.
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The Effect of Obesity on Complications Following
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TABLE 1: Demographics and Clinical Characteristics Among Patients Undergoing PCL
Reconstruction
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Demographics

Non-Obese

Obese

Total patients, n

258

156

Female

57 (22.1)

38 (24.4)

Male

201 (77.9)

118 (75.6)

Sex, n (%)
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Caucasian

Posterior cruciate ligament (PCL)
injuries most commonly occur due
to sports or motor vehicle accidents.1
PCL reconstruction has a relatively
high complication rate of up to 20.1%,
2
therefore, it is imperative to assess
preoperative risk factors that may
impact the complication rate. Obesity
is a known risk factor for post-surgical
complications across various orthopedic procedures, including diferent
arthroscopic surgeries.3-5 Obesity has
been associated with a higher cost of
care related to managing comorbidities,
increased operative time, and longer
hospital stays afer surgical procedures.
Terefore, when selecting patients for
surgery, especially procedures with
a high complication rate like PCL
reconstruction, it is crucial to consider
the potential increased risk of postsurgical complications in patients with
an elevated BMI.

0.446
133 (73.5)

92 (70.8)

Black or African American

17 (9.4)

14 (10.8)

Hispanic

17 (9.4)

19 (14.6)

American Indian or Alaska
Native

1 (0.6)

1 (0.8)

Asian

9 (5.0)

2 (1.5)

Native Hawaiian or Pacifc
Islander

4 (2.2)

2 (1.5)

ASA, n (%)
I or II
III or IV

76

0.595

Ethnicity, n (%)
1

p-value

< 0.001
255 (98.8)

140 (89.7)

3 (1.2)

16 (10.3)

50 (19.4)

33 (21.2)

0.662

2 (0.8)

3 (1.9)

0.293

Mean age, yrs (SD)

30.91 (10.97)

35.88 (12.18)

< 0.001**

Mean BMI (SD)

25.43 (3.09)

35.08 (5.60)

< 0.001**

Smoker, n (%)
Dependent Functional Status,
n (%)

Pearson’s chi-squared test
**Analysis of variance
Bolding equals signifcance p<0.05
The literature is limited when
examining the impact of elevated BMI
on postoperative outcomes in patients
undergoing PCL reconstruction. In
order to understand what risk factors
contribute to the high complication rate
associated with PCL reconstruction
4 and adverse surgical outcomes, it is
important to assess complication risks
for isolated PCL injuries. In addition,
most PCL reconstruction surgeries
occur in the outpatient setting, and the
need for whether or not patients require

postoperative hospital admission afer
surgery is important for surgical planning. Te purpose of this study was to
utilize an extensive database to assess
the risk of 30-day complications for
obese patients, defned as a BMI > 30.0
kg/m2, undergoing isolated PCL reconstruction. We hypothesized that obese
patients would have an increased risk
of postoperative complications
From the years 2006 to 2019, the
Continued on p. 77
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National Surgical Quality Improvement
Program database was queried for
patients undergoing isolated PCL
reconstruction. Two patient cohorts
were defined in this study: patients
who were obese (BMI > 30.0 kg/m2)
and non-obese patients (BMI < 30 kg/
m2). Patients’ baseline demographics
and medical comorbidities were collected and compared between the two
groups. Postoperative outcomes were
also assessed with the use of bivariate
and multivariate analyses.
Of 414 patients who underwent PCL
reconstruction, 258 patients (62.3%)
were non-obese, whereas 156 patients
(37.7%) were obese. Obese patients were
more likely to be older, have a higher
American Society of Anesthesiologists
classification, and have hypertension compared to non-obese patients
(p<0.05 for all) (Table 1). Following
adjustment on multivariate analyses,
relative to patients without obesity,
those with obesity had an increased risk
of admission to the hospital overnight
(OR 1.66; p=0.048) (Table 2).
Our results and the heterogeneity
in the literature indicate that obesity
has a signifcant impact on the rates

TABLE 2: Multivariate Analysis of Postoperative Complications of Patients Following
PCL Reconstruction
Obese (versus Non-Obese)
Postoperative Admission

Odds Ratio
1.661

95% CI
1.004

P Value
2.749

0.048

Bolding equals signifcance p<0.05
PCL, posterior cruciate ligament; CI, confdence interval
of hospital admission following PCL
reconstruction. Though no studies
have examined whether weight loss
before PCL surgery improves outcomes,
having patients lose weight prior to the
procedure has the potential to reduce
costs. Additionally, it merits consideration of refraining from performing
isolated PCL injuries on obese patients
in stand-alone surgery centers as
there is an increased complication of
unintended hospitalization. Overall,
it is important for surgeons to carefully weigh the risks and benefts of
operating on obese patients and to
plan surgery settings accordingly, as
obese patients may require postoperative hospital admission. Tis study
indicates that patients with BMI > 30
are at increased risk of requiring postoperative hospital admission afer PCL
reconstruction.
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Surgical approaches for diseases of the
cervical spine have evolved considerably
since the early 20th century. Anterior
cervical discectomy and fusion (ACDF)
was frst implemented in the 1950s as
an alternative to the posterior approach
for easier access to the intervertebral
disc space.1 Several long-term studies
support ACDF as an effective treatment option for patients with cervical
myelopathy, radiculopathy, and cervical
degenerative disc disease (CDDD). 2
However, ACDF does not preserve the
natural segmental motion of the spine,
resulting in reduced range of motion
and increased risk of developing adjacent segment disease (ASD).3 Cervical
disc replacement (CDR) was initially
described in 1966 by Fernstrom et al who
aimed to maintain segmental motion in
all three rotational planes of the spine
by using a ball and socket prosthesis.4
In the past decade, CDR has gained
traction as an alternative treatment
option for radiculopathy, myelopathy,
displacement of cervical intervertebral
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Hazard
Ratio

95%
Confidence
Inten,al

95%
Confidence
Inten·al

(Lower)

(Upper)

P-,·alue

Total
Anterior ReYision

0.348

0.242

0.498

<0.001

Posterior Relision
Decompression Laminectom,·

0.568
0.680

0.434
0.523

0.744
0.884

<0.001
<0.001

discs without myelopathy, and CDDD.5
single-level ACDF. Relative to the
However, as more patients undergo
ACDF cohort, patients in the CDR
CDR, questions remain regarding the
cohort had a signifcantly lower risk
safety and effectiveness of this proof anterior revision surgery (Hazard
cedure. The aims of this study were
Regression (HR): 0.35; 95% Confdence
to evaluate 5-year surgical outcomes
Interval (CI): 0.24-0.50; p<0.001), posas well as 90-day medical outcomes
terior revision surgery (HR: 0.57; 95%
between patients who
underwent CDR and those
Our study showed that CDR has a lower
who underwent ACDF.
A retrospective study
incidence of anterior and posterior revision
was per formed using
patient data collected from
the PearlDiver database
surgery compared to ACDF, supporting the
between 2010 to 2020.
Patients who underwent
results of prior randomized control studies
single-level CDR or ACDF
with a follow-up of at least
and international database studies.
fve years were identifed
and included in this study.
CI: 0.43-0.74; p<0.001), and decompresUnivariate and multivariable analyses
sion laminectomy (HR: 0.68; 95% CI:
were performed to determine the rate
0.52-0.84; p<0.001) within 5-years of
of 5-year surgical outcomes as well as
90-day postoperative complications
index surgery (Table 1). Additionally,
among the CDR and ACDF cohorts.
patients who underwent CDR had lower
In tota l, 53,139 patients were
odds of hematoma, respiratory failure,
included in this study, of which 1,324
and stroke within 90-days of index
patients (2.5%) underwent single-level
CDR and 51,815 (97.5%) underwent
Continued on p. 79
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surgery when compared to the ACDF
cohort (Table 2).
CDR and ACDF are ofen recommended as treatment options for similar pathologies. Our study showed that
CDR has a lower incidence of anterior
and posterior revision surgery compared to ACDF, supporting the results
of prior randomized control studies
and international database studies.
As surgeons gain greater experience
with this relatively novel technique,
CDR may become the gold standard
for treating cervical radiculopathy and
other cervical pathologies resulting
from degenerative processes.
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As the percentage of the United States
population above age 65 has grown, so
too has the proportion of individuals
who are elderly and overweight.1 In
a 2019 report, 39% of men and 32%
of women aged 65 to 74 years were
overweight, with these percentages
increasing to 47% and 35%, respectively,
in those 75 years and older.2 Te rise in
BMI and the aging population have
coupled with an increase in lumbar
spondylosis and spondylolisthesis
diagnoses. 3,4 Te rise in these spinal
pathologies has led to a vast increase in
lumbar fusion operations, which is an
established treatment option to stabilize painful vertebral segments.3,4 From
2004 to 2012, the volume of lumbar
fusion operations increased 62.3% with
the greatest increases seen in the population 65 years and older.4 Although
previous research has identifed complication rates in elderly obese patients
following lumbar fusion, elderly overweight patients are poorly studied
despite comprising a large portion
of the U.S. population.5 Te primary
purpose of this study is to examine
complication and readmission rates
in overweight individuals following
anterior, posterior, or transforaminal
interbody lumbar fusion operations in
an elderly population.
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TABLE 1: Bivariate Analysis of Postoperative Complications of Patients Following
Lumbar Fusion.
Complications

Overweight (BMI
25.0 & ~ 29.9)

p-value,

Total patients, n

Normal Weight
(BMI ~ 18.5 & ~
24.9)
6,171

Major complication, n (%)**

179 (2.9)

344 (2.7)

0.453

Minor complication, n (¾)tt

1,145 (18.6)

2,070 (16.3)

<0.001

Superficial Surgical Site
Infection, n (%)

42 (0.7)

85 (0.7)

0.930

Deep Surgical Site Infection, n
(%)

28 (0.5)

59 (0.5)

0.917

Wound Dehiscence, n (%)

16 (0.3)

32 (0.3)

0.926

Pneumonia, n (%)

80 (1.3)

124 (1.0)

0.046

Renal Insufficiency, n (%)

11 (0.2)

15 (0.1)

0.296

Pulmonary Embolism, n (%)

37 (0.6)

84 (0.7)

0.617

Urinary Tract Infection, n (%)

130 (2.1)

266 (2.1)

0.958

Stroke, n (%)

18 (0.3)

33 (0.3)

0.693

Transfusion Requirement, n (%)

948 (15.4)

1,647 (13.0)

< 0.001

Deep Vein Thrombosis, n (%)

46 (0.7)

116 (0.9)

0.240

Myocardial Infarction, n (%)

39 (0.6)

82 (0.6)

0.911

Sepsis, n (%)

41 (0.7)

80 (0.6)

0.782

Death, n(¾)

34 (0.6)

39 (0.3)

0.011

Extended Length of Stay, n (%)

1,140 (18.5)

2,140 (16.9)

0.006

Readmission, n (%)

367 (7.5)

707(7.1)

0.292

Reoperation, n (%)

182 (2.9)

411 (3.2)

0.288

~

12,697

Pearson' s chi-squared test
Bolding equals significance p<O.05
**Includes deep surgical site infection, renal insufficiency, pulmonary embolism, stroke,
myocardial infarction, sepsis, or mortality.
ttincludes superficial surgical site infection, wound dehiscence, urinary tract infection,
transfusion requirement, deep venous thrombosis, or pneumonia.

The National Surgical Quality
Improvement Program database, a
national registry that includes patient
data from numerous medical centers
nationwide, was used for this study.
It was queried for patients aged 65
years or older undergoing lumbar
fusion from 2005 to 2019. Two patient
cohorts were defined: patients who

were normal weight (BMI > 18.5 kg/
m2 and < 24.9 kg/m2) and patients
who were overweight (BMI > 25.0 kg/
m2 and < 29.9 kg/m2). In this analysis,
demographics, medical comorbidities,
and postoperative complications were
compared between the two diferent
Continued on p. 81
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cohorts using bivariate and multivariable regression analyses.
Of 18,868 geriatric patients with a
BMI < 30 kg/m2 undergoing lumbar
fusion, 6,171 patients (32.7%) had a
normal weight whereas 12,697 patients
(67.3%) were overweight. Bivariate
analyses revealed that when compared
to overweight patients, patients who
were normal weight were at increased
risk of minor complications, pneumonia, transfusion requirement, mortality, and extended length of stay
(p<0.05 for all). Following adjustment
with multivariable analysis to control
for patients’ demographics and comorbidities, there were no differences
in any postoperative complications
between the normal weight and overweight groups.
Given the lack of research in the
overweight population, defined as
BMI 25-29.9 kg/m2, this study sought
to determine thirty-day complication
rates in the elderly and overweight
population following lumbar fusion
operations. While the initial bivariate
analysis indicated that lumbar fusion
patients with normal BMI had a higher
rate of postoperative complications, the
small diferences between the groups
were likely not clinically meaningful
and did not hold up on the multivariable analysis. Despite increased BMI,

TABLE 2: Multivariate Analysis of Postoperative Complications of Patients Following
Lumbar Fusion.
T
P-Value
Overweight (versus
Odds Ratio
95%CI
Normal Weight)
0.981
Minor Complicationtt
0.845
1.139
0.797
Pneumonia
0.619
1.058
0.838
1.808
0.917
0.297
Transfusion Requirement
0.780
1.079
1.324
0.533
Death
0.548
3.198
0.973
0.721
Extended Length of Stay
1.131
0.837
Bolding equals significance p<0.05
ttincludes superficial surgical site infection, would dehiscence, urinary tract infection, transfusior
requirement, deep venous thrombosis, or pneumonia
CI, confidence interval

the results afer multivariate adjustment demonstrated that there are no
diferences in thirty-day postoperative
complication rates following lumbar
fusion operations between normal
weight and overweight elderly patients.
Further research should be conducted
to determine potential longer-term
complications in the overweight and
elderly population. Additionally, future
studies could also evaluate at which
specifc point does a change in BMI
have an impact on complications.
Including more relevant weight classes,
such as obese and morbidly obese, for
this patient population may add more
information to the existing literature
and may be the basis for future research
studies.
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Osteoporosis, a musculoskeletal disorder characterized by low bone mineral density (BMD) and reduced bone
quality, causes more than 8.9 million
fractures each year globally.1 Prior
studies have demonstrated that lossof-function mutations in low-density
lipoprotein receptor-related protein 5
(LRP5), found in the Wnt/β-catenin
pathway, can cause low BMD, while
gain of function mutations can result
in high BMD. 2 The purpose of this
study was to expand our understanding
of the impact of LRP5 variants on
bone quality phenotypes in cohorts
of Caucasian and African American
young adults.
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COHORTS: Te Assessing Inherited

AIMMY: Caucasian males with

Markers of Metabolic Syndrome in the
rs634008 CT genotype were found
Young (AIMMY) cohort consisted of (i)
to have increased total BMD in comhealthy African American young adults
parison to those with TT genotype
(n=166, 47 male, 119 female, 18-25 ages)
(p=0.0326), while rs4988300 was not
from Howard University (HU) and (ii)
associated with total BMD. African
healthy Caucasian young adults (n=117,
American females with rs634008 CT
58 male, 59 female, 18-35 ages) from the
genotype were found to have decreased
University of Calgary (UC) recruited
weight in comparison to those with CC
for a study aiming to identify genotypes
genotype (p=0370).
associated with risk factors for metaFAMuSS: Females with rs634008
bolic syndrome. Te Functional Single
CT genoty pe were found to have
Nucleotide Polymorphism Associated
decreased non-dominant arm baseline
with Human Muscle Size
and Strength (FAMuSS)
This study explored the association of TT
c ohor t c on si s te d of
hea lt hy Caucasia n
genotype with BMD and found reduced
young adults (n=438, 170
male, 268 female, 17-40
total BMD in a population of Caucasian
ages) who participated
in a non-dominant arm
males in the AIMMY cohort. This fnding
strengthening program
for three months.

GENOTYPING:

which exhibits sexual dimorphism may have

DNA samples in
implications for long-term fracture risk.
AIMMY and FAMuSS
cohorts were genotyped
with TaqManTM Alleleic
Discrimination Assays (Applied
whole arm volume in comparison to
Biosystems) and QuantStudioTM Flex
those with CC genotype (p=0.0229).
Real-Time PCR System.
Males with rs634008 TT genotype
SNPs were evaluated for Hardy
were found to have increased dominant
Weinberg Equilibrium. Genotype
arm post-strengthening one-repetition
associations were explored using
maximum strength in comparison to
analysis of covariance (ANCOVA)
those with CC genotype (p=0.0350).
additive models with covariates of
Wang et al. linked rs634008 TT
age and/or weight. Post hoc pair-wise
genotype with reduced total hip and
comparisons were conducted, and
femoral neck BMD in cohorts of Han
p-values were adjusted using the Sidak
ethnicity. 3 This study explored the
method. Statistical analysis confrmed
association of TT genotype with BMD
Hardy Weinberg Equilibrium of (i)
and found reduced total BMD in a
rs4988300 in the FAMuSS and AIMMY
population of Caucasian males in the
HU cohorts and (ii) in rs634008
AIMMY cohort. Tis fnding which
FAMuSS, AIMMY HU, and AIMMY
UC cohorts (p> 0.05).
Continued on p. 83
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exhibits sexual dimorphism may have
implications for long-term fracture
risk. Here we demonstrate the association of rs634008 CT with reduced body
weight in African American females
from the AIMMY cohort. Prior studies
have reported both positive and negative associations of total body weight
and bone health. While increased
mechanical loading in individuals
with high body weight benefts BMD,
studies have indicated that metabolic changes associated with obesity
increase pro-infammatory cytokines
which negatively impact bone. 5 Tis

study demonstrated additional associations suggesting that variants in
LRP5 may impact muscle phenotypes,
indicating the need for further investigation. Tis study is limited by the
absence of BMD measurements for
African American young adults in the
AIMMY and FAMuSS cohorts.
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Although adolescents and young adults
represent only 25% of the sexually active
population, they account for nearly
50% of all newly diagnosed sexually
transmitted infections (STI) annually.1,2
Failure to diagnosis and treat STIs in a
timely manner can lead to worse health
outcomes, including pelvic infammatory disease. Adolescents ofen receive
sexual and reproductive health services
in the emergency department (ED).
However, when adolescents are prescribed outpatient treatment for STIs
in the ED, less than 60% of prescriptions are flled.3 Lack of STI treatment
adherence can further perpetuate the
STI epidemic among this high risk
group. Te objective of this study was to
evaluate the impact of a mobile health
(mHealth)/text messaging intervention
on prescription fll rates and treatment
adherence following STI diagnosis in
the ED.
From June 1, 2021 to Sept. 10,
2021, patients age 15–21 years were
approached for study enrollment in
person or by phone following their ED
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visit if they were tested for gonorrhea/
were lost to follow-up, and 4 (12.1%) are
chlamydia in the ED, prescribed outpacurrently active as this is an ongoing
tient STI treatment, and had a cell phone
study. Nearly all enrolled participants
with text messaging (TM) capabilities.
(93.9%) flled their prescription and 18
Enrolled patients received daily TM
(90%) of those who completed the study
reminders to fll their prescription and
reported finishing their medication.
barrier support for up to seven days.
Te majority of participants found the
Once patients reported filling their
texts to be helpful reminders to fll their
prescription, they received daily TM
prescriptions (95%) and to take their
reminders to take their medicine twice
medications (100%).
a day. Research team helped
address any identifed barText messaging can be an effective tool
riers to prescription filling
or treatment through TM.
to address treatment adherence in adoStudy participants responded
to a survey via text or phone
after completion of their
lescent ED patients, an at-risk population
treatment on the usefulness
of the reminders and TM
who may otherwise be diffcult to reach.
support. Primary outcomes
were prescription flling and
self-reported STI treatment adherence
Text messaging can be an efective
(finishing medication), and the sectool to address treatment adherence in
ondary outcome was attitudes toward
adolescent ED patients, an at-risk poputext messaging. Prescription filling
lation who may otherwise be difcult
data were abstracted from the electo reach. mHealth provides additional
tronic health record via SureScripts,
support to patients following their ED
an informatics network that collects
visit, which can help increase treatment
data about prescription filling from
adherence and reduce the spread of STIs,
participating pharmacies and insurance
which is key for the broader manageplans. Descriptive statistics were used to
ment of public health.
summarize the data.
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Management of neonatal upper airway
obstruction (UAO) in patients with
Robin Sequence (RS) may impact the
need for intensive care unit (ICU) care
following primary palatoplasty (PP)
later in life. Te current study investigated the necessity for ICU admission
afer PP in patients with RS, based upon
prior upper airway management.
We conducted a review of patients
with RS who underwent PP between
2006-2020. Patient demographics,
perioperative characteristics, ICU
admission, and postoperative airway
and non-airway complications were
compared, based on prior airway management, as determined by multidisciplinary team evaluation and consensus.
Fify-eight patients were included.
Median [IQR] age at PP was 12.9
[10.8,15.6] months. Three groups
were compared: Conservative (n=30),
tongue-lip adhesion (TLA) (n=14) and
mandibular distraction osteogenesis

TABLE 1: Comparison of airway and non-airway outcomes between the study groups.
Complications

Overall
(N= 58)

Conservative
(N= 30)

TLA
(N= 14)

MDO
(N= 14)

P value

Non-airway
complications, n (%)

13 (22.4)

8 (26.7)

1 (7.1)

4 (28.6)

0.320

—Prolonged time to
feeding (>24 hours)

7 (12.1)

4 (13.3)

1 (7.1)

2 (14.3)

0.999

—Unexpected gavage
feeding

1 (1.7)

1 (3.3)

0 (0.0)

0 (0.0)

0.999

—Transfusion

1 (1.7)

1 (3.3)

0 (0.0)

0 (0.0)

0.999

—Fistula

2 (3.4)

2 (6.7)

0 (0.0)

0 (0.0)

0.999

—Readmission

4 (6.9)

2 (6.7)

0 (0.0)

2 (14.3)

0.531

25 (43.1)

8 (26.7)

9 (64.3)

8 (57.1)

0.034

—Prolonged intubation
(>4 hours)

3 (5.2)

1 (3.3)

2 (14.3)

0 (0.0)

0.283

—Reintubation

4 (6.9)

2 (6.7)

1 (7.1)

1 (7.1)

0.999

—Mechanical ventilation

5 (8.6)

2 (6.7)

1 (7.1)

2 (14.3)

0.826

—Supplementary oxygen
via nonbreathable
mask, nasal cannula,
aerosol mask, previous
tracheostomy

12 (20.7)

4 (13.3)

4 (28.6)

4 (28.6)

0.338

—Length of stay > 2 days

18 (31.0)

6 (20.0)

6 (42.9)

6 (42.9)

0.161

Airway complications,
n (%)

(MDO) (n=14). While ICU admission
(conservative, 33.3%; TLA, 78.6%;
MDO, 78.6%; p=0.002) and overall
airway-related complications were signifcantly higher in patients with prior
TLA and MDO (conservative, 26.7%;
TLA, 64.3%; MDO, 57.1%; p=0.034),
rates of major post-PP airway events
(prolonged intubation >4h, unexpected
ventilatory support via pre-existing
tracheostomy, or reintubation) that
would have required ICU care were
low and insignifcant between groups
(0-14.3%; p>0.05); post-hoc analysis
documented significant differences
only in overall airway events between
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TLA vs. conservative airway groups
(64.3% vs. 26.7%; p=0.02).
ICU care afer PP in patients with
RS may not be necessary in infants
who had appropriate management of
neonatal UAO, potentially preserving
resources for patients with greater
need. Special attention may be prudent
for post-PP patients who underwent
neonatal TLA.
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TABLE 2: Comparison of airway and non-airway outcomes between the study groups
stratifed by major and minor events.
Overall
(N= 58)

Conservative
(N= 30)

TLA
(N= 14)

MDO
(N= 14)

P value

—Minor event

12 (20.7)

7 (23.3)

1 (7.1)

4 (28.6)

0.516

—Major event

1 (1.7)

1 (3.3)

0 (0.0)

0 (0.0)

—Minor event

19 (32.8)

6 (20.0)

7 (50.0)

6 (42.9)

—Major event

6 (10.3)

2 (6.7)

2 (14.3)

2 (14.3)

Outcomes
Non-airway complications, n (%)

Airway complications, n (%)
0.135

*P values were obtained from Fisher’s exact test
5. Gosain AK, Moore FO. Embryology of the
head and neck . In: Aston SJ, Beasley RW,
Torne CH, eds. Grabb and Smith's Plastic

Surgery . 5th ed. Boston, Mass: Little Brown
and Co. In press.
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Robin sequence (RS) is defined by
micrognathia and glossoptosis that
result in upper airway obstruction
(UAO). In RS patients who undergo
tracheostomy, long-term goals include
decannulation without further surgical
intervention (natural decannulation).
Te objective of this study was to identify long-term trends in rate and length
of time to natural decannulation.
A retrospective chart review was
performed on 151 RS patients treated
at a large pediatric tertiary center from
1995 to 2020. Patients with UAO treated
with tracheostomy were grouped by
year of tracheostomy: 1995-2004, 200514, and 2015-20. Demographic data,
UAO management, postoperative care,
complications, and time to decannulation were recorded.
Tirty-six patients (n=36) met the
inclusion criteria (50% syndromic RS).
Median UAO treatment age was 9.5 [0
to 571] days of age. Nearly 53% (n=19) of
patients were naturally decannulated.
Overall median time to decannulation
was 5.5 years. Natural decannulation
rate was higher in the non-syndromic

CLINICAL TRANSLATIONAL RESEARCH | OTOLARYNGOLOGY

RS patients (78% non syndromic vs.
28% syndromic; p= 0.003) and during
the frst study period (1995-2004: 73%,
2005-2014: 36%, and 2015-2020: 43%;
p<0.05). Pre-operative capillary blood
gas max-CO2 was higher in patients
with syndromic RS (80 mEq/L vs.
67 mEq/L; p= 0.036). Univariate and
multivariate regression analyses failed
to demonstrate signifcant factors associated with barriers in getting decannulated. Rate of tracheostomy-specifc
complications was 54%, with an overall
mortality rate of 3%. Lastly, median
follow-up time afer tracheostomy was
5.88 [2.15 to 10.32] years.
Syndromic RS and higher pre-op
max-CO2 were associated with longterm t racheostomy dependenc y.
Decannulation rates were higher in
the 1995-2004 patient subgroup, likely
because tracheostomy is now only used
in the most severe cases at our institution and mandibular distraction osteogenesis has become accepted primary
surgical treatment in severe RS upper
airway obstruction.
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Sclerotherapy, or ethanol ablation (EA)
has been shown to be a safe, cost-efective, and minimally invasive alternative
to surgical intervention for the treatment of a range of head and neck cysts.1
Tis study aims to describe the use of
ultrasound-guided EA in the treatment
of benign cystic lesions of the head and
neck within the otolaryngology clinic
setting, reducing the need for external
referrals and streamlining the treatment by a single provider.
Tis study further aims to assess
the efcacy and safety profle of EA
for the treatment of various cystic
lesions of the head and neck. A total
of 25 patients who received ethanol
ablation (EA) of head and neck cystic
lesions by an otolaryngologist at a single
institution between October 2017 and
October 2020 were identifed. Patient
demographics, clinical characteristics,
treatment details, and treatment outcomes at follow up visits were obtained
by retrospective review of electronic
medical records. For the descriptive
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FIGURE 1: The median volume prior to treatment was 2.52mL (range, 0.40-94.34mL).
Median volume following EA was 0.40mL (range, 0.00-10.49mL) with 76.73% cyst
reduction by volume (range, 37.50-100.00%) (p=0.002).
statistical analysis, the categorical
following EA was 0.40mL (range, 0.00variables were expressed as numbers
10.49mL) with 76.73% cyst reduction
and percentages, and the continuous
by volume (range, 37.50-100.00%)
variables were expressed as medians
(p=0.002). Te median time to the last
and ranges. Te volume of cyst prior to
follow-up was one month (range, 0.5-18
treatment and volume of
the cyst at last follow-up
Sclerotherapy, or ethanol ablation (EA) has
were compared using
Wilcoxon signed-rank
been shown to be a safe, cost-effective, and
test. Statistical significance was declared at
minimally invasive alternative to surgical
p<0.05. The statistical
analyses were performed
intervention for the treatment of a range of
using the SPSS sofware
version 27.0 (SPSS Inc.,
Chicago, IL).
head and neck cysts.1
Twenty-fve patients
who underwent ethanol
ablation of head and neck cystic lesions
months). One patient received surgery
were included, with a median age of 52
despite treatment success to obtain a
years old (range,19-81 years) and 12
defnitive diagnosis of the mass. No
males (47.0%). Te most common cysts
other patients received further surgical
treated with EA were thyroglossal duct
management. Te treatment success of
cysts (n=8, 32.0%) and lymphoepithelial
EA, as defned by >70% volume reducparotid cysts (n=7, 28.0%). Te median
tion or the resolution of symptoms, was
volume prior to treatment was 2.52mL
(range, 0.40-94.34mL). Median volume
Continued on p. 89

Fusion | 2022

Continued from p. 88
91.3%. All patients were satisfed with
the outcome (n=23,100.0%) and had no
reported complications. In conclusion,
EA is an efective and safe alternative
to surgery for the treatment of head
and neck cystic lesions that can be
performed in an outpatient setting by
an otolaryngologist.

>70%,Red11.1e
•

<70%,Re ucito
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"Jotal--25
FIGURE: The treatment success of EA, as defned by >70% volume reduction or
the resolution of symptoms, was 91.3%. All patients were satisfed with the outcome
(n=23,100.0%) and had no reported complications.
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Newborn hearing screenings have
become a universal practice in order to
limit delays in childhood development.
At present, the diagnosis of hearing loss
is accomplished by testing otoacoustic
emissions (OAE) and auditory brainstem response (ABR). In recent years,
ABRs have grown in use and as they can
be conducted in children and infants
unable to undergo traditional hearing
tests due to age or disability. Tis noninvasive test measures electrical activity
along the auditory pathway in response
to auditory stimuli including clicks,
tonebursts, and chirps.1
Current Early Hearing Detection
and Intervention (EHDI) guidelines
recommend a hearing screen by one
month of age, diagnosis of hearing loss
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by three months of age, and enrollment
in early intervention programs by six
months of age. Previous reports identify that adherence to these guidelines
is signifcantly associated with better
vocabulary, language abilities, and
speech intelligibility.2,3
To date, the use of ABR testing and
its relationship to the EHDI guidelines
has not been studied despite its role in
early hearing loss detection. Te primary purpose of this study is to evaluate
for discrepancies in diagnostic ABRs
between Children’s National Hospital
(Children’s National), a pediatric medical center, and outside facilities (OSH)
that referred patients to Children’s
National for confrmatory evaluation.
Such discrepancies could impact EHDI
timelines.
Retrospective chart review from
an internal database of patients who
under went diagnostic ABR from
2017–21. Only patients with ABR
results from both Children’s National
and OSH were analyzed. Demographic
data, external and internal test results,
and intervention data were obtained.
Hearing loss severity was graded on a
scale of 0-9 (0 = normal, 1 = normal to
mild, 2 = mild, 3 = mild to moderate,
4 = moderate, 5 = moderate to severe,
6 = severe, 7 = severe to profound, 8 =
profound, 9 = could not be determined).
Each patient’s score was the average
between the lef and right ear.
Forty-eight patients met the inclusion criteria. The average age was
138.9 days and bilateral hearing loss
was noted in 37 patients at Children’s
National and 35 patients at OSH (p =
0.637). Median hearing loss severity at
Children’s National was 3.0 (mild to
moderate) compared to 4.0 (moderate)
at OSH (p = 0.002). Of note, 26 of 48

(54%) went on to ultimately receive a
hearing amplifcation device: 18 (69%)
were fitted for hearing aids while
remaining eight (31%) got cochlear
implants. ABR results from Children’s
National and OSH differed in 20 of
these patients; six (30%) had worse
hearing loss on Children’s National
ABR and 14 (70%) had worse hearing
loss on OSH ABR.
Our results showed statistical significance in median severity of hearing loss
between Children’s National and OSH.
A substantial proportion (77%) of children in our dataset who had received a
cochlear implant or hearing aids had
ABR discrepancies between Children’s
National and OSH. Tese fndings have
implications with regards to appropriate
usage of health care resources and
maintaining Early Hearing Detection
and Intervention timelines.
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Over the last decade, standard of care
has shifed towards evaluation of men
with elevated prostate specifc antigen
(PSA) with prostate MRI, for identifcation of suspicious lesions and targeted
MRI-ultrasound fusion guided biopsy.1
Correlation of MRI imaging features
with prostate cancer Gleason grade
(GG) is critical for the diagnosis of
clinically signifcant prostate cancer
(csPCA), defned as GG of greater than
or equal to 3. Te purpose of this study
is to calculate the apparent difusion
coefficient (ADC) and T2 signal of
csPCA and determine if it correlates
with GG.
Methods: Patients who had a preoperative MRI and prostatectomy at
GW Hospital between January 2015
and December 2019 were identified
using electronic medical records. Out of
148 initially screened patients, 41 were
included in the study. Patients were
included if the index cancer, defned
as the highest GG cancer on surgical
pathology, could be confdently localized on MRI using the pathology report
and 3 Tesla MRI scan was performed.
Patients were excluded if prostatectomy
was performed for benign prostatic
hypertrophy, 1.5 Tesla MRI exam was
performed, or MRI artifact obscured
the index cancer. Surgical pathology
reports were reviewed and correlated
with pre-operative MRI to identify

FIGURE: Axial T2 and ADC map, prostate with tracing (ROI) around the index cancer.
However, ADC was only shown to
the index cancer on imaging. Region
approach signifcance in this analysis.
of interests (ROIs) were drawn around
Te absence of correlation may be due
the index cancer on axial T2 and ADC
to the small study population. Te large
sequence. Mean and 95% confdence
size of the prostate cancers included
intervals for T2 and ADC signal were
in this study and intra-tumoral hetcalculated for low-grade (GG1 and 2)
erogeneity may also account for lack
and csPCA (GG3, 4, and 5) and compared with T-tests.
Results: Mean T2
and ADC signals as
The large size of the prostate cancers included in
well as frequency for
each GG can be found
this study and intra-tumoral heterogeneity may
in the included table.
For T2 imaging, the
also account for lack of correlation: the index
mean signal value for
low-grade was 225.78
cancer may be a small portion of the overall ROI
(9 5% C I 18 9. 4 9 262.08) and 236.87
selected on imaging.
for csPCA (95% CI
210.81-262.93). The
mean ADC signal
of correlation: the index cancer may
value for low-grade was 1075.89 (95% CI
be a small portion of the overall ROI
991.57-1160.20) and 982.04 for csPCA
selected on imaging. Further study with
(95% CI 914.50-1049.58). Tere was no
a larger sample size that has more GG4
statistically signifcant diference in T2
and GG5 could illustrate the expected
signal (p = 0.615) and ADC signal (p =
trend of more aggressive cancers having
0.097) between low-grade and csPCA,
lower T2 and ADC signal values.
although ADC signal was approaching
It was also found that 49% of
signifcance.
patients had discordance between
Conclusion: Based on existing
their pre-operative biopsy and surgical
studies, it was expected for ADC signal
2,3
to negatively correlate with GG.
Continued on p. 92
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pathology GG; biopsy GG was lower in
15 patients, higher in 5 patients. Given
this high discordance between biopsy
and pathology, it would be helpful if
MRI could predict the GG of lesions
identifed on MRI. On a similar note,
imaging data from this study can be
used to train and test machine learning
algorithms in identifying csPCA and
predicting their GG.
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TABLE: T2 and ADC Signals for Low and Signifcant Grade Cancers

GGl/2:
GG3:
GG4:
GG5:

N=

T2 Signal

ADC Signal

13
16

225.78
238.92
224.00
237.51

1075.89
987.04
1129.20
924.11

3
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Hemorrhage from ruptured intracranial vessels displaces brain parenchyma
creating an intracranial hematoma
(ICH). Despite the high mortality
rate reported in the acute phase,
surgical evacuation still fails to show
improvement over medical treatment
of ICH.1,2 Proposed reasons include
lack of intraoperative visualization of
the hematoma and iatrogenic damage
to surrounding tissue induced by the
rigid tools used even in minimally invasive procedures.1,3,4 An MRI-guided
aspiration robot will overcome these
limitations reducing the risk associated
with the surgical evacuation of ICH.
It will allow for real-time targeting of
deep-seated hematomas while sparing
critical brain structures. This study
examines the beneft of using an archbased tube as opposed to straight tubes
used in current practice.
Three configurations were tested
and were defned as a) a straight line
(S1), b) straight line with a single circular arch (SA1), and c) a straight line
with two concentric circular arches
(SA2) as demonstrated in Figure 1.
Nine randomly chosen ICH’s in the
basal ganglia region were set as targets
to test these three confgurations using

S1

SA2

SAl

FIGURE 1: Confgurations of the three paths S1: straight line, SA1: straight line with
single arch, SA2: straight line with two concentric arches.
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FIGURE 2:Visualization of the white matter fbers (blue), cerebral arteries (red), and
the hematoma (black).
an optimization algorithm that calculates a risk value by summing up the
impact on critical structures, i.e., blood
vessels and cranial white matter fbers.
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The spatial distribution of cerebral
arteries was defned using Mouches et
Continued on p. 94
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al probabilistic atlas and the fber tracts
were set using the difusion spectrum
imaging (DSI) based atlas developed
by Yeh et al which is represented in
Figure (2).4,5
In the 9 tested ICH cases, SA1 and
SA2 configurations were associated
with a lower risk value than the S1 confguration. Comparing SA1 and SA2,
a lower risk value was associated with
SA2 in only fve of the cases, whereas in
the four remaining cases, the risk values
of SA1 and SA2 were equal.
The trajectory of an arch-based
tube with one or two arches is associated with a better safety profle than
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a straight tube. In addition, an archbased tube with two arches is safer than
a tube with a single arch in only some
cases where a more tortuous path is
needed. Taken together, an arch-based
tube minimizes the risk posed to cranial white matter tracts and blood vessels located along the trajectory to deep
ICH. Tis work lays the foundation for
the design of a robot with a dynamic
aspiration needle that has the potential
to revolutionize the way ICH is treated.
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I N T RO D U C T I O N: Mo s t s e ve re

FIGURE 1: (A) Preoperative view with the EED nodules on both knees, right tibial

appearing keloids tend to occur around
joints due to the increased extensional
stimulation of the scar in those areas.
On the other hand, erythema elevatum
diutinum (EED) appears more commonly on friction sites including
extensor surfaces of the extremities and
dorsal surfaces of joints. EED-afected
areas tend to be more reddish-brown or
burgundy in color, and ofen morphologically appear as plaques or papules.1
CASE PRESENTATION: A 42-yearold woman presented with frm, browncolored tumorous nodules on her bilateral lower extremities (Figure 1). Te
patient started noticing the growths
afer sustaining some insect bites in
these areas. Te dermatologist she initially visited diagnosed her with keloids
and subsequently treated her with triamcinolone injection and steroid tape.
However, the patient did not respond
to treatment, and the nodules did not
sofen or reduce in size. When she later
visited our keloid specialty outpatient
department in Nippon Medical School
Hospital, the examination revealed
dark-brown colored nodular lesions on
bilateral knees, the right tibial region,
dorsum of the lef foot, the right calcaneal area, and the lateral side of the lef
foot (Figure 1A). Te nodules on her
lower extremities manifested in one of

region, left dorsum of foot, right calcaneal area, and lateral side of the left foot. (B)
Design of the local fap.. {C) Immediately after surgery. (D) Six months post-operative
view.
two ways; frst type of nodule appeared
very similar to keloids, but the other
type was partially rounded in shape,
unlike a usual keloid. Ultimately, the
original diagnosis of keloids was reaffrmed and surgery along with radiation therapy was determined to be the
best course of treatment. Te nodules
were resected under general anesthesia
with subsequent administration of 18
gray per 3 fraction continuous radiation
therapy. Afer the initial course of treatment, a biopsy was sent to pathology.
The histopathological examination
revealed tuberous lesions in the dermis,
increased wired collagen fbers, neutrophilic infltrate with nuclear dust,
and edematous endothelial cells in the
small vessels (Figure 2). Trough these
histological fndings, the patient was
subsequently diagnosed with EED.
Post-surgery, the patient reported no
recurrence of EED or incidence of
abnormal scar formation, including
keloids or hypertrophic scars. The
patient provided informed consent for
the photographs and publication of this
case report.
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DISCUSSION: Whereas clinical
fndings of EED are similar to that of
keloids, the mechanisms of the two
conditions difer considerably, leading
to varying management strategies.
EEDs can be misdiagnosed as Keloids
on several grounds; they can both
appear morphologically similar, exhibit
as stif lesions, demonstrate chronic
infammation of the reticular dermis,
and appear anywhere on the body.
Te only defnitive method of diferentiating between the two is through
histopathological examination.
CONCLUSION: Diagnosing cutaneous manifestations simply through
clinical fndings might have its merits
as the most cost and time effective
method of diagnosis. However, there
are instances where further investigation is necessary for accuracy, and this
was the case with the patient discussed
in this report. Our study suggests that,
when treating keloidal lesions on friction sites, EED should be considered
as a possible diagnosis, and a biopsy
Continued on p. 96
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should be performed to confrm before
administering treatment. On the same
token, this report indicates that the
medical field could benefit from an
inquiry into the mechanism of mass
formations of EED nodules that morphologically appear similar to keloids.
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FIGURE 2: Nodular lesions in the dermis. In the lesions, increasing characteristic
wired collagen fbers, infltration of neutrophils, and swelling of small endovascular cells
are presented.
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Acute ischemic stroke is the 5th leading
cause of death in the United States
and number one cause of disability.1
Carotid artery atherosclerotic stenosis
is responsible for up to 30% of ischemic strokes.1 Te underlying pathophysiology of the ischemic stroke is
plaque rupture and distal embolism.1
Treatment is recommended for the
prevention of future stroke in symptomatic patients with >70% stenosis and
can be benefcial in those with 50–69%
stenosis, depending on patient-specifc
clinical and anatomical characteristics.1 Carotid endarterectomy (CEA)
is an established frst-line modality of
treatment.1 Transfemoral or transradial carotid artery stenting (CAS) is
another treatment modality usually
used for patients who cannot undergo
open surgery.1,2 Transcarotid artery
revascularization (TCAR) is a relatively new procedure.3,4 Tis treatment
approach carries the advantage of fow
reversal during stent deployment and
angioplasty to prevent distal embolic
complications and thus provide neuroprotection.5 Te purpose of this study
was to add to the literature by providing

TABLE 1: Univariable and multivariable logistic regression for TIA or stroke within 30
days.
Odds Ratio

95% Confdence
Interval

Age

0.99

0.95-1.02

0.631

Sex (male)

0.40

0.18-0.88

0.024*

Diabetes mellitus

1.07

0.47-2.43

0.861

Hypertension

0.88

0.39-1.99

0.768

Hyperlipidemia

0.82

0.36-1.86

0.644

Atrial fbrillation

0.81

0.24-2.74

0.738

Left side

0.90

0.41-1.95

0.797

Symptomatic

6.83

0.91-50.81

0.060

Intraprocedural TIA or stroke

2.17

0.27-17.25

0.462

Age

0.99

0.95-1.02

0.565

Sex (male)

0.38

0.17-0.87

0.023*

Diabetes mellitus

1.1

0.49-2.75

0.718

Hyperlipidemia

0.76

0.31-1.82

0.760

Atrial fbrillation

1.04

0.29-3.68

0.951

Left side

0.77

0.34-1.71

0.526

Symptomatic

6.49

0.861-49.05

0.070

Intraprocedural TIA or stroke

2.61

0.30-22.56

0.383

Variable

P-value

Univariable analysis

Multivariable analysis

Abbreviation: TIA, transient ischemic attack
*Statistically signifcant
real-world data comparing the safety
and efectiveness associated with the
performance of these carotid revascularization techniques by dual-trained
neurosurgeons.
We performed a retrospective
review of carotid stenosis databases at
two U.S. centers.
Patients treated by CEA, transfemoral CAS, or TCAR for atherosclerotic
carotid artery disease were included.
Clinical outcomes at 30 days post procedure were compared.
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A total of 780 patients were included
(583 CAS, 165 CEA, and 32 TCAR).
Overall, 486 (62.3%) patients were men,
and 393 (50.4%) had lef-sided carotid
disease. Most patients (617; 79.1%) had
symptomatic disease. Among the three
treatment groups, there were no statistically signifcant diferences with respect
to 30-day ischemic events: CAS, 3.8%;
CEA, 1.8%; and TCAR, 6.2% (p=0.267);
or 30-day mortality rates: CAS, 3.6%;
Continued on p. 98
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TABLE 2: Univariable and multivariable logistic regression for 30-day mortality.

CEA, 2.4%, and TCAR, 3.1% (p=0.857).
Male sex had signifcantly lower odds of
30-day transient ischemic attack (TIA)
or stroke on both univariable (p=0.024)
and multivariable (p=0.023) regression
models. Increasing age had signifcantly
higher odds of 30-day mortality on univariable (p=0.006) and multivariable
regression (p=0.003). Patients with the
occurrence of 30-day TIA or stroke also
had signifcantly higher odds of 30-day
mortality on univariable (p<0.001) and
multivariable regression (p<0.001).
Our real-world experience suggests
that with appropriate selection all three
treatment modalities carry comparable
safety and efectiveness in revascularization of the carotid artery.

Variable

ABBREVIATIONS
CAS, carotid artery stenting; CEA, carotid endarterectomy; CI, confdence interval; CMS, Centers
for Medicare and Medicaid Services; mRS, modifed Rankin Scale; NASCET, North American
Symptomatic Carotid Endarterectomy Trial;
NIHSS, National Institutes of Health Stroke Scale;
OR, odds ratio; TIA, transient ischemic attack;
TCAR, transcarotid artery revascularization
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Odds Ratio

95% Confdence Interval

P-value

Age

1.06

1.01-1.11

0.006*

Sex (male)

0.59

0.27-1.30

0.198

Diabetes mellitus

1.13

0.49-2.58

0.761

Hypertension

0.59

0.26-1.31

0.197

Hyperlipidemia

0.47

0.21-1.03

0.060

Atrial fbrillation

1.19

0.40-3.55

0.743

Left side

1.14

0.52-2.51

0.730

Symptomatic

NA

NA

0.995

Intraprocedural TIA or stroke

NA

NA

0.999

17.12

6.62-44.24

<0.001*

Age

1.08

1.02-1.12

0.003*

Univariable analysis

30-day TIA or stroke
Multivariable analysis
Sex (male)

0.63

0.26-1.55

0.323

Diabetes mellitus

1.65

0.64-4.20

0.293

Hypertension

0.53

0.19-1.45

0.221

Hyperlipidemia

0.57

0.22-

0.256

Atrial fbrillation

1.29

0.39-

0.672

Left side

0.95

0.39-2.28

0.911

Symptomatic

NA

NA

0.995

Intraprocedural TIA or stroke

NA

NA

0.999

*Statistically signifcant
Abbreviations: NA, not applicable; TIA, transient ischemic attack
for stroke prevention: A meta-analysis
of clinica l tria ls. J Am Coll Cardiol.
2017;69:2266-2275
3. Kashyap VS, Schneider PA, Foteh M,
Motaganahalli R, Shah R, Eckstein HH, et
al. Early outcomes in the roadster 2 study
of transcarotid artery revascularization
in patients with signifcant carotid artery
disease. Stroke. 2020;51:2620-2629

4. Kwolek CJ, Jaf MR, Leal JI, Hopkins LN,
Shah RM, Hanover TM, et al. Results of the
roadster multicenter trial of transcarotid
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Bariatric Left Gastric Artery Embolization: An Overview of
Mechanism, Technique, and Reported Literature
Chenyu Liu,
MSII

TABLE: Baseline characteristics of studies included in the pooled-study and metaanalysis.

ADVISOR: Qian
Yu MD1

Author/Year

1. University
of Chicago
Department of Radiology, Division of
Interventional Radiology

Bai 2018

Ghrelin, a 28-amino acid hormone, is
secreted by the gastrointestinal tract and
acts on the central nervous system to
stimulate hunger and appetite. Recently,
lef-gastric artery embolization (LGAE)
has been investigated for weight-loss
purposes as a minimally invasive
procedure.1,2 Through percutaneous
vascular access, the lef gastric artery
that supplies the ghrelin-producing cells
in the gastric fundus is embolized with
microspheres. Blood flow restriction
in this area reduces ghrelin secretion,
achieving hunger suppression and
weight-loss.1 In this study, our goal is
to describe the mechanism of action,

Region

Sample
Size

Followup

China

5

9
months

500-700

Weight, waist circumference, waistto-height ratio, adipose tissue,
ghrelin, leptin, complications

Elens 2018

Belgium

16

12
months

300-500;
500-700

Weight, complications, appetite,
satisfactory assessment

Kipshidze
2015

USA

5

24
months

300-500

Weight, ghrelin

Pirlet 2018

Canada

7

12
months

300-500

Weight

Syed 2016

USA

4

6
months

300-500

Weight, ghrelin, leptin,
cholecystokinin, complications

20

12
months

300-500

Weight, ghrelin, complications,
IWQOL-Lite scores, SF-36 scores,
HbA1C, Hunger score, cholesterol,
triglyceride, HDL, LDL

Weiss
2019*

USA

Microsphere Measured outcomes
(um)

*Certain included data were obtained from previous published preliminary results of the
same clinical trial.

catheterization of the celiac artery
could be performed with an angiographic catheter. Digital subtraction
angiography of the
celiac a r ter y a nd
superior mesenteric
[Left-gastric artery embolization] is safe and
artery would allow
the identifcation of
feasible intervention in achieving weight-loss
the lef gastric artery
a nd ot her potenin patients who have failed conservative mantial accessory gastric arteries. After
agement and are high risk surgical candidates.
confrming location
with angiography,
using a microcathprovide a technical illustration, and
eter, microspheres could be injected to
review the preliminary clinical studies
embolize the LGA until achieving stasis.
of bariatric LGAE.
Post-procedural weight loss demFirst, percutaneous vascular access,
onstrated an upward trend in terms
such as femoral artery and radial
of statistical signifcance at 1-month,
artery, should be established. Next,
3-month, 6-month, and at the study
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endpoints (p=0.283, 0.116, 0.064, and
0.045, respectively).1-6 On average,
every study suggested weight loss during
follow-up periods, and the mean weight
loss demonstrated an upward trend
overtime. According to the pooledanalysis, by 6-month, the mean weight
loss was 9.8 kg, and this value increased
to 11.5 kg at or greater than 1 year. Only
two studies reported excess weight
losses (EWL).3,5 Both studies suggested
an upward trend of EWL over the frst 6
months post-bariatric embolization: 8.6,
12.4, and 14.0 kg at 1-month, 3-month,
and 6-month respectively.
Three studies measured serum
ghrelin levels at baseline and during
follow-up.1,3,4 Although Bai et al and
Kipshidze et al observed an initial
Continued on p. 100

99

Continued from p. 99
decrease at three months, subsequent
ghrelin levels were approaching the baseline. Te maximal ghrelin decreased 24
pg/ml from the baseline on average. Te
mean serum ghrelin at 6-month postprocedural was 365.9 pg/ml, decreased
from 453.9 pg/ml at baseline. However,
the diference between six months and
baseline was not statistically signifcant
(p=0.173).Two studies reported serum
leptin levels.3,4 No apparent trend could
be appreciated based on the pooled
analysis. No signifcant diference in
leptin levels was found before and afer
bariatric embolization (p=0.554).
LGAE is safe and feasible intervention in achieving weight-loss in
patients who have failed conservative
management and are high risk surgical candidates. Serum ghrelin level
in clinical setting is not as reliable in
predicting weight-loss. This might
result from its hourly f luctuation
throughout the day. A more reliable test
is necessary to characterize its change
afer LGAE. Future research can focus
on maximizing selective reduction of
ghrelin-producing cells while avoiding
complications such as gastric ulcers.
More clinical data and larger sample

100

\
FIGURE: LGAE mechanism and methodology. Left: X/A-like cells secretes ghrelin
that stimulates hunger. Middle: the left gastric artery is catheterized from the radial
artery access. Right: Embolization with microspheres leads to local blood fow
restrictions, decreasing the amount of ghrelin secretion and suppressing hunger.
size are required before statistically
signifcant conclusions can be drawn.
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Gender dysphoria (GD), a condition of
incongruence between an individual’s
perception of sex and biological identity, has been increasingly recognized
in the past decade.1 Based on a nationwide survey in the United States,
0.6% responders identify themselves
as transgender.2 A higher prevalence
of co-existing psychiatric illness was
observed in this population.3 Genderconfirming surgery (GCS) has been
proven effective in improving these
individuals’ quality of life and alleviating psychological distress.4 From 2010
to 2015, the number of GCS increased
by fve times among insured patients
in the United States.5 Among male-tofemale individuals, breast implant is
considered the most important compared to other surgical procedures.
Despite extensive literature in
oncoplastic breast reconstruction,
articles on breast augmentation as
GCS were limited to case reports,
small case series, and retrospective
cohort studies. No society guideline
was available regarding the technical
aspects of the surgery and postoperative care. While skin necrosis, seroma,
hematoma, and capsular contracture
were well-described adverse events
among breast reconstruction afer mastectomy for cancer, their incidence and

management among male-to-female
hematoma, infection, capsular conpatients afer GCS were less clear. Tus,
tracture and reoperation rate were
the present study aims to evaluate the
collected and analyzed. Among the 17
safety and efcacy of breast augmenselected studies, four studies including
tation as a GCS for male-to-female
a total of 723 patients, the incidence
patients through meta-analysis of pubof having an asymmetry/malposition/
lished individual and cohort study data.
shape problem is 4%. In three studies,
PubMed, Embase, and the Cochrane
including a total of 689 patients, the
Library were queried for studies pubincidence of implant rupture is 3.8%. In
lished up to March 2021. Te following
eight studies, including a total of 1,074
keywords were used: “transgender”,
patients, the incidence of hematoma
“transfeminine”, “implant”, “augmenis 0.8%; the incidence of infection is
tation”, “breast”, and “chest”. Primary
0.1%. In eight studies, including 1,347
outcomes of interest were complicapatients, the incidence of reoperation
tion (ie hematoma, seroma, infection,
is 11.7%. Further, a chi-square test
capsular contracture, general implant
comparing capsular contracture and
problem, asymmetry/malposition,
implant-related complications between
hemorrhage, skin or
systemic complicaGender-confrming surgery (GCS) has been
tions), satisfaction,
and reoperation rates.
proven effective in improving these indiBreast implant surgery
complications were
viduals’ quality of life and alleviating psychocompared bet ween
cis-gender and translogical distress.4
gender patients as well.
Quantitative analyses were performed
with STATA 15.1 statistical sofware
cis-gender vs trans-gender breast
(STATA Corp., College Station, TX,
augmentation surgery was performed.
USA). Rates were pooled with the
Incidence of capsular contracture was
-metaprop function and reported in
signifcantly higher in the cis-gender
95% confdence intervals. A chi-square
group whereas there is no signifcant
test was performed to analyze the
difference in incidence of implant
incidence of complications between cisrelated complications between the two
gender vs trans-gender female breast
groups.
augmentation.
Due to lack of standardized report
A total of 17 studies, 1958 patients
and scant of data, no direct comparison
were included in this project. Studies
of the outcomes between subglandular
were conducted in various regions
vs subpectoral approach of breast
including the USA, Netherlands,
augmentation in transgender females
Belgium, Switzerland, Germany, and
can be made. However, the pooled
France. Complications and outcomes
outcomes of complications illustrate
including breast asymmetry/malposition/shape problem, implant rupture,
Continued on p. 102
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data to t he table. Behav ior genetics.
2018;48(2):95-108.

a variability in the rates of diferent
complications between cis-gender vs
trans-gender females. Future standardized comparative studies should be
conducted.

3. García-Vega E, Camero A, Fernández M,
Villaverde A. Suicidal ideation and suicide
attempts in persons with gender dysphoria.
Psicothema. 2018;30(3):283-288.
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INTRODUCTION: Acromegaly is
characterized by slowly progressive
somatic abnormal hyperplasia caused
by overproduction of growth hormone
(GH) and insulin-like growth factor
1 (IGF 1) and is frequently associated
with pituitary adenomas. This disorder commonly results in mandibular
hyperplasia and orofacial deformities
requiring surgical correction.
Here, we describe a novel use of
virtual surgical planning in reduction
mandibuloplasty for correction of
mandibular hyperplasia secondary to
acromegaly.
CASE: A 25-year-old female presented to our clinic with mandibular
hyperplasia secondary to a growthhormone secreting pituitary adenoma,
consistent with facial manifestations of
acromegaly. Tis had been treated with
a combination of prior surgical resection and lanreotide. Interestingly, she
presented with normal occlusion, and
reported this to be at her pre-morbid
baseline. Afer clearance by endocrinology, a surgical plan was developed
for a reduction genioplasty and mandibuloplasty to reduce her lower facial
proportions without altering her current normal occlusion.

FIGURE 1: Virtual surgical planning was used to assist in planning ostectomies of the
lower mandible for correction of mandibular hyperplasia secondary to acromegalu. (Left)
Pre-operative mandible (grey) interposed with a “generic” female mandible (orange).
ªRight) Planned bomne for resection is shown in green, and repositioned bone is shown
in blue after T-shaped ostectomy to reduce the chin.
To facilitate intraoperative bone
resection, virtual surgical planning
(3D systems, Littleton, CO) was used
to develop pre-fabricated cutting
guides for reduction genioplasty, and
ostectomy of the inferior border and
gonial angles of the mandible. The
planned degree of bone resection was
facilitated during a planning session by
overlay of the patient’s CT scan images
with a “generic” female mandible model
(Figure 1).
An intraoral approach was used for
reduction genioplasty and mandibuloplasty, with a technique similar to that
used for feminizing mandibuloplasty.5
Osseous genioplasty was performed
with a T-shaped excision of bone to
allow for reduction of chin dimensions
in both horizontal and vertical vectors,
with reduction amounts of 12.0mm
and 7.2mm respectively. Rigid titanium
osteosynthesis of the remaining chin
segments was performed. Ostectomy
of the inferior border of the mandible
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was continued posteriorly and included
the gonial angles to further reduce
mandibular proportions. A surgical
drain was placed for 24 hours. Routine
post-operative oral hygiene and antibiotic prophylaxis was instituted, and
the patient recovered uneventfully. A
post-operative CT scan demonstrated
efective mandibular reduction with
contours approximating those of the
“generic” female mandible used for
surgical planning (Figure 2).
DISCUSSION: Acromegaly results
in overgrowth of skeletal and soft
tissues, with typical enlargement of
the mandible being seen. Te most
prominent facial manifestation of acromegaly is mandibular prognathism due
to excessive jaw overgrowth, and the
ramus is more ofen afected than the
body of the mandible.2-3 Patients with
acromegaly typically exhibit enlargement of all parts of the neurocranium
Continued on p. 104
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and orofacial bones, though often
sparing the maxilla, and common
manifestations include dental malocclusion. Tis ofen warrants orthognathic surgery for correction of associated
orofacial deformities. “Horseshoe
horizontal osteotomy” has also been
utilized to reduce the vertical dimension of the body of the mandible.4
Interestingly, in our case, the lower
facial enlargement was associated with
normal occlusion and a plan for lower
mandible reduction was implemented.
We found the use of VSP in planning
the appropriate osteotomies to be a
useful tool in determining the degree
of bone resection to mirror a “generic”
female mandible proportion with a
pleasing end result.
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FIGURE 2: Post-operative CT scan demonstrates reduced mandible proportions,
mirroring those of the “generic” female mandible used for surgincal planning.
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Geriatric patients are at an increased
risk of severe injury from relatively
minor mechanisms, such as ground
level falls. Many are also on anticoagulation due to their morbidity which
sometimes present unique injuries
requiring special treatments. In this
case report, we present a geriatric
patient afer a fall with a large necrotic
hematoma dissecting her skin, most
likely due to her anticoagulation. Tis
presents a management challenge for
surgeons depending on the wound size
and degree of tissue loss.1 Literature is
limited but typical treatment is incision
and drainage, debridement, and split
thickness skin graf. Here, we treated
the patient’s large dissecting hematoma
with skin avulsion with early evacuation of hematoma followed by in-situ
skin grafing (the patient’s own traumatic skin fap) and negative pressure
wound therapy (NPWT). Others have
evaluated similar use of autologous skin
grafing in traumatic wounds.5
We describe a case of an 83-year-old
female with a past medical history of
diabetes, hypertension, hyperlipidemia,
congestive heart failure with reduced

Figure 7

Figure 8

Figure 9

Figure 10

FIGURES 1–10:
ejection fraction, obesity, obstructive
sleep apnea, bilateral breast cancer,
and vulvar squamous cell carcinoma
status post right groin dissection and
subsequent lymphedema of the right
lower extremity (RLE), presented to
the Emergency Department (ED) afer
sustaining a traumatic injury to her
RLE. She reported taking Rivaroxaban
daily for atrial fbrillation. Te patient
avulsed the skin on her RLE and developed a large hematoma measuring 20 x
15cm, distal to the knee. Figure 1 illustrates the skin changes and signifcant
clot burden. The patient underwent
resuscitation with two units of packed
red blood cells (pRBC) due to persistent hypotension in the ED. Within
24 hours the surgical team brought
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the patient to the operating room for
wound debridement and washout of
subdermal adipose tissue and hematoma. Te skin fap was meshed with a
#11 blade scalpel to facilitate drainage,
then fitted and stapled peripherally
along the wound. Afer securing the
skin fap, the surgeon applied a single
layer of Adaptec gauze followed by
Negative Pressure Wound Therapy
(NPWT) using a VAC device (VAC;
KCI, San Antonio, Texas). Figures 2-8
demonstrate these stages in succession.
Te patient received 1 additional unit
of pRBC post operatively and remained
in the hospital for an overall uncomplicated course. She required pain
Continued on p. 106
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control, physical therapy, and transfer
to an acute rehabilitation facility. She
presented to the ofce on post-operative
day 5 for wound vac removal. Figure 9
demonstrates the wound’s progression,
with approximately 60% graf uptake.
Te surgical team discontinued NPWT
and utilized Xeroform with gauze wrap
for ongoing outpatient wound care. Te
wound demonstrated persistence of
central necrosis, but ongoing healing
elsewhere at the patient’s two week
follow up visit in fgure 10.
Traumatic lower extremity hematomas in the elderly frequently result
in surgical consultation, and management techniques widely difer. Despite
their frequent presentation to trauma
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surgeons, traumatic lower extremity
hematomas are sparsely represented
in literature. No single algorithm
exists addressing up-front management, timing of surgical debridement
(if necessary), reconstruction style,
or subsequent wound care for such
injuries. We offer a novel approach
using the patient’s own avulsed skin
as a meshed biologic dressing. We suggest that with ongoing local wound
care, this approach has shortened the
patient’s healing time and bypassed the
morbidity of donor site creation in traditional skin grafing. Further studies
are needed to confrm this fnding.
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Te 4Kscore is a relatively new, bloodbased tool used to stratify the degree of
prostate cancer disease aggressiveness.
Since its advent within the last decade,
this cheaper, less invasive test is associated with far fewer complications, and
allows for clinical prediction of disease
aggressiveness and the subsequent plan
of treatment to become more individualized as to avoid overtreatment and
unnecessary costs and health burdens
to patients and systems alike. Recent
studies have indicated that a shift
towards a 4Kscore based clinical workup
paradigm has the potential to save over
160 million dollars compared to standard of care, defned as prostate biopsy.1
Prostate cancer risk is signifcantly
higher in African American individuals, with reports indicating a nearly
two times higher rate compared to
White males.2 Continued integration
of 4Kscore into the clinical workup of
elevated PSA warrants investigation

into the tool’s use and performance. Te
and African American males (sensilandmark 4Kscore trial to validate the
tivity=1.0, specifcity=0.67, NPV=1.0).
test’s performance focused primarily on
4Kscore is efective in both White
and African American patients. Tere
a cohort of White, Northern European
were no differences in performance
individuals, thereby limiting the tool's
characteristics between the two groups.
external validity across a wider range
However, the results indicate African
of demographics.3 Tis study aims to
assess race-based 4Kscore utilization
American males were signifcantly less
and efcacy to be able to qualify the
likely to have documented 4Kscore
performance of the test across patient
than White males, limiting comparison
demographics.
sample size. Our data suggests that
We c o n d u c t e d a
single-institution review
Our data suggests that 4Kscore is a capable
of patients who underwent prostate biopsy
tool in assessing risk of harboring csPCa,
with recorded 4Kscores
between 2016–20 and
and further investigation across racial democlassi f ied pat ients
as W hite or African
graphics should be continued to promote
A mer ic a n ba s e d on
self-report (other races
equitable utilization during clinical workup.
excluded). High-risk
4Kscore was defned as
values ≥7.5%, consistent with conventional interpretation.
4Kscore is a capable tool in assessing risk
Clinically signifcant prostate cancer
of harboring csPCa, and further inves(csPCa) was defned as a biopsy Gleason
tigation across racial demographics
score greater than/equal to 3+4. Receiver
should be continued to promote equiOperating Characteristic curve analysis
table utilization during clinical workup.
was used, along with Area Under the
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11% of medical school deans are URMs.

Sarah Schmitt, MSIII

The COVID-19 pandemic has exacerbated and uncovered the health
disparities present in our communities and has increased the push for
health equity across the country. With
a majority-minority nation on the
horizon for 2044, the need for physicians who resemble and represent our
population demographics is increasingly important. Historically, minority
populations have been restricted from
opportunities and promotions in their
medical training, memberships, and
professional activities, which subsequently excluded them from participating and impacting decisions at the
institutional level. Minority physicians
are also important in solving the
issues revolving around the shortage
of primary care physicians. Black
and African American physicians do
not account for the majority of active
physicians in the United States, yet a
plurality of Black or African American
physicians practiced primary care
(41.4% vs 30.6% of White physicians)
in 2018.1 Primary care physicians play

108

•••
•••
•••••• •
•••
•••
••• ••••
•••••••
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school deans in 2019. We identifed
an essential role in the prevention of
that only 11% of deans were underrephospitalizations and the management
resented minorities, 16% of deans were
of chronic conditions, and evidence
primary care physicians, and 18% of
demonstrates more primary care physideans were women.1 When compared
cians are associated with better health
with the makeup of physicians in the
outcomes. Despite this evidence, it is
estimated that by 2025
there will be a defcit of
By hiring deans with a variety of race/ethniciup to 31,000 adult primary care physicians in
ties, specialties, and genders, schools set an
the United States.2
Med ica l schools
important precedent that could lead to more
have a n i mpor t a nt
directive: to train the
pipeline programs, increased underreprenext generation of physicians. Faced with a
primary care physician
sented faculty retention, and more primary
shortage, increasing
numbers of under-repcare physicians.
resented faculty leaving
academic medicine,
low representation of women in leadUnited States and the population as a
ership positions, and an ongoing panwhole, these numbers are unrepresentademic, medical schools have a duty
tive of national demographics.
to implement solutions to alleviate
Te diversity of senior leadership
these issues. Eforts have been made
matters to students.3 Medical schools
should hire deans and senior leadership
to create more diverse medical school
that represent a diversity of specialclasses, but those eforts are not mirties, genders, races, and ethnicities.
rored in senior faculty demographics.
Future physicians need to acquire
Te demographics of medical school
skills to care for increasingly diverse
deans in comparison with the United
groups by learning about the unique
States’ demographics and the current
needs of minority populations and
composition of active physicians was
analyzed. We looked at the specialty,
race/ethnicity, and gender of medical
Continued on p. 109
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by including social determinants of
health, cultural humility, and systemic
racism in medical curricula.4 By hiring
deans with a variety of race/ethnicities,
specialties, and genders, schools set an
important precedent that could lead
to more pipeline programs, increased
underrepresented faculty retention, and
more primary care physicians.
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FIGURE:

modifed checklist based on the literature was used to assess the presentations. Two members of the research
Effective information transfer relies
team extracted data from the included
on the proper use of educational tools.
presentations and disagreements were
Presentations in surgery are comreviewed collaboratively. We calculated
monly used to share research fndings
the crude mean diference in the perand innovative surgical techniques.
centage of detractions using various
Evaluating the quality of presentations
presentation characteristics.
A tot a l of 9 6
presentations were
The use of a checklist, with concepts like
i nc lude d i n t h i s
sample and there
those presented in this study, to evaluate a
was an average of 9.6
detractions per presentation. Misused
presentation may aid in the development of
graphics, ambiguous
content (undefined
more effective presentations in hand surgery.
abbreviations, undefned symbols, etc.),
will permit us to improve educational
and overdetermined slides for the
materials in hand surgery. Our specifc
allotted time were the most common
aims were to assess the quality of hand
detractions identifed in the sample.
surgery presentations at a national
One-way ANOVA analysis of presenter
meeting using a checklist of presentarole found a signifcant diference in
tion standards from the literature and
the mean number of detractions (F (2,
to identify areas of improvement.
93) = 7.36, p = 0.001) among diferent
Our sample included presentations
types of presenters with surgeon prefrom the Clinical Papers Sessions at the
senters exhibiting more detractions
2020 American Society for Surgery of
than other students and other health
the Hand (ASSH) Annual Meeting. A
care professionals.
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Te use of a checklist, with concepts
like those presented in this study, to
evaluate a presentation may aid in the
development of more efective presentations in hand surgery. A collaborative
peer-review process incorporating
feedback from multiple trainees, audience members, and colleagues may
facilitate efective information transfer
through presentations.
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The Impact of the COVID-19 Pandemic on
Medical School Pathway Programs
Nick
Jennings,
MSII

TABLE 1: Characteristics of Schools Participating in the Pathway Programs During
COVID-19 Survey, 2021
Number Invited
(% of 198)

Number
Participating
(% of 112)

Response
Rate (%)

155 (78.3)

93 (83.0)

60.0

43 (21.7)

19 (17.0)

44.2

Midwest

42 (21.1)

24 (21.4)

57.1

Northeast

43 (21.7)

21 (18.8)

48.8

75 (37.9)

40 (35.7)

53.3

34 (17.1)

24 (21.4)

70.6

4 (2.0)

3 (2.7)

75.0

Public

101 (51.0)

59 (52.7)

58.4

Private

97 (49.0)

53 (47.3)

54.6

R1 Doctoral Universities (15)

78 (39.2)

47 (42.0)

61.5

R2 Doctoral Universities (16)

31 (15.6)

14 (12.5)

48.4

Characteristic

ADVISORS: Sonal
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School Type
Allopathic (MD)
Osteopathic (DO)

1. George Washington University (GW)
School of Medicine and Health Sciences
2. Milken Institute School of Public Health
at GW

Region

South

African Americans, Latinos, and
Native Americans account for 11.1
percent of U.S. physicians1 while constituting 32.1 percent of the total population.2 A diverse physician workforce
is associated with improved quality
of care, increased access to health
care services, and reduced health care
disparities. 3,4 Medical schools have
implemented pathway programs to
increase the diversity of the physician
workforce. In 2020, the coronavirus
(COVID-19) pandemic created a mass
disruption for programs across the
country with schools adjusting from
in-person schooling to a new online
environment. Te aim of this study is
to investigate how pathway programs
at medical schools have been impacted
by COVID-19.
Tis cross-sectional mixed-method
study was conducted in two phases
sequentially. Te frst qualitative phase
consisted of semi-structured interviews with a sample of medical school
pathway program administrators and
academic leaders. Tese identifed key
themes in changes to pathway programs in 2020 compared to previous
years. Te second quantitative phase
consisted of a survey sent to all medical

West
Puerto Rico
Institution Type

Institution Classifcation

R3 Doctoral Universities (17)

12 (6.0)

5 (4.5)

41.7

Medical Schools and Centers (25)

70 (35.2)

44 (39.3)

60.0

7 (2.5)

2 (1.8)

40.0

198 (100)

112 (100)

56.6

All others (18, 19, 21)
Total

schools to further quantify the impact
of COVID-19 on programs.
Of the 198 schools invited to participate in the survey phase, 112 responded
(56.6%). The response rate for allopathic schools (60%) was greater than
that of osteopathic schools (44.2%),
and schools geographically located
in the western United States (70.6%)
responded at a higher rate than those
in the northeast (48.8%). One-hundred
and six (95%) schools had pathway
programs during the pandemic, with
community-based schools having
less programming. Forty-two (37.5%)
respondents reported canceling some

CLINICAL TRANSLATIONAL RESEARCH

or all of their programs due to the
pandemic. Regardless of funding
source, most programs reported they
were able to retain funding. Of those
schools that run elementary grade
level pathway programs, above half
(52%) closed during the pandemic.
This contrasts with the percentage
of high school (10%), undergraduate
(8%) and post-graduate (7%) pathway
programs that were closed during the
pandemic. Table 2 lists the specifc programmatic activities included across
pathway programs. The number of
Continued on p. 112

111

Continued from p. 111
schools providing distanced learning
support doubled during the pandemic
and growth was equivalent in all
groups. Te most common program
type ofered was mentoring, which was
least afected by the pandemic, along
with distanced learning support. Tere
were signifcant relationships between
Carnegie classifcation and academic
support (Fischer exact p=0.052; χ2
p=0.002) as well as Carnegie classifcation and psychosocial support (Fischer
exact p=0.045 χ2 p=0.03). Additionally,
public universities represented 13 of
the 16 research opportunities that were
halted due to the pandemic (p=0.041).
In assessing opinions of school leadership, most support increased funding
for psychosocial support (87%) and
distance learning (88%) post-pandemic.
Narrative responses described challenges in keeping students engaged in
the virtual environment and equity
issues regarding broadband internet
access, while at the same time allowing
for broader reach. Budget efects seemed
to be generally mixed depending on
funding source.

112

TABLE 2: Program Services Provided Before and During the COVID-19 Pandemic
Program Type

Continued Providing During
Provided Before
Pandemic (Percent of
Pandemic (Percent of Total
Program-Type Providers)
Respondents, n=112)

Academic Support

95 (84%)

91 (95%)

Test Prep

62 (55%)

58 (94%)

Distanced Learning Support

21 (19%)

21 (100%)

Mentoring

103 (92%)

100 (97%)

Psychosocial Support

73 (65%)

67 (91%)

Research

80 (71%)

64 (80%)

Shadowing/Internship

88 (79%)

37 (42%)

Financial Support

70 (63%)

64 (91%)

Although the long-term impacts
of the COVID-19 pandemic on the
diversity of the physician workforce
will take decades to elucidate, this
study provides insight into the early
and potential impacts of the pandemic
on these important pathway programs.

REFERENCES
1. Figure 18. Percentage of all active physicians by race/ethnicity, 2018. Association
of American Medical Colleges. (Accessed
Aug. 16, 2021 at https://www.aamc.org/datareports/workforce/interactive-data/fgure18-percentage-all-active-physicians-race/
ethnicity-2018.)

2. Quick facts. United States Census Bureau.
(Accessed Aug. 16, 2021 at https://www.
census.gov/quickfacts/fact/table/US/
RHI225219.)
3. Smedley BD, Butler AS, Bristow LR. In the
Nation’s Compelling Interest: Ensuring
Diversity in the Health-Care Workforce.
National Academies Press; 2004.
4. Missing Persons: Minorities In the Health
Professions. Sullivan Commission on Diversity in the Healthcare Workforce. 2003.

Fusion | 2022

Medical School During a Pandemic: A Retrospective Study on
United States Medical School Reopening Policies
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Total Number or U.S. MD Schools

155

Number or Schools Examined

100

Number or Schools with School-Specific Plans

25

Mandatory mask usage

25(100'1<,)

Social distancing regulations

25(100'1<,)

Enhanced disinfection techniques (responsibiltty of individual and by pa,d staff)

25(100'1<,)

Daily screening of symptoms

19(76%)

COVID·19 testing of asymptomatic students

4(16%)

COVID·19 testing on return to campus

5(20'1<,)

Pre-clm,ca/ option of ent,re/y v,rtua/ vs. in·person for small group act1vit1es

2(8%)

FIGURE:
Daniel J. Muller,
MPhil, MSIII

Zach Silverstein,
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BACKGROUND: The COVID-19
pandemic has resulted in innumerable
unprecedented challenges in the medical education system. Among other
factors, personal protective equipment
(PPE) restrictions, contact limitations,
and social distancing measures have
all signifcantly altered the structure
of undergraduate medical education
and have required rapid adaptation to
an ever-changing environment. As the
pandemic surpasses one year in duration and the undergraduate medical
education system concludes its first
full pandemic year, we refect on how
medical schools have responded thus

far to this crisis, where the current data
immediately due to travel restrictions.3,4
stands in relation to safety of school
Lab closures efectively quelled many
reopening, and how the structure of
signifcant summer research projects.4,5
undergraduate medical education has
In effect, undergraduate medical
been changed forever.
education came to a screeching halt,
For the majority of institutions,
and school administrators had to act
in-person courses and rotations were
swifly to ensure that student training
halted abruptly in mid-March as
proceeded as safely as possible. The
schools were forced
to transition to a
c omple t e l y v i rThe COVID-19 pandemic has resulted in a radical
tual learning
env ironment for
upheaval of undergraduate medical education
the remainder
of the 2019-2020
at both the preclinical and clinical levels.
academic year1. 1
A natomy, sk i l l s
labs, and in-person
problem-based learning sessions
2019–20 academic year ended with
ceased.2 Instead of traditional clinical
most pre-clinical and clinical students
work, students on rotations completed
(pre-clinical and clinical) learning from
their clinical training using virtual
home, wondering whether they would
cases. 3 A subset of second-year prebe returning to campus in the fall.
clinical students (including the author,
Heading into the 2020–21 acaKlein) became trapped in a cycle of
demic year with the knowledge that
exam cancellations and clerkship
the COVID-19 pandemic would afect
delays. Away acting internships, interthe fall semester at the very least, many
national electives, conference attenContinued on p. 114
dance, and interviews were prohibited
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Continued from p. 113
medical schools developed plans to
reopen in some capacity.
METHODS: Te publicly available
reopening plans of U.S. MD programs
were evaluated at the start of fall
semester and at the end of fall semester.
RESULTS: All schools adopted a
version of hybrid medical education,
and mask use, social distancing of more
than 6 feet at all times, and enhanced
disinfection of common areas were
universally implemented. Twenty-three
of 25 medical schools continued to
require that students attend activities
like anatomy lab and clinical skills
simulations in-person. Every school
prohibited clinical students from taking
care of patients with a confrmed or
suspected diagnosis of COVID-19.
Strategic testing of asymptomatic
medical students for COVID-19 was
not widely implemented at the time of
this study.

114

CONCLUSION: The COVID-19
pandemic has resulted in a radical
upheaval of undergraduate medical
education at both the preclinical and
clinical levels. In the span of one year,
preclinical education transitioned from
traditional, classroom-based learning
to a predominantly hybrid model. Te
elimination of in-person large lectures
and focus on small group discussion
has generated a much more interactive
learning environment, despite, in some
cases, students being dispersed across
the country. Additionally, clinical
students learnedare learning in a completely different environment from
their predecessors and will be more
prepared than previous generations
to handle similar crises in their own
careers.
For further reading, please visit https://
hphr.org/31-article-klein/ for the full
article.
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Do Orthopedic Surgery Residency Program
Websites Address Diversity and Inclusion?
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Orthopedic surgery is one of the least
diverse medical specialties.1,2 Other
medical specialties have employed diversity-related initiatives to increase the
number of students underrepresented
in medicine (URM). 3 Furthermore,
with the suspension of visiting student
rotations during the COVID-19 pandemic, medical students used residency
program websites as a main source of
program-specifc information.4
Te purpose of this study was to
measure the extent to which orthopedic surgery residency program websites describe diversity and inclusion
initiatives.
The Electronic Residency
Application Service was used to identify U.S. orthopedic surgery residency
programs. Te programs’ websites were
reviewed, and data on commitments to
diversity and inclusion were collected.
Descriptive statistics of these data were
generated.
Tere were 192 residency programs
identified; three were excluded from
the analysis due to lack of websites. Of
the remaining 189 residency program
websites, only 55 (29.10%) contained
information on diversity and inclusion. Information on a commitment to
improving diversity and inclusion was
the most prevalent data point found
among program websites, although it
was found on only 15% of program sites.

FIGURE: The map shows percentages of U.S. orthopaedic surgery residency program
websites with diversity and inclusion information by geographical divisions according to
the U.S. Census.

TABLE: Percentages of orthopaedic surgery residency program websites (n = 189)
providing information on diversity and inclusion.
Type of information

Percentage of program Web sites containing information

Depattment-spedfic Web site for diversity and inclusion
Commitment to diversity and inclusion
Diversity-related opportunities for early exposure to orthopedic surgery
links to a non-department-specific Web site for diversity and inclusion
Unconscious bias
Audition rotations for students under-represented in medicine
Details on faculty diversity
Any diversity and Inclusion-related lnformadon

Orthopedic surgery residency programs rarely address topics related
to diversity and inclusion on their
program websites. An emphasis on
opportunities for URM students and
initiatives related to diversity and inclusion on program Websites may improve
URM outreach and serve as one method
for increasing URM matriculation into
orthopedic surgery.
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TABLE 1: Baseline Demographic and Smoking Characteristics of Participants
Age, mean (SD)

Total (N = 80)

T&Q (n = 40)

T4C (n = 40)

42.2 (11.6)

42.4 (12.4)

42.1 (10.8)

Gender, n (%)
Male

31 (38.8)

17 (42.5)

14 (35.0)

Female

49 (61.2)

23 (57.5)

26 (65.0)

Less than high school

20 (25.0)

11 (27.5)

9 (22.5)

High school or more

60 (75.0)

29 (72.5)

31 (77.5)

African American

72 (90.0)

36 (90.0)

36 (90.0)

Other

8 (10.0)

4 (10.0)

4 (10.0)

Employed (full or part time)

36 (45.0)

20 (50.0)

16 (40.0)

Unemployed or don’t work

44 (55.0)

20 (50.0)

24 (60.0)

Up to $15,000

44 (55.7)

19 (48.7)

25 (62.5)

Greater than $15,000

35 (44.3)

20 (51.3)

15 (37.5)

Education, n (%)

Race, n (%)

Employment, n (%)

Annual income, n (%)

INTRODUCTION: Automated text
messaging programs have been studied
as a treatment tool, but have not
been studied as an outreach tool to
increase the reach of smoking cessation
treatment.
AIMS AND METHODS: Two
distinct text messaging programs
were developed. One was aimed
at connecting smokers to quitline
phone counseling via text message
(Text4Coach [T4C]) and the other
was aimed at connecting smokers to a
smoking cessation text messaging program (Text&Quit [T&Q]). Adult daily
smokers with Medicaid insurance (N =
80) were recruited from the Emergency
Department at an urban hospital and
randomized to T4C or T&Q. Te primary outcome was program reach.
RESULTS: Outreach text messages were found to have moderately
high uptake, with the majority of
participants (63.8%) opting into their
assigned tobacco treatment program
and younger and female participants
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Cigarettes per day, mean (SD)

8.5 (5.1)

8.3 (5.0)

8.6 (5.2)

Quit attempt in the past year, n (%)

58 (72.5)

29 (72.5)

29 (72.5)

FTCDa score, mean (SD)

3.1 (1.4)

3.1 (1.6)

3.0 (1.3)

Admitted to ED

12 (15.0)

7 (17.5)

5 (12.5)

23 (30.1)

8 (22.2)

14 (37.8)

Top reasons for ED visit
Orthopedicb

12 (16.4)

5 (13.9)

7 (18.9)

Nonspecifcd

16 (21.9)

9 (25.0)

7 (18.9)

Other

23 (31.5)

14 (38.9)

9 (24.3)

Internal organ

c

ED = emergency department; T&Q = Text&Quit; T4C = Text4Coach.
a
Fagerstrom Test for Cigarette Dependence.
b
Includes any joint, limb, muscle, or skeletal pain.
c
Includes pain in any internal organs, including abdominal pain.
d
Includes general symptoms such as fever, cough, nausea, and dizziness.

more likely to opt in (p < .01). Receipt
of the treatment portion of the program
differed among the programs with
67.5% of T&Q receiving the treatment
program and 27.5% of T4C receiving
the program (p < .001). Most participants across both groups replied to at
least one message (71.3%) and very few

unsubscribed from the service over the
3-week trial. Te majority of participants reported overall satisfaction with
their program (63.8%), found it helpful
for quitting smoking (60.0%) and would
recommend the program to a friend
Continued on p. 117
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TABLE 2: Program Engagement and Smoking-Related Outcomes
(62.5%). Overall, 11 (13.8%) participants
reported being abstinent from smoking
for the past 7 days at follow-up, with no
diferences between groups.
Conclusions: Outreach text messages were found to have moderately
high reach among Medicaid smokers.
Larger trials are needed to evaluate the
impact of such programs on helping
low-income smokers quit.
IMPLICATIONS: Automated text
messaging programs have been tested
as a treatment tool, but have not been
tested as an outreach tool to increase
the reach of smoking cessation treatment. Tis study tests a new way of
conducting outreach to smokers in a
health system through text messages.
It tests the effect of outreach on (1)
rates of opting in and (2) successful
treatment delivery. Results may inform
new models of providing outreach for
tobacco treatment in health systems.

Total (N = 80) T&Q (n = 40)

T4C (n = 40)

Reach and acceptability
Program uptake, n (% joined)

51 (63.8)

27 (67.5)

24 (60.0)

Received program, n (% received program)a

38 (47.5)

27 (67.5)

11 (27.5)

Replied to at least one message, n (%)b

57 (71.3)

29 (72.5)

28 (70.0)

N/A

22 (55.0)

N/A

2 (2.5)

0 (0.0)

2 (5.0)

Overall satisfaction

51 (63.8)

26 (65.0)

24 (60.0)

Helpfulness for quitting

48 (60.0)

24 (60.0)

24 (60.0)

Recommend to friend

50 (62.5)

24 (60.0)

26 (65.0)

5 (6.3)

2 (5.0)

3 (7.5)

Total (n = 69)

T&Q (n = 34)

T4C (n = 35)

Seven-day point prevalence abstinence, n (%)

11 (15.9)

8 (23.5)

3 (8.3)

Seven-day point prevalence abstinence,
with imputation for missing, n (%)d

11 (13.8)

8 (20.0)

3 (7.5)

25 (37.3)

16 (48.5)

9 (26.5)

Replied to the program to set quit date, n (%)
Unsubscribed, n (% opted-out)
Program satisfaction, n (% agreeing)c

Experienced technical problems, n (%)c
Self-reported smoking outcomes

Set quit date, n (%)
Quit attempt, n (%)

44 (62.9)

23 (67.7)

21 (58.3)

Change in cigarettes per day, mean (SD)

−2.7 (6.6)

−1.9 (8.2)

−3.5 (4.6)

Longest continuous period without smoking,
mean (SD)

3.2 (4.4)

3.4 (5.1)

2.9 (3.6)

Use of any additional smoking cessation
services in the past 3 weeks, n (%)

50 (71.4)

24 (70.6)

26 (72.2)

Type of smoking cessation service used, n (%)
Telephone helpline or quitline

10 (14.3)

3 (8.8)

7 (19.4)

Counseling from a doctor or nurse

5 (7.1)

3 (8.8)

2 (5.6)

Self-help materials

6 (8.6)

2 (5.9)

4 (11.1)

E-cigarettes

4 (5.7)

2 (5.9)

2 (5.6)

Website

3 (4.3)

1 (2.9)

2 (5.6)

Other

23 (32.9)

13 (38.2)

10 (27.8)

Medication

22 (31.4)

9 (26.5)

13 (36.1)

Nicotine patch

15 (21.4)

8 (23.5)

7 (19.4)

Nicotine gum

7 (10.0)

1 (2.9)

6 (16.7)

Nicotine lozenges

1 (1.4)

1 (2.9)

0 (0.0)

Varenicline or Chantix

2 (2.9)

2 (5.9)

0 (0.0)

QL = quitline; T&Q = Text&Quit; T4C = Text4Coach. Bold indicates signifcant differences.
aProgram is assigned treatment program of T&Q or QL counseling.
bExcludes texting STOP to opt out.
cSelf-report: n = 35.
dN = 80.
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INTRODUCTION: Any given night,
an estimated 553,000 individuals
experience homelessness in the United
States. Many turn to hospitals for
health care, food, and shelter. Tese
factors and lack of follow-up care
upon discharge contribute to high
rates of early readmission and frequent
ED visits. Due to frequently missed
homelessness status by health care
providers, it is difcult to assess patient
demographics and readmission rates
among this population.
T h e Hom e l e s s M a n a ge m e nt
Information System (HMIS) collects
information on indiv idua ls t hat
have stayed at shelters or transitional
housing in Washington, D.C. We
utilized the HMIS to identify patients
experiencing homelessness at an urban
academic hospital.
ME THODS: Fu l l na me s a nd
birthdates from adults in HMIS were
searched in the Electronic Medical
Record (EMR) to locate patient matches.
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Inclusion criteria were having had at
Cardiology (14.5%), Surgery (11.8%),
least 1 ED visit (without admission)
and Intensive Care (3.18%). Te 30-day
or hospital admission from 9/1/2019ED revisit rate including only ED visits
2/29/2020. Descriptive statistics were
without admission was 27.99%. 10.11%
performed for demographics (gender,
of admitted patients were readmitted
race, age, family status) and encounter
within 30 days. Patients were, on
information from the EMR. We used
average, older [45.23 years old (SD=14.7)
Fischer’s exact test or unpaired t-test to
versus 43.26 (SD=15.92);p=0.0034],
compare the demographics of patient
more commonly African American
matches to those of HMIS-listed
(87.32% versus 77.22%; p<0.0001) and
individuals who did not have hospital
less commonly Hispanic (4.42% versus
records.
9.45%; p<0.0001) when compared to
RESULTS: Out of 5,025 HMIS
non-patients. Fewer homeless patients
entries searched, 2,523 (50.2%) had
than non-patients were male (59.26%
hospital records, with 702 patients
versus 71.44%; p<0001).
(14%) having had
at least 1 ED visit
Any given night, an estimated 553,000 indior admission in our
6-month timeframe.
viduals experience homelessness in the United
From 702 patients,
we rev iewed 586
States. Many turn to hospitals for health care,
ED visits without
admission and 188
food, and shelter.
a d m i s s i o n s (u p
to 1 ED visit and
1 ad m ission per
patient). 2507 unmatched persons
CONCLUSION: Homeless patients
in HMIS were used as non-patient
in this urban academic hospital were
comparisons. Most patients were
mostly middle-aged African American
single adults without families (93.5%).
men. Compared to non-patients, there
Most patients had Medicaid (39.59%
was a higher percentage of women and
of ED visits, 54.26% of admissions)
African Americans among patients,
or municipally-funded insurance for
and a lower percent of Hispanics.
low-income residents (29.18% of ED
More admitted patients had Medicaid
visits, 30.85% of admissions). 23.04%
and more ED visits without admission
of patients who visited the ED without
were among uninsured patients. More
admission and 7.54% of admitted
than half of admitted patients were
patients had no insurance. Te most
cared for by Internal Medicine and
common primary diagnosis was acute
Psychiatry teams. Readmission rates
ingestion or drug abuse/overdose
were low, however nearly one-third
(15.8%) in ED visits, and psychiatric
of ED visits had a subsequent ED visit
disease (19.5%) in admissions. Primary
within 30 days. Tis information may
teams caring for admitted patients were
help guide the distribution of resources
Internal Medicine (37.0%), Psychiatry
for interventions within hospitals.
(2 0.0%), OB/GY N (15.4%), a nd
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A p p r o x i m a t e l y 4 0 % o f f i r s ttime adult shelter users have an
Emergency Department (ED) visit
or hospitalization within one year of
shelter entry. Physicians must know
patients’ housing statuses to develop
appropriate care plans afer discharge.
Standardized tools for universa l
screening exist, however, the rate of
correct identifcation of homelessness
appears to be low and is not widely
studied. One barrier to study is the
lack of “true” comparison information
without surveying patients in real-time.
We i nve s t i gat e d t he r at e of
correctly identified homelessness
documented during ED visits and
hospital admissions. We used the
Homeless Management Information
System (HMIS) to identify individuals
who stayed at shelters or transitional
housing in Washington, D.C., during
a 6-month period and compared this

to Electronic Medical Records (EMRs)
documentation was in the physician
during the same time period.
note (89%), social work note (22%) or
HMIS data on adults using homeless
nursing note (15%). Among admitted
services between 9/1/2019-2/29/2020
patients whose housing insecurity was
was shared with researchers through
correctly documented, documentation
a data use agreement. Using names
was in the physician note (72%), social
and dates of birth, 5,025 individuals
work note (56%), discharge summary
from the HMIS were searched in
(54%), discharge note (46%), initial ED
the EMR. Inclusion criteria were
physician note (37%) or ICD-10 coded
age >17, matching to a record in the
using Z59.0 (19%).
EMR, and having at least one ED
Our data show that homelessness
visit or inpatient admission within
was not documented in at least onethe same 6-month period. Charts
third of hospital admissions and
were reviewed for documentation of
two-thirds of ED visits for patients
housing status for up to 2 ED visits and
who used shelters or transitional
2 inpatient admissions per matched
housing. More data points may have
patient, including
where in the chart
Our data show that homelessness was not docuit was documented.
Simple percentages
mented in at least one-third of hospital admiswe re c a lc u l at e d
and Fisher's exact
sions and two-thirds of ED visits for patients who
test was used to
compare rates
used shelters or transitional housing.
in the ED versus
admissions. This
study was approved
by the George Washington University
been missed, as other patients may
IRB.
have had housing insecurity without
Out of 5,025 HMIS entries searched,
utilizing shelters or transitiona l
2,523 (50.2%) had EMR charts, with
housing. Homelessness may be more
702 patients (14%) having had at least
often correctly documented during
1 ED visit or admission in the 6-month
admissions due to the more thorough
study period. Out of 813 ED visits
nature of the encounter, additional time
without admission (586 patients; 227
available, better documentation, and
with second visits), housing insecurity
need to create more detailed discharge
was identifed in 37% (303/813). Out
plans that incorporate housing barriers.
of 220 admissions (188 patients; 32
Some EMRs incorporate screening
second admissions), housing insecurity
alerts to improve identification of
was identifed in 64% (140/220). Te
housing insecurity, however George
diference in identifcation of housing
Washington University’s EMR lacks
insecurity during ED visits versus
these. Further study should include the
admissions was signifcant (p<.0001).
impact of using these tools on correctly
Among ED patients whose housing
identifying housing insecurity.
insecurity was correctly documented,
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FIGURE: Rate of Readmission Among Different Racial Groups Over Time.
Race has been identified as a social
determinant of health associated with
numerous surgical outcomes. Given
the national attention to disparities
in health care, understanding the
variation in the health care provided
to minorities becomes increasingly
important. Plastic surgery researchers
have investigated the efect of sexual
orientation, sex, and race on care.1-4
Nonetheless, the current literature on
race focuses on access of plastic surgery care and traditional outcomes.2,5
Efforts to reduce health disparities
continue to increase and becomes
more important as the United States
(US) health care system transitions to
a value-based system. In this study, we
examined the efect of race on the rate
and cost of unplanned hospitalizations
afer abdominoplasty and breast reconstruction procedures.
We performed a population-based
analysis of patients in the Healthcare
Cost and Utilization Project (HCUP)
from 2006 to 2015. Adult patients
undergoing implant-based and autologous breast reconstruction and
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abdominoplasty were included in
our study. We calculated the rate of
unplanned emergency department and
hospital visits and associated expenditures among patients of diferent races.
Multivariable analyses were performed
to determine the association among
race and readmissions and health care
expenditures.
A total of 17,745 patients were
included in the fnal cohort. Te rate of
an unplanned visit afer discharge was
fve percent. In a univariate analysis,
Black patients (6%) and Hispanic
patients (7%) had a signifcantly higher
rate of readmissions compared to White
patients (5%). However, afer controlling for patient-level characteristics,
race was not an independent predictor
of an unplanned hospital visit. In this
study, we did not fnd any signifcant
diference in readmission rates or cost
of readmissions for different racial
groups over time. Figure 1 illustrates
rate of readmission among diferent
racial groups and Figure 2 depicts the
average cost of readmission among

different racial groups from 2009
to 2015. Te cost of readmission for
non-White patients was signifcantly
higher than for White patients: Black
patients ($12,491), Hispanic patients
($12,216), or patients included in the
other category ($18,838) had greater
average cost for their readmission
compared to White patients ($10,537).
Additionally, in our expenditure model,
Black patients (adjusted cost ratio, 1.28
[95% CI, 1.05 to 1.56]) and Hispanic
patients (adjusted cost ratio, 1.27 [95%
CI, 1.03 to 1.58]) were at increased
odds of incurring a greater cost for
their readmission compared to White
patients.
It is imperative to identify the
numerous racial disparities that exist
in medicine. Developing solutions on
the consequences of racial disparities is
integral to create equitable care for individuals among diferent racial groups,
sexual orientations, gender identities,
and socioeconomic statuses. Although
Continued on p. 121
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race is not an independent predictor of
an unplanned hospital visit afer surgery, racial minorities bear a higher cost
burden afer controlling for insurance
status, further stimulating health care
disparities. Adjusted payment models
may be a strategy to reduce disparities
in surgical care, fostering more equitable care. Additionally, both direct and
indirect measures of disparities should
be used when examining health care
disparities to identify consequences of
inequities more robustly.
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INTRODUCTION: A recent study
found that 10% of emergency department (ED) patients experiencing homelessness had their housing status
documented by the health care team.
Identification of homelessness may
inform care decisions and direct
patients toward community resources,
both of which may improve health
outcomes. Standardized screening
tools for homelessness exist but are
not commonly used. We investigated
patient characteristics associated with
missed identification of homelessness to inform the development and
implementation of efective screening
strategies.
METHODS: We used the Homeless
Management Information System
(HMIS), a database of information
on individuals who have stayed at
shelters or transitional housing in
Washington, D.C. to identify homeless individuals. Full names and dates
of birth from adults in HMIS between
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9/1/2019-2/29/2020 were searched in
p<.0001), as were those with priour Electronic Medical Record (EMR)
mary psychiatric diagnoses (aOR 0.24
for matches. Inclusion criteria were
[0.13-0.42], p<.0001). During hospital
having had at least 1 ED visit or inpaadmissions, missed homelessness was
tient admission during the 6-month
significantly associated with having
period. Charts were reviewed for docuDC Alliance insurance (aOR 2.76 [1.29
mentation of homelessness for up to 2
– 5.93], p=.009); correct identifcation
ED visits and 2 inpatient admissions
was associated with a primary psychiper patient within the 6-month period.
atric diagnosis (aOR 0.14 [0.04-0.49],
Instances of missed identifcation of
p=.002).
homelessness were recorded. We used
CONCLUSIONS: In this study,
multivariable logistic regression to
homelessness was not documented in
identify patient characteristics indea large percentage of patients during
pendently correlated with missed idenED visits and hospital admissions.
tifcation of homelessness, including
Characteristics associated with missed
age, gender, race,
primary diagnosis,
In this study, homelessness was not documented
type of insurance,
and prior or curin a large percentage of patients during ED
rent use of shelters or
transitional housing.
visits and hospital admissions.
We report adjusted
Odds Ratios (aOR).
This study was
approved by the George Washington
documentation were diferent for ED
University IRB.
visits and admissions, but it is unclear
RESULTS: Out of 5,025 adults
why having DC Alliance insurance
in HMIS, 2,523 (50.2%) had hospital
was associated with this for both.
records, and 14% (702 patients) met
DC Alliance covers District residents
inclusion criteria. Housing insecurity
<200%FPL who are not eligible for
was correctly identifed in 37% of ED
Medicaid or Medicare. Use of tranvisits (303/813 visits) and 64% of admissitional housing was associated with
sions (140/220 admissions). In the fnal
missed identifcation in the ED, which
multivariable model with visits nested
may refect that health care teams are
within patients, signifcant indepenbetter at picking up housing insecurity
dent predictors of missed homelesswhen present in its most severe forms,
ness during ED visits included prior
highlighting the need to use standardor current use of transitional housing
ized screening tools. Having a primary
(aOR 1.92 [95% CI 1.07-3.44], p=.03),
psychiatric diagnosis was associated
Black or African American race (aOR
with correct identification in both
2.13 [1.33-3.40] p=.0016) and having
settings, which may indicate that comDC Alliance insurance (aOR 1.65 [1.14ponents of the psychiatric interview
2.40], p=.009). Homeless patients aged
include housing screening questions.
60 or older were more likely to be correctly identifed (aOR 0.40 [0.26-0.61],
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INTRODUCTION: Homelessness is
ofen underrecognized in the healthcare
setting, preventing quality discharge
planning, care coordination, and connection to community resources. Once
found, effective documentation of
homelessness in the electronic medical
record (EMR) can inform future providers. We investigated how prior
homeless documentation in the EMR
infuenced the identifcation of patient
homelessness in subsequent encounters.
METHODS: The Homeless
Management Information System
(HMIS) is a database of individuals that
have stayed at shelters or transitional
housing in Washington, D.C. Full
names and dates of birth for adults in
HMIS from Sept. 1, 2019 to Feb. 29, 2020
were searched in our EMR to locate
matching patient records. Inclusion
criteria were having had at least one
ED visit without admission or inpatient
admission at our hospital during the
6-month period. Charts were reviewed

for documentation of homelessness for
There was a significant association
up to the frst two ED visits and frst
between the identifcation of homelesstwo inpatient admissions per patient
ness in the sentinel admission and the
during the 6-month period. We then
admission second encounter (β=13,
examined the persistence of correct
p=0.0318) or ED visit second encounter
homeless identification among two
(β=12.94, p=0.0403).
consecutive encounters: ED visit to ED
CONCLUSION: These data sugvisit, ED visit to admission, admission
gest that homelessness is more ofen
to admission, or admission to ED visit.
correctly documented during hospital
Univariable logistic regression was used
admissions than ED visits. Correct
to analyze the association between coridentifcation in the EMR during a senrect identifcation of homelessness at the
tinel ED visit or admission was associfirst encounter with
correct identifcation
Among patients for whom homelessness was
at the second. For
second encounters, we
correctly identifed during a sentinel ED visit, it
examined the diference in identifcation
rate between ED visits
was again identifed in 63.86% of 83 ED visit
and admissions using
Fischer’s exact test.
second encounters compared to 90.91% of
RESULTS: Using
the HMIS, we iden22 admission second encounters (p=0.0177).
tif ied 702 patients
experiencing homelessness; from their hospital records
ated with correct identifcation during
we reviewed 813 ED visits and 220
a subsequent encounter, however this
admissions. Among patients for whom
was less ofen true when the subsequent
homelessness was correctly identifed
encounter was in the ED. Whether
during a sentinel ED visit, it was again
homelessness was documented during
identified in 63.86% of 83 ED visit
a sentinel admission or sentinel ED visit,
second encounters compared to 90.91%
both resulted in successful identifcaof 22 admission second encounters
tion in only about 60% of second ED
(p=0.0177). There was a significant
visits. Tis suggests that ED providers
association between correct identifcaare less likely to locate existing homeless
tion of homelessness in the sentinel ED
status information in the EMR. Tis
visit and the ED visit second encounter
may reflect that our health system’s
(β=9.717, p<0.0001) or admission
EMR has separate applications for ED
second encounter (β=7.778, p=0.0208).
and admission documentation, with
Among patients for whom homelessinpatient providers more commonly
ness was correctly identifed during a
accessing both applications. These
sentinel admission, it was again identifndings highlight the need for efecfed in 81.25% of 16 admission second
tive screening and documentation of
encounters compared to 54.05% of 37
housing status in an EMR location easily
ED visit second encounters (p=0.0728).
accessed by all providers.
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Annually, there are approximately
400,000 children born with sickle cell
disease (SCD); 90% of these children
live in sub-Saharan Africa.1 Afected
children are at risk for a range of health
efects, most importantly silent or overt
strokes that can cause cognitive and
neurological impairments.2 Despite the
high prevalence and incidence of SCD
in sub-Saharan Africa, medical monitoring for disease status is frequently
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less than in high-income countries.2
Even if patients are found to be at high
risk of adverse consequences of SCD,
medical interventions are infrequently
available.2 Tis is the case in Malawi, a
country where 1 to 3% of all children
are afected.1,3
Tra nscra nia l Doppler (TCD),
which has recently become available
in Malawi, is reliably used to assess the
risk of strokes in children with SCD.
Because this technology is new to this
region, there are concerns that families
do not understand why TCD is being
performed. In response, we created and
validated an educational brochure for
families of children with SCD who were
enrolled in a TCD monitoring clinic
at Queen Elizabeth Central Hospital
in Blantyre, Malawi. We reviewed
educational brochures about SCD and
other disease processes in use in other
African countries.
Following these models, we developed questions and answers related to
SCD and TCD using simple language.
The narrative was translated into
Chichewa, a regional, native language.
We obtained feedback on the pilot

version after review by Malawian
nurses and parents for content validity
and ease of understanding. We then
revised the brochure accordingly.
Te fnal product was illustrated and
printed, creating a deliverable, educational brochure focused on Malawian
families of children with SCD. Future
directions for this work may include
interventional clinical trials to ascertain whether family education using
this brochure improves compliance
with medications, clinic attendance,
and SCD outcomes.
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To evaluate recent trends in national
procedura l volume of computed
tomography angiography (CTA) and
computed tomography perfusion
(CTP) of the head with specifc evaluation of emergency department (ED)
utilization.
Physician Summary Procedure Files
(PSPS) from the Centers for Medicare
and Medicaid Services (CMS) were
obtained for the years 2010 – 2019. Total
fee-for-service Medicare benefciaries
were obtained from CMS Program
Statistic Reports. CT Angiography
and CT Perfusion procedures were
identified using current procedural
technolog y (CPT) codes. Annual
procedural volume was analyzed.
Subsequent analysis by procedure location including ofce, inpatient hospital,
outpatient hospital, and emergency
rooms was then performed.1,2
From 2010 to 2019, the total number
of Medicare fee-for-service beneficiaries ranged from 36.0 million to
38.7 million persons. Total number of
CTA studies increased from 138,189
to 550,903 per annum, a gain of 299%.
Total number of CT Perfusion studies
increased from 10,096 to 60,297 per
annum, a gain of 497% (Fig. 1C). Afer
adjustment for Medicare enrollment,

CLINICAL PUBLIC HEALTH | GLOBAL

FIGURE 1: A. CTA Head and CT Perfusion procedures performed per 100,000 feefor-service Medicare benefciaries, 2010-2019. B. Percentage of Reimbursement of
CTA Head and CT Perfusion by Medicare, 2010-2019. C. CTA head and CT perfusion
procedural volume, charges, and reimbursement 2010–19, in Medicare Fee-For-Service
Benefciaries.

these values represent an increase in
department also rose from 30.8% to
CTA utilization from 383.9 to 1,428.1
49.4% (p < 0.001) between 2010 and
(+272%) per 100,000 persons per year,
2019. Te largest single-year increase
and an increase in CTP utilization from
occurred between 2018 and 2019 (43.6%
28.0 to 156.3 (+457%) per
100,000 persons per year
Our analysis captured over 36 million
(Fig. 1A).
Over the study period,
Medicare benefciaries and revealed that
a statistically significant
increase in the proporon a per capita basis, use of both head
tional procedural volume
of both CTA Head and
CTA and cerebral CTP studies increased
CT perfusion were performed in the emergency
department (Fig. 2). The
several-fold over the last decade.
proportion of CTA Head
procedures performed in
to 49.4%, +5.8%, p < 0.001) with the
the emergency department rose from
second highest single-year increase
13.9% in 2010 to 43.4% in 2019 (p <
occurring between 2017 and 2018
0.001), with the largest single-year
(38.2% to 43.6%, +5.4%, p < 0.001).
increase occurring between 2015 and
Percent reimbursement of CTA
2016 (26.8% to 34.3%, +7.5%, p < 0.001)
of the head and CT perfusion were
and the second largest increase occurevaluated by comparing yearly charges
ring between 2018 and 2019 (39.9% to
43.3%, +3.5%, p < 0.001). Utilization
of CT Perfusion in the emergency
Continued on p. 126
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Continued from p. 125
A.

to Medicare compared to reimbursement for each procedure (Fig. 1B).
Predictably, there was a decrease in CT
perfusion payments, which declined
approximately 100% in reimbursement
rate between 2011 and 2013. Tere was
also a decrease in reimbursement for
CTA head from Medicare between
2010 and 2019, which fell from 21.7%
to 17.6% (-20%).
Our analysis captured over 36
million Medicare beneficiaries and
revealed that on a per capita basis, use
of both head CTA and cerebral CTP
studies increased several-fold over
the last decade. Likewise, during this
study period, we found a statistically
signifcant increase in the procedural
volume of both CTA Head and CT
perfusion performed in the emergency department. With the advent
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FIGURE 2: CTA Head and CT Perfusion by Procedure Location in Medicare Fee-forService Benefciaries, 2010–19.

of Medicare’s episode-based bundled
payments beginning in 2013, there was
near complete decline in CT perfusion
reimbursement with the greatest drop
occurring between 2011 and 2013 with
an approximately 20% drop in payment
for the bundled procedure of CTA head.
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Health care made the abrupt and
rapid transition to providing services
remotely via telehealth during the
SARS-CoV-2 pandemic.
Formerly a tool to increase access to
care in primarily rural areas, telehealth
was scaled up to become the dependedupon mode of health care delivery
despite a lack of evidence-based preparation and tested infrastructure. To
ensure the improved quality and efcacy of telehealth services in future,

it is incumbent upon policymakers,
researchers, and the public health
community to conduct data collection
and evaluation while the pandemic
continues.
Tis article acknowledges known
limitations of current telehealth technologies, questions the potential impact
of widespread implementation on
patient care, outlines current gaps
in evaluation, and points to further
avenues for study.
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